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Abstract 
Background: The Growmore Study was an observational cohort study of adolescents 
born preterm, in Newcastle-upon-Tyne. The cohort were born between 1993 and 
1998: mean gestation at birth was 31 weeks (range 24+5d to 36+2d) and birthweight 
1392g (690-2200g). Individuals were originally recruited into one of two randomised, 
controlled trials (‘growth’, n=113; and ‘protein’, n=134). As separate groups they were 
followed up at intervals, undergoing assessment of growth and development. From 
247 children originally recruited, 220 completed assessments to 24 months of age. At 
age 10 underwent cognitive assessment. Between 9 and 13 years old, the two cohorts 
were amalgamated to a single cohort and underwent further auxological and 
metabolic testing (n=153/247) including DEXA scan (n=109) and bloods (n=139). The 
current study revisited the cohort, aged between 12 and 18 years old.    
Aims: The study aimed to explore relationships between: growth in early life; body fat 
deposition; mitochondrial oxidative capacity; and quantitatively assessed diet and 
activity in ex-preterms.  
Methods: 60 of the 235 traceable members of the original cohort were recruited into 
this study. They underwent multimodal assessment, including: auxological measures; 
body composition measurement by air-displacement plethysmography and skinfold 
thickness; magnetic resonance spectroscopy (MRS), using a 3-Tesla scanner, custom-
built coils and a tailored scanning routine to quantify skeletal muscle mitochondrial 
oxidative capacity, lipid content of the liver, and fat-containing tissue at the L2/3 
vertebral level; a standard OGTT (bloods taken at 0 and 120minutes); and serum 
insulin, glucose, lipid profile, liver function and Vitamin D measurement. Dietary intake 
was assessed using a computer-based recall diary and physical activity by wearing of 
accelerometers. Data was analysed by using a variety of statistical methods including 
comparative, correlation and regression analysis. 
Results: The 60 adolescents recruited for this study had a mean gestation at birth of 31 
weeks (range 26+1d to 34+4d) with birthweight of 1370g (range 840-1870g). Their 
mean age at study was 15.5 years and M:F ratio was 1:1.4. Analysis showed they were 
not significantly different from their peers at the previous cohort assessment and both 
of the two original RCTs were almost equally represented (‘growth’: ‘protein’ = 1:1.07). 
The current study showed that amongst this cohort subgroup, vitamin D status 
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correlated with time of year (p=0.046) and current weight SDS (p= 0.039). Skeletal 
muscle oxidative function was significantly related to vitamin D status (p=0.021) and 
gestational age at birth (p=0.005); combined r2:0.31; p=0.002). Earlier gestational age 
(GA) at birth and lower serum vitamin D was associated with reduced oxidative 
capacity. Physical activity was not associated with oxidative capacity.  Visceral adipose 
tissue (VAT), circulating triglyceride (TG) and waist circumference were strongly 
associated with hepatic lipid content (all p<0.001); dietary intake was not. VAT and TG 
were highly significant when the model was adjusted for Tanner Stage (r2: 0.4; 
p=0.0002). GA and birthweight were not related to hepatic lipid deposition. Insulin 
sensitivity by two different measures was predicted by triglyceride levels (p<0.001), 
light activity (P<0.05) and vitamin D levels (p<0.05).  
Conclusion: Environment and early life both have an influence on adolescent 
physiology. The strength of association between vitamin D and muscle oxidative 
capacity has been observed in other conditions, but the contribution of gestation at 
birth in those born preterm is a novel finding. This may reflect either a variance in 
muscle fibre type or mitochondrial density directly related to developmental arrest or 
delay as a result of preterm birth. Vitamin D status also influences insulin sensitivity, as 
seen in other populations: Vitamin D status is an obvious target for dietary advice. 
Absence of an association between gestation and adiposity, and correlation between 
VAT and hepatic lipid deposition suggests that there are opportunities for children 
born preterm to improve their health in adolescence, and by implication, their future 
adult health. 
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Chapter 1. Introduction 
The notion that the adult phenotype is mainly determined by environmental influences 
encountered through life and the influence of inflexible, inherited genotype (in terms 
of health outcomes) is one that has been increasingly challenged by research evidence 
over the last 30 years.  
In the late 1980’s and 1990’s, Barker et al used epidemiological methods to examine 
the relationship between birth weight, size in infancy and cardiovascular risk in adults 
(Barker, 1995). They found that low birth weight and weight at one year, small head 
circumference and ponderal index at birth was associated with increased risk of 
cardiovascular disease as an adult (Barker et al., 1993). From this they concluded that 
intrauterine life and early childhood was important in laying down the foundations of 
adult health and predisposition to illness (now known as the ‘Fetal Origins’, or ‘Barker’, 
hypothesis). The mechanism was, however, unclear. 
Further work led to the proposal of the ‘thrifty phenotype’ (Hales and Barker, 1992) 
which suggested that in-utero, the fetus samples the nutritional environment and 
alters the rate of organ growth to optimise growth of key organs (brain and liver). 
When in nutritionally poor times, this leads to asymmetrical growth by the time of 
birth, but enhances post-natal survival when poor quality or intermittent nutrition 
continues. By contrast, if energy dense food subsequently becomes available, the 
‘thrifty’ mechanisms do not down-regulate and obesity and metabolic morbidity 
ensues. However, diet in the immediate post-natal period (after a normal pregnancy) 
can also have a profound effect on outcome (Desai et al., 1996). Similarly, over-
nutrition has been shown to have unwanted effects in later life in rodent models 
(Hahn, 1984). This suggests that the mechanisms are not simply the result of metabolic 
up-regulation secondary to a sub-optimal, in-utero environment, or ‘thrift’. 
This was taken further by Lucas (Lucas, 1994), who postulated that genetic make-up 
played an important role in the health outcomes by either: 
 “...induction, deletion or impaired development of a somatic structure during a critical 
period; or physiological ‘setting’ by an early stimulus or insult at a critical period, with 
long term consequences for function.” 
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This is now known universally as ‘programming’. Specifically, Lucas was referring to the 
role that nutrition in-utero and in early infancy might play in altering the adult 
phenotype. The notion that a ‘programming’ stimulus (nutrition, or otherwise) during 
any given critical phase of early development could have a predictable effect on 
somatic response to a stimulus or stress not yet encountered, led to an appreciation 
that modification of adult health outcomes might need to begin even before a disease 
process had started. The environments to which the gamete, fetus and infant are 
exposed are likely to exert significant influence on eventual adult health outcome by 
means of programming the way the body will react to future events (Gluckman and 
Hanson, 2004; Gluckman et al., 2005).  
Preterm delivery is a cataclysmic interruption of the ‘normal’ processes of human fetal 
development and modification of the environment in which the newborn finds itself. 
The interruption of normal gestation exposes the fetus to the physiological stress of 
trying to survive ex-utero with immature organ systems, as well as stimuli that it would 
not normally have been exposed to. In rats, the effect on offspring of even a slight 
difference in how well they were nursed as pups has been shown to greatly alter their 
behaviour in response to future stressors (Weaver et al., 2004). It could be expected 
that being ex-utero at a preterm gestation would have a profound developmental 
effect. In addition, nutrition is provided to preterm infants using a mixture of tailored 
parenteral and enteral preparations which would not be otherwise encountered by the 
fetus in-utero. Therefore the potential to encounter one of Lucas’ ‘nutritional stimuli’ 
at a ‘critical’ phase is greatly increased.  
As an example: aggressive parenteral nutrition in extreme prematurity is extremely 
important to prevent catabolism and maintain growth in the immediate neonatal 
period (Embleton et al., 2001; Ibrahim et al., 2004). There is evidence, however, that 
growth restricted infants experience liver injury with this approach more often than 
their well grown counterparts (Baserga and Sola, 2004). It is also thought-provoking to 
note that very similar preparations of lipid are used in aggressive parenteral nutrition 
to the infusions which can be used to experimentally induce reduced insulin sensitivity 
in adults (Roden et al., 1996). While the ‘critical period’ is not defined in this example, 
it is clear from evidence of damage and by virtue of the lipid infusion, that there is 
exposure to a stimulus which may lead to harm through programming. Body habitus 
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differences between infants born extremely preterm and their term born peers have 
been well known for 10 years (Uthaya et al., 2005) 
Nutrition is not the only possible stimulus to which fetuses and newborn infants may 
be exposed that might lead to altered adult health outcomes. Other events and 
interventions which might impact on the ex-utero preterm infant trying to survive are 
protein intake (both low and high), vitamin supplementation (especially vitamin A), 
glucocorticoid administration, exposure to inhaled nitric oxide and antibiotics 
interfering with normal bowel flora development (Kalhan and Wilson-Costello, 2013). 
All of these are regular occurrences in the Neonatal Intensive Care setting and could 
have profound impact on the future health of an individual if exposure did, or perhaps 
didn’t, occur during a critical window.  
It is important to note that this ever widening scope of potential interactions with 
delayed effect is reflected in the rapid ‘academic evolution’ of programming and the 
fetal origins hypothesis into the wider field of research under the label of 
Developmental Origins of Health and Disease (DOHaD) (Gluckman and Hanson, 2006). 
This field includes the science of epigenetic analysis (Groom et al., 2010; Relton and 
Davey Smith, 2010). Inheritable changes made to DNA and DNA-associated proteins 
which influence and change gene expression without altering gene sequence may 
result from environmental exposure and therefore provide a significant mechanism by 
which programming, and much of what is encompassed within DOHaD, might plausibly 
be explained at cellular level.  
1.1 Infant growth and health outcomes 
There are four important groups of infant studied in the literature with respect to 
growth and outcome: Term infants who have growth appropriate for gestational age 
(AGA), preterm infants who are also AGA, term infants who are small for gestational 
age (SGA) and preterm SGA infants. The aim of neonatologists to date has been to 
provide adequate nutrition for all groups to ensure good growth. This, however, 
requires different amounts of nutrition for different infants. Embleton et al 
demonstrated that with accepted levels of nutrition (at the time), preterm infants 
inevitably accumulated a deficiency in nutrition in the first few weeks of life on the 
neonatal unit (Embleton et al., 2001). This could be directly linked to postnatal growth 
4 
 
impairment and was unlikely to be recovered with ‘normal’ daily nutritional intake. In 
addition, there is good evidence that neurodevelopmental outcome is linked to early 
growth. Lucas et al found that in infants who have a higher early protein intake, 
neurodevelopmental deficits are reduced (Lucas et al., 1998). In infants born 
prematurely and SGA, growth such that they ‘catch up’ to a more appropriate size was 
also linked to improved neurodevelopmental outcomes (comparable to AGA infants) 
(Latal-Hajnal et al., 2003). The same study also demonstrated that AGA infants whose 
growth was poor (so that they had ‘catch down’ growth) had poorer 
neurodevelopment (comparable to SGA infants who had not demonstrated catch up 
growth). These outcomes are used to support the use of aggressive nutritional 
intervention in preterm infants, and would seem to justify trying to achieve and 
maintain ‘catch up growth’.  
To achieve an energy density suitable to promote catch-up growth in the growth-
restricted and/or preterm infant, the nutrition provided often has very high lipid and 
glucose concentrations (Thureen, 2007). It is also difficult to achieve high levels of 
protein intake, since appropriate assimilation of protein for growth relies on provision 
of large amounts of non-protein calories to prevent the newborn using the protein as 
an energy source. The necessary high concentrations of glucose and lipid to achieve 
this (above that which the fetus in utero would experience) might be expected to have 
an impact on metabolic outcome, particularly on insulin-regulated processes. The 
current evidence specifically relating to preterm birth in humans and altered insulin 
sensitivity (IS) is summarised later.  
Rat models suggest that in-utero hypoxia (as a method of inducing intra-uterine 
growth restriction and thus SGA offspring) is associated with changes in metabolism 
that lead to development of the metabolic syndrome when exposed to a high fat diet 
(Rueda-Clausen et al., 2011). Indeed, catch-up growth in humans (usually defined as an 
increase of >0.67 standard deviation score [SDS] in a defined time period) has been 
associated with cardiovascular death, hypertension, T2DM and obesity (Hales and 
Ozanne, 2003). Conversely, in other mammals, ‘beneficial under-nutrition’ has been 
associated with improved life expectancy (Thureen, 2007). It is also very difficult to 
tease out the long term effects of perinatal exposure to other stimuli: for example,  
corticosteroids might have an influence on longer term glucose homeostasis, given 
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their in-vivo effects once administered and have been shown to affect insulin 
sensitivity later in life (Dalziel et al., 2005). Recent work also shows that infants who 
are born at term and who are innately small (but would qualify as being SGA by 
population standards) are, in fact, metabolically healthy in later life(Milovanovic et al., 
2012). Aggressive nutrition in these infants might program for adverse health later in 
life. Infants in this category may also delivery prematurely, but it is not possible to 
accurately identify SGA preterms as innately SGA, or not, at delivery. 
One of the measurable outcomes in neonates used to reflect the outcome of 
nutritional programming is body composition; especially the location and quantity of 
fat stores. DEXA, air-displacement plethysmography and MRI have both been used to 
quantify and describe body composition and lipid deposition in term and preterm 
infants. Uthaya and colleagues used MRS and anthropometric measures to 
characterise in-vivo compartmentalisation of adipose tissue in infants born aged <32 
weeks gestation (at term corrected age) in comparison to full-term controls (Uthaya et 
al., 2005). They found that the ex-preterm infants were lighter and shorter but with 
preserved head circumference, and reduced subcutaneous fat mass. However, they 
had increased intra-abdominal fat mass relative to their healthy controls. Early 
accelerated post-natal weight gain was associated with increased fat mass overall 
(subcutaneous and intra-abdominal), but illness severity was the major determinant of 
increased (inappropriate) intra-abdominal fat. The authors therefore concluded that 
illness in the preterm period altered the partitioning of lipid compartments and 
therefore begins to explain the association of prematurity with metabolic disease later 
in life. The same group also showed that specific intra-hepatocellular lipid deposition 
in preterms (at term corrected age) was greater than in healthy adults or term-
matched controls (Thomas et al., 2008). Gianni et al measured percentage fat-mass by 
plethysmography in premature and term SGA infants (Gianni et al., 2009). They found 
that the more preterm the SGA infant was, the higher the percentage fat-mass it had 
by term. There is, therefore, evidence to support the abnormal deposition of fat in 
preterm and SGA infants, suggesting a potential pathway by which metabolic 
abnormalities might be developing or exerting influence. The immediate post-natal 
period was examined using DEXA by Cooke et al (Cooke et al., 2010) who found that in 
the first year, from term correct age onwards, there was no increased adiposity by 
6 
 
giving infants nutrient-enriched formula but catch-up growth was seen. This suggests 
that appropriate extra nutrition (not just calories) can have a beneficial effect by 
increasing lean mass and that changes which may occur in the pre-term period are 
modifiable.  
There is also evidence to suggest that as children get older, their contemporary body 
composition becomes more strongly associated with their health status and metabolic 
state, and that some associations which existed in the perinatal period become less 
pronounced (Jeffery et al., 2006; Parkinson et al., 2013; Tinnion et al., 2014). Evidence 
from the ALSPAC cohort suggests that in the modern era, childhood and adolescence 
may be more directly influential times for excessive increases in body weight (and fat 
mass) than infancy and the perinatal period (Hughes et al., 2011). Epidemiological 
evidence also supports the notion that postnatal, pre-pubertal rate of growth has a 
strong influence on health outcome, with those children underweight at birth who 
display greatest increase in body mass index by 11 years old being at greatest risk for 
hypertension and T2DM (Barker et al., 2002). Therefore, there is a possibility that 
modifiable factors may be at work and provide a therapeutic/preventative option in at-
risk individuals provided that the ‘critical windows’ can be identified.  
It seems most likely that the immediate perinatal period has a significant role to play in 
‘setting’ metabolism (as Lucas proposed) but as children grow older, the health 
outcomes at an individual level may well be dependent on multiple other contributory 
factors.  
1.2 Metabolic syndrome and reduced insulin sensitivity 
There has been a well-documented increase in obesity in the general adult population 
in westernised societies, especially over the last 20 years (Baskin et al., 2005). Along 
with this obesity ‘epidemic’, there has been the emergence and characterisation of the 
associated ‘metabolic syndrome’; a collection of clinical findings which, when present 
in an individual, are significant risk factors for developing cardiovascular disease and 
type 2 diabetes mellitus (T2DM), thus risking premature death. The diagnostic criteria 
required to make a diagnosis of metabolic syndrome (Alberti et al., 2009) are: 
 Increased waist circumference (specific cut-offs for differing ethnic groups) 
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 Hypertension: systolic blood pressure ≥ 135mmHg and /or diastolic blood 
pressure ≥85mmHg 
 Elevated triglycerides (TG): ≥ 1.7mmol/L  
 Reduced high-density lipoprotein cholesterol (HDL-C): ≤ 1.0mmol/L [male] or ≤ 
1.3mmol/L [female] 
 Elevated fasting glucose: ≥ 100mg/dL 
These criteria cannot, however, predict the rate of development of subsequent illness. 
The proposed contributory factors to the obesity ‘epidemic’ are many (McAllister et 
al., 2009). Various ‘environmental’ factors (such as infection and inflammation, calorie-
dense, easily-available food, reduced exercise levels and sedentary lifestyle), ‘genetic’ 
factors (promoting the ‘thrifty phenotype’ (Hales and Barker, 1992)) combine to 
promote (in individuals) unhealthy deposition of fat. There is also compelling evidence 
that nutritional programming in early life has an important effect in determining adult 
health outcome (Lucas, 1994).  
In the paediatric population, there is even less consensus(Ford and Li, 2008) about how 
to define and diagnose the ‘metabolic syndrome’. It is clear that, while there is 
potentially greater morbidity and earlier mortality associated with acquisition of 
features consistent with the ‘metabolic syndrome’, three major problems exist. Firstly 
there is a tension between accurate diagnosis (with predictive power) and burden of 
investigation. The more detailed and multi-partite a definition is, the more tests need 
to be done. Correspondingly, the more room there is for error (for example in where to 
measure waist circumference or how to adjust for variation between ethnic groups).  
Secondly, children have periods of their lives where they are rapidly changing from 
both a hormonal and metabolic perspective. During these times, assumption of static, 
reliable, measurable parameters may be incorrect. At these times of growth and 
change, children also  change at different rates within peer groups (especially during 
puberty) and even in a small population sitting within apparently tightly, age-limited 
definitions there will be child-to-child variations which could influence the 
effectiveness of the criteria to detect changes. Lastly, there are less data available as 
you look at younger children and it is harder to elucidate with certainty a causal 
association into middle and late adulthood (in terms of health outcomes).    
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The International Diabetes Foundation definitions(Zimmet et al., 2007) try to strike a 
pragmatic approach to clear criteria for diagnosing metabolic syndrome in different 
ages of child (without relying on many reference value tables for different groups). This 
approach is clinically pragmatic, and therefore helpful in practice(Mancini, 2009; 
Poyrazoglu et al., 2014), but has potential for under-detection through reduced 
specificity (fewer criteria) and sensitivity (fixed cut-offs).  
While the underlying causal relationships between physiology and disease are still 
being elucidated in both animal and human models (Bremer et al., 2012), it is clear 
that reduced sensitivity to insulin (either global or tissue-specific) is a significant 
common feature of the current, collective understanding of the metabolic syndrome. 
To understand the extent to which an infant born preterm might be at risk of adverse 
metabolic outcome, it is reasonable to consider, therefore, the evidence of association 
of decreased insulin sensitivity must be examined alongside the evidence for outcomes 
in preterm infants as they grow up.  
1.3 Programmed Insulin Sensitivity and Prematurity 
The studies to date which specifically address insulin sensitivity and prematurity are 
mostly observational cohort studies. I have published a literature review of these 
studies previously (Tinnion et al., 2014). The studies reviewed were published between 
2000 and 2013 and had participants whose ages ranged from a few days after preterm 
birth to middle adulthood. The studies were worldwide (New Zealand, Australia, UK, 
Turkey, Cyprus, Brazil, Chile, Netherlands, Italy, South Africa, Germany, Finland and 
Sweden), representing mostly ‘first world’ medical practice and described a total of 20 
unique cohorts.  
There were a number of different methods used to quantify or assess insulin 
sensitivity. Thirteen studies used a variation of a glucose tolerance test (GTT; 
intravenous short- or frequently-sampled-GTT(Leipala et al., 2002; Bazaes et al., 2004; 
Hofman et al., 2004; Regan et al., 2006; Willemsen et al., 2009; de Kort et al., 2010; 
Kerkhof et al., 2012) or oral glucose load (Fewtrell et al., 2000; Dalziel et al., 2007; Hovi 
et al., 2007; Pandolfi et al., 2008; Chan et al., 2010) or milk bolus(Gray et al., 2002)) 
combined with insulin sampling and modelling (such as Bergman’s Minimal Model or 
Homeostasis Model Assessment [HOMA]) to give a measure of IS. Three studies 
9 
 
(Rotteveel et al., 2008a; Rotteveel et al., 2008b; Rotteveel et al., 2011) conducted 
hyperinsulinaemic-euglycaemic clamp studies to calculate glucose disposal, as a 
measure of sensitivity to insulin. The remaining studies used measures of glucose 
metabolism such as fasting insulin and glucose, 32-33 split pro-insulin and Insulin-like 
Growth Factor Binding Protein (IGFBP), combined with a modelled estimation of IS 
such as HOMA to quantify sensitivity to insulin. The study methodology reflected, in 
part, the age of the participants. Chronological age is a factor in normal variance of 
insulin sensitivity, for example during puberty (Kurtoglu et al., 2010) and some of the 
cohorts were longitudinally followed-up through childhood. As the cohort in this study 
are adolescents, this is the age group that I will concentrate on here, though the full 
life-course can be seen in the systematic review. The logic model showing changing 
associations with insulin sensitivity over the life-course, based on the findings of the 
systematic review is shown in figure 1. 
1.4 Effect of preterm birth on Insulin Sensitivity (IS)  
1.4.1 Insulin Sensitivity in adolescence (10 to 18 years) 
Three preterm cohort studies investigated IS in adolescence. Fewtrell and 
Singhal(Fewtrell et al., 2000; Singhal et al., 2003) followed-up a cohort originally 
enrolled into a nutritional intervention (<1850g, Median GA 31 weeks) (Lucas et al., 
1984). At 9-12years of age(Fewtrell et al., 2000) fasting bloods (insulin, glucose and 
pro-insulin levels n=279) were  strongly related to current weight SDS, 30-minute 
insulin levels and split pro-insulin: 1 SD increase in current weight SDS increased 30-
minute insulin by 25.6% and split pro-insulin by 31.7%. Regression modelling showed 
that change in weight SDS from 18months to current age was related positively to 
insulin, proinsulin and split pro-insulin. Individuals with the greatest increase in weight 
SDS from 18months to follow-up had the lowest IS. Birthweight had a strong negative 
correlation with 30-minute glucose levels. 
By 13-16 years of age (Singhal et al., 2003) a decrease in IS for current weight SDS was 
seen (13.4% change in 32-33 split pro-insulin per BMI SDS score). Those adolescents 
randomised to higher nutrient intakes as neonates had greater split pro-insulin levels 
even after adjustment for potential confounders (coefficient 18.4%; p= 0.016). A step-
wise increase in adjusted 32-33 split pro-insulin was found to mirror quartiles of 
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weight gain in the first two post-natal weeks (11.9% increase per 100g weight 
increase).  
Chan et al(Chan et al., 2010) investigated 11-15 year old children  born preterm or 
term and measured fasting and 2 hour glucose and insulin (standard 75g OGTT). They 
showed lower glucose levels at 2 hours post-load in those born preterm (0.25mmol/L 
lower than term controls; p=0.03). 
Reinehr et al (Reinehr et al., 2010) studied SGA children 5-13 years age who were 
obese (BMI >97th percentile) at the time of study. The cohort consisted of 341 children 
of whom 24 were preterm. The authors assessed the effects of a multifactorial lifestyle 
intervention (aimed at promoting weight loss) on IS and other metabolic parameters. 
The authors found that reduced obesity was associated with improved IS (12mU/L 
drop in serum fasting insulin per BMI-SDS reduction). Birth weight had a small 
association with IS (4mU/L increase per additional kg of birthweight: p=0.001; 0.7 
increase in HOMA index per additional kg birth weight: p=0.007). Weight loss only 
accounted for 10% of the variance in IS.  
1.5 Comparison of IS between those born preterm and appropriate for 
gestational age vs. preterm and small for gestational age 
1.5.1 Insulin Sensitivity in Adolescence (10 to 18years old) 
Reinehr et al.(Reinehr et al., 2010) demonstrated improved IS with programmed 
weight loss. Whilst SGA status predicted changes in HOMA status with weight loss 
(accounting for 14% of variance) both term and preterm infants were in the AGA/SGA 
groups. Chan et al(Chan et al., 2010) found no difference between SGA/AGA groups in 
IS, however, preterm SGA children had higher insulin levels  2 hours after OGTT.  
1.6 Summary of evidence 
As described by the logic model, the impact of prematurity, and being born AGA vs. 
SGA preterm on subsequent insulin sensitivity is complex. The evidence suggests that 
for infants born prematurely, there is an association with an increased risk of reduced 
insulin sensitivity in childhood. By adulthood, the significance of preterm birth is 
surpassed by strong associations with body habitus and composition  (Parkinson et al., 
2013) in line with findings of studies of insulin sensitivity in the general adult 
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population. The emergence of body composition as a key associate of sensitivity to 
insulin appears to coincide with puberty and adolescence. The evidence does not, as 
yet, provide any insight as to any mechanistic role of puberty in this transformation, 
though it is accepted that insulin sensitivity decreases during puberty in humans 
(Kurtoglu et al., 2010; Sinaiko and Caprio, 2012). Unravelling the effects of puberty 
from the effects of prematurity in adolescents with respect to changing insulin 
sensitivity is something that is not addressed in any of the literature. 
It is also not clear from the evidence whether reduced insulin sensitivity in childhood is 
causal in altering body composition or vice versa. The association of growth patterns 
and insulin sensitivity during childhood is similarly unresolved: as children move 
through childhood, the influences of disordered (excessive) catch up growth can be 
seen to adversely affect insulin sensitivity and there are suggestions of different critical 
periods of growth (in line with current programming theories) during which nutrition 
may have its greatest effect. 
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Figure 1: logic model representing influences on insulin sensitivity on individuals born 
preterm during the life-course (from Tinnion et al, 2014). 
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While early maintenance of normal protein and energy intake (preventing catabolism) 
is clearly important, subsequent enteral over-nutrition may well be less desirable than 
focussed supplementation and aiming for appropriate (only) catch up growth. Singhal 
et al (Singhal et al., 2003)showed that a lower-nutrient diet during the neonatal period 
was associated with improved insulin sensitivity in childhood and Pittaluga et al 
(Pittaluga et al., 2011) demonstrated that specific nutritional changes in the post-natal 
period had a measurable effect in infancy. Both studies support the potential for 
nutrition to program later metabolism and suggest that early appropriate nutrition and 
specific supplementation without overnutrition may be key in ensuring good long term 
metabolic outcome.  Importantly, excessive lean growth (e.g. height beyond genetic 
potential) may be as harmful as excessive fat mass increase. However, there is still 
disagreement about how best to measure catch-up growth and use of BMI alone is 
misleading as a substitute for other measures such as truncal fat deposition or lean 
tissue mass (Wells et al., 2010) which might have more metabolic significance.  
The evidence appears to show that SGA and AGA preterms are born with similar levels 
of insulin sensitivity and that the immediate post-natal nutritional environment has 
potential to alter later normal growth, and thus alter measured insulin sensitivity. 
Through adolescence and adulthood, there is little evidence to support any difference 
between ex-AGA/SGA preterms and the strength of association with early growth 
pattern appears to wane. In three studies (Gray et al., 2002; Leipala et al., 2002; 
Pittaluga et al., 2011) the measured glucose levels between AGA and SGA groups did 
not differ suggesting, perhaps, that the insulin sensitivity of a neonate/infant (using 
glucose levels as a proxy measure) is linked more strongly to GA at delivery (reflecting 
the in-utero environment) than with glucose metabolism. The potential interruption to 
ongoing production of growth factors such as Insulin-Like Growth Factor (IGF) 1 
occurring because of preterm delivery(Yumani et al., 2015) may also affect circulating 
glucose levels and thus postnatal interpretation of insulin sensitivity in these babies.  
Modern neonatal medicine, and the ability to support babies born at very early 
gestations to term equivalent age and beyond, is young enough that it is unlikely that 
there is any evolutionary survival advantage to having a reduced baseline insulin 
sensitivity as a neonate, when born preterm. It is possible, however, that surviving this 
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early state becomes a disadvantage after puberty leaving, unmasked, metabolic 
problems with the residual levels of reduced insulin sensitivity.  
It is important to mention, specifically for children born preterm, there is still no clear 
answer to the nutrition conundrum facing clinicians: should early care be focussed on 
catch-up growth to promote neurodevelopment at the risk of long term metabolic 
morbidity, or should more focussed protein nutrition be implemented and maintained 
without focus on optimised overall growth? (Harding et al., 2013) 
1.7 Potential Aetiologies of Reduction in Insulin Sensitivity 
Reduced sensitivity to insulin  is closely associated with a metabolically inflexible, 
obese phenotype in the general adult population (Kelley, 2005). However, it has also 
been possible to study insulin sensitivity in the offspring of those who have developed 
T2DM and who are not obese and do not have T2DM themselves. Reduced insulin 
sensitivity can be induced in healthy, insulin sensitive individuals(Roden et al., 1996) by 
administering a lipid infusion intravenously. This mechanism is particularly pertinent in 
view of the association of reduced insulin sensitivity with a high-fat, western diet and 
the metabolic syndrome and also because one of the commonest interventions in the 
nutritional management of preterm infants is administration of parenteral lipids while 
enteral milk feeds are being introduced slowly. 
The lipid-induction theory offers an explanation for the development of insensitivity to 
insulin (Samuel et al., 2010). It may also provide a mechanism by which to explain the 
association of prematurity and young children with reduced insulin sensitivity via 
hepatic lipid(Sandboge et al., 2013), as well as lifestyle and body-habitus-associated 
reduction in  insulin sensitivity in teenagers and adults. The lipid induction theory is 
particularly relevant to the Growmore study because of the possibility, ultimately, that 
lipid-induced insulin insensitivity may be modifiable from very early on in the life of 
infants born preterm. This in turn could preventing significant disease burden in later 
life. For discussion, lipid-induced insulin insensitivity has been divided into hepatic and 
peripheral.  
1.7.1 Hepatic Lipid Induction of reduced Insulin Sensitivity  
Non-alcoholic fatty liver disease (NAFLD; sometimes referred to as non-alcoholic 
steato-hepatitis) is a well-established clinical entity (Angulo, 2002). It is closely 
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correlated with reduced insulin sensitivity and obesity (Petersen et al., 2005a), and is 
seen in adults and children (McCullough, 2004). Recent research has also suggested 
that nutritional programming may have a role to play in the eventual phenotypic 
expression of NAFLD: being born SGA or having excessive catch up growth and 
becoming obese in adulthood after SGA status at birth has been shown to increase risk 
of adult hepatic steatosis (Sandboge et al., 2013). 
The action of insulin, at the cellular level in the liver, is mediated by tyrosine 
phosphorylation of insulin receptor substrates 1 and 2 at the cell membrane. These 
then interact with 1-phospatidyl-inositol 3-kinase (PI3K). This has two main effects: 
inhibition of gluconeogenesis and promotion of glycogen synthesis (by inhibition of 
Glycogen Synthase Kinase; GSK) (Previs et al., 2000). Thus, in a post-prandial, high-
insulin state, glucose is taken up into the liver and converted to glycogen whilst serum 
glucose levels would remain normal.   
In lean adult subjects with reduced insulin sensitivity who had comparable visceral fat-
mass to lean, insulin-sensitive controls, a glucose load was been shown to cause an 
elevation in serum insulin levels but a blunting of muscle glycogen synthesis as 
measured by 13C-MRS. Alongside this, there was a concurrent increase in hepatic 
triglyceride content and increased fasting plasma triglyceride levels (Petersen et al., 
2007). Accumulation of hepatic lipid has been shown to be associated with activation 
of PKCε in rodent models (Savage et al., 2006). This novel PKC directly inhibits the 
signalling pathway (described above) in the insulin-sensitive liver, thus inhibiting the 
normal changes in the cell metabolic processes usually stimulated by insulin. This 
therefore reduced metabolic sensitivity to insulin. It has also been shown that in 
individuals with reduced hepatic insulin sensitivity that in parallel to a deceased ability 
to inhibit gluconeogenesis in the face of elevated serum glucose and insulin levels 
there is a parallel and paradoxical enhancement of hepatic lipid deposition stimulated 
by insulin (via the sterol regulatory binding protein (SREBP)-1c. This increases 
intrahepatic triglyceride deposition as well as formation of very low density 
lipoproteins (VLDL) for export around the body (associated with increased cardio-
metabolic risk). The increase in these lipids directly stimulates activation of PKCε, thus 
reinforcing the reduction in sensitivity to insulin and propagating metabolic inflexibility 
(Kelley, 2005; Brown and Goldstein, 2008) 
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Hepatic triglyceride levels have also been shown to be higher in lean Asian-Indian men 
who, though lean, are genetically at a higher risk of being insulin-insensitive compared 
to weight-matched white male controls (Petersen et al., 2006). When transgenic mice 
which have an over-expression of ApoC3 are given an high-fat diet there is increase in 
hepatic DAG and insulin compared to wild-type mice (Samuel et al., 2010). 
Polymorphisms in the ApoC3 gene have been described, in man, in individuals at 
higher risk of NAFLD and reduced insulin sensitivity (Petersen et al., 2010). In the 
ApoC3 transgenic mice, there also appears to be hepatic activation of PKCε. When 
PKCε is blocked using antisense compounds, hepatic insulin sensitivity is preserved 
(Savage et al., 2006).  
It is likely, therefore, that during the development of reduced global insulin sensitivity, 
hepatic insulin insensitivity may occur in tandem, or precede, peripheral insensitivity 
(see below) due to high levels of circulating lipid overwhelming the hepatocyte and 
adipocyte capacity for processing, leading to secondary ectopic deposition of 
lipids(Weiss et al., 2013). Importantly, NAFLD (in adults with T2DM) has been shown to 
be reversible with exercise (Petersen et al., 2005a; Trenell et al., 2008) and therefore 
may be modifiable by diet and exercise at a younger age before clinically significant 
reduced insulin sensitivity is reached. 
1.7.2 Adipose tissue and reduced insulin sensitivity 
Adipose tissue is not an inert ‘store’ in the metabolic milieu of the body as perhaps 
once thought. In addition, not all fat is ‘equal’: differential distribution and deposition 
of fat in adipose tissue had different effects on the baseline homeostasis. Visceral fat is 
less sensitive to the effects of insulin but is more sensitive to catecholamines 
(Wajchenberg, 2000). If lipolysis occurs in visceral fat, the released free fatty acids will 
(physiologically) drain via the hepatic portal system(Bjorntorp, 1990) which might 
contribute to hepatic steatosis via overload, as a mechanism by which visceral fat 
directly leads to reduced hepatic insulin sensitivity. Subcutaneous fat increase is 
associated with reduced insulin sensitivity in obese individuals but a causative link has 
not yet been demonstrated. Work by Taksali and colleagues suggests further that it 
may be the ratio of visceral to subcutaneous adipose tissue that is important in the 
overall final effect, independent of total volume of either in any given individual 
(Taksali et al., 2008).  
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1.7.3  ‘Peripheral’ reduction in Insulin Sensitivity 
The term ‘peripheral’ is used to describe the changes in sensitivity to the action of 
insulin that occurs, in some conditions, in skeletal muscle. The literature regarding this 
is focussed mainly around Type 2 Diabetes Mellitus (T2DM) as this chronic condition 
provides a population of individuals who have varying degrees of reduced sensitivity to 
insulin, phenotypes and who are well enough to participate in research. There is 
obvious overlap between this group (where genetic inheritance will have a key role) 
and those who become insulin resistant because of other causes, but caution must be 
exercised before any assumption that the processes ongoing are the same, despite the 
similarity of outcome.  
Lipid deposition in muscle and potential effects 
In obese patients with T2DM, there is a clearly documented association between 
reduced insulin sensitivity and ‘inappropriate’ or ‘ectopic’, intracellular lipid deposition 
within skeletal muscle (Samuel et al., 2010). Adult children of parents with T2DM (who 
have measureable reduction in insulin sensitivity without clinical T2DM and who are 
not clinically obese) have also been shown to have significantly higher levels of 
intramyocellular lipid (IMCL) than closely-matched, insulin-sensitive, control subjects 
(Petersen et al., 2004). Muscle biopsies from non-diabetic, male, Pima  Indians (who 
are more likely than the general population to go on to develop diabetes) have also 
shown increased levels of IMCL (Pan et al., 1997).  Petersen et al also showed that with 
normal ageing, IMCL content increased and in tandem with reducing peripheral insulin 
sensitivity with no specific increase in the triglyceride content of the liver (Petersen et 
al., 2003).  
The lipid induction theory describes a possible association between decreased insulin 
sensitivity, impaired cellular glucose uptake and increased IMCL, by impairment of cell 
uptake of glucose (similar to the process in the liver). IMCL may impair mobilisation of  
inducible glucose transporters (Shepherd and Kahn, 1999)) which usually provide an 
additional route into the cell for glucose when serum insulin is in high concentration. 
Translocation of these proteins to the cell wall is impaired in in-vitro cell cultures from 
individuals with T2DM (Ciaraldi et al., 1995; Garvey et al., 1998) thus suggesting a 
mechanism for reduced response to the action of insulin. This process is also reduced 
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in individuals receiving lipid infusions who demonstrate marked reduction in insulin 
sensitivity (Dresner et al., 1999) suggesting it does not get activated in lipid-induced 
reduced insulin sensitivity.  
Lipid in muscle and oxidative function: cause or effect? 
In unhealthy, obese individuals, the accumulation of intramyocellular lipid by virtue of 
persistent delivery of excessive dietary free fatty acids to the myocyte is one 
explanation of the source of lipids associated with reduced insulin sensitivity. The 
other possibility, as outlined above) is that as other sources of lipid production 
overwhelm storage capacity in the liver and adipose tissue, excess VLDL is deposited as 
‘ectopic’ deposits in muscle. This occurrence may lead to precipitation of increased 
morbidity in individuals, or may reflect a metabolic tipping point beyond which 
increased morbidity follows quickly, but not actually be a primary cause in the 
development of metabolic syndrome(Weiss et al., 2013). 
Skeletal muscle metabolism in healthy individuals displays a robust preference for fat 
oxidation, but can flexibly switch to glucose metabolism under the control of insulin 
(whilst fat oxidation is correspondingly inhibited). The degree to which this oxidative 
flexibility exists in vivo has been studied using MRS. In individuals with reduced insulin 
sensitivity, it has been demonstrated (using 31-P MRS) that the rates of ATP synthesis 
and rates of flux of the citric acid cycle (using 13C-MRS) are decreased by ≈30% (under 
hyperinsulinaemic/euglycaemic clamp conditions when compared to healthy 
controls)(Petersen et al., 2004; Petersen et al., 2005b; Befroy et al., 2007). It has also 
been demonstrated that there is a reduction in the intramyocellular transport of 
phosphate in these individuals (Petersen et al., 2005b).  
The observations described above have been made in individuals who are already 
overweight and/or insulin insensitive, or in healthy subjects under experimental 
‘supra-physiological’ (hyperinsulinaemic or hyperlipidaemic) conditions. In addition to 
this, the selection of subjects for examination took the extreme (Petersen et al., 2004) 
phenotypes (most and least insulin sensitive) in their study groups and so the 
differences in effects at mitochondrial level would potentially be exaggerated in both 
directions from a ‘normal’ phenotype.  
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There is strong evidence from MRS that exercise can improve lipid oxidation in T2DM 
without changes in mitochondrial function (Trenell et al., 2008) and that the time 
course of turnover of ATP in skeletal muscle under hyperinsulinaemic conditions does 
not support it as a rate limiting step in initiation of insulin-stimulated glycogen 
synthesis (Lim et al., 2010). Indeed, in insulin-sensitive subjects, an increase in ATP was 
not seen during the first 45 minutes of a euglycaemic/ hyperinsulinaemic clamp, 
suggesting the acute metabolic effects of insulin are not directly related to oxidative 
capacity (Lim et al., 2011c). 
There is compelling evidence that raised IMCL in the setting of T2DM has an effect on 
insulin sensitivity within the cell (by reduction of glucose transport into the cell) and 
that reduced insulin sensitivity is associated with the presence of raised IMCL in the 
metabolically inflexible phenotype. Measured reduced oxidative capacity does not, 
however, suggest a true primary underlying defect in mitochondrial function leading to 
increased IMCL: reduced insulin sensitivity and impaired oxidative capacity have not 
been described in the absence of raised IMCL. It is as plausible that the reported 
reduction of oxidative capacity simply reflects a primary reduction in mitochondrial 
number.  
Therefore it seems likely that the primary focus for lipid induction of reduced insulin 
sensitivity in this study should be in the liver and visceral adipose tissue: the evidence 
is not conclusive enough at present to look at skeletal muscle as a primary focus. It 
seems likely that skeletal muscle changes are ‘downstream’ of insulin insensitivity in 
the liver and visceral adipose tissue (Bremer et al., 2012) and in a population of 
children, searching for early changes in lipid should be focussed where it is likely to be 
found. However, concurrent assessment of oxidative capacity of the muscles with 31P-
MRS to ensure that this is as expected in the study group is sensible in view of the 
reported changes that can occur, as a proxy for early muscle metabolic alteration.  
Other influences on skeletal muscle insulin sensitivity 
Though the lipid theory of induction of reduced insulin sensitivity is prominently cited 
in the literature reviewed for this thesis, there are other mechanisms which have been 
proposed for influencing ‘peripheral’ insulin sensitivity. As skeletal muscle is one of the 
largest metabolic organs in the body when considered as a single entity, any process 
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that alters the skeletal muscle insulin sensitivity has potential to alter the metabolic 
flexibility of the muscle to change from fat oxidation in muscle to glucose oxidation 
when under insulin stimulated conditions and thus have huge effect on the 
body(Kelley, 2005). In addition, the presence of high levels of lipid in myocytes has to 
be put into context: elite athletes can have high levels of myocellular lipid as a store of 
energy to use during exercise but are usually very sensitive to the actions of insulin: 
the threshold for when they convert from fat oxidation is altered and, most likely, 
there is compartmentalisation of lipids in a different way to metabolically inflexible 
individuals(Goodpaster et al., 2001). This is also seen in some knockout mouse 
models(Liu et al., 2007).  
As outlined above, a primary mitochondrial defect does not seem to be the underlying 
problem in T2DM (as an insulin resistant state) as apparent basal reduction in 
mitochondrial function can be overcome with imposed hyperglycaemic conditions. 
Alongside the proposed mechanism by which intramyocellular lipid reduces insulin 
sensitivity, other processes interrupting expression of glucose transporters (GLUT) on 
the cell surface in response to insulin signalling, or ones which decondition and reduce 
the volume of skeletal muscle, have potential to alter skeletal muscle insulin 
sensitivity.  
Myostatin is a negative regulator of skeletal muscle growth. It has been noted in 
individuals with T2DM that they often have a raised level of myostatin(Brandt et al., 
2012). In animal models, inhibition or absence of myostatin has been associated with 
increased expression of glucose transporters, specifically GLUT-4(Takahashi et al., 
2014). Myostatin, therefore, may have an important role to play in insulin resistant 
state. 
Adipokines (including adiponectin and leptin) are a group of hormones which are 
intimately involved in appetite, metabolism and glucose homeostasis, and exert effects 
on skeletal muscle. Leptin, in animal models where diabetic states have been induced 
by streptozotocin, has been shown to restore some glucose uptake and enhance the 
lipid oxidation in skeletal muscle(Hidaka et al., 2002). Adiponectin is another adipokine 
which is present in lower amounts in the serum in those with T2DM(Arita et al., 1999) 
and which is known to be insulin-sensitising(increasing glucose uptake into skeletal 
muscle and increasing lipid oxidation). In animal models of T2DM, it has been shown 
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that the induction of adiponectin production improves insulin sensitivity(Liu et al., 
2009b). While the adiponectin and leptin levels measured in the study cohort when 
they were reviewed between age 9 and 13 did not show any correlation with either 
body composition or insulin sensitivity (Korada, M; personal communication) the 
potential for adipokines modifying insulin sensitivity over a longer time, in a population 
of ex-preterm infants, is huge through programming or other mechanisms. 
Inflammation and the associated generation of reactive oxygen species has also been 
linked with reduced insulin sensitivity through transcriptional and post-translational 
modification which ultimately inhibit insulin action, specifically in the pathogenesis and 
maintenance of T2DM, as well as in the metabolic syndrome(Hotamisligil, 2005; 
Shoelson et al., 2006). Preterm infants are exposed to metabolic stress, inflammation 
and infection as part of intensive care. They are also often given gaseous oxygen as 
part of respiratory care which can lead to serum hyperoxia, in turn leading reactive 
oxygen species damage. The extent to which this neonatal exposure may lead to 
longer terms effects in skeletal muscle is not known, but this mode of damage and 
influence on insulin sensitivity cannot be discounted as at least part of the overall 
picture. 
1.8 Body composition assessment 
Assessment of body composition in clinical practice and research can be done using 
numerous methods but may be limited by both access to technology and the 
cooperation of the patient/subject. In the literature looking at fat deposition, lipid 
partition and sensitivity to insulin, several different strategies are used by authors to 
obtain the information needed.  
1.8.1 Body fat assessment 
Indirect measures 
Measurement of skinfold thickness is a quickly and easily performed procedure which, 
when the investigator is trained (and their technique appraised regularly) can produce 
consistent measurements of the depth of subcutaneous fat deposits. Use of an 
averaging technique to ensure smoothing of the data from each site, followed by a 
summation of the totals, generates a number which can then be entered into standard 
equations to produce a percentage of total body fat (Durnin and Rahaman, 1967; 
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Durnin and Womersley, 1974; Slaughter et al., 1988). This technique is superior to 
simple calculation of body mass index (BMI) in measurement of ‘fatness’ as it involves 
direct measurement of the subcutaneous fat compartment. However, it is subject to 
some of the same assumptions about consistency of distribution of fat between 
compartments across individuals (i.e. it does not necessarily take account of body 
‘shape’), and it does not allow assessment of individual fat compartments (visceral vs. 
subcutaneous). As, the confidence intervals around any single measurement will be 
wide (between 3 and 11% of the estimate(Wang et al., 2000)). It is also subject to 
limitations around the normative data which produced the original conversion 
equations, much of which was generated in North America and is therefore not 
necessarily reliably generalizable to a UK population. It is also quite old data with 
normative z-scores last generated in 1993; (Davies et al., 1993). In recent years the 
changes in childhood body composition in the population mean that, again, 
generalisability is not guaranteed. Some work using skinfold thickness in addition to 
BMI showed that it improved accuracy of estimation of body fat, but only in non-obese 
children(Freedman et al., 2007). It remains an important method to consider, 
however, as it can be readily applied in a clinical setting. 
Air displacement plethysmography (using the BODPOD™) is used to provide a variety 
of data about body composition and metabolic rate. The cost of the BODPOD™ means 
that it remains, for the most part, a research tool. Air-displacement plethysmography 
utilises comparison of measurement of air displacement against a standard volume in 
conjunction with mass measurement to generate a body density. The technique uses 
the mean of two readings within 150ml measured volume or takes a third if the two 
originals are more discrepant than that. In order to measure total body volume, the 
BODPOD can calculate an estimated lung volume based on height and weight 
parameters or the test subject can perform a series of manoeuvres via a closed 
breathing circuit which allow a direct measurement. The literature suggests that with 
the latter, the BODPOD is accurate to within 2% of other gold-standard measures for 
generating a body volume (such as hydrodensitometry) but it has the obvious 
advantages of being a dry method, quick, and less complex for younger subjects(Ball, 
2005). BODPOD has been validated for use in children (Fields et al., 2002; Fields et al., 
2004b) Once a body density is calculated, the BODPOD uses a 2 compartment model 
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based on either the equations of Siri or Lohman (Siri, 1961; Lohman, 1989). It is, 
therefore, subject to some of the same imposed methodological limitations as outlined 
for skinfold measurements.  
The two other commonly used methods for estimating fat mass in humans are 
bioelectrical impedance analysis (BIA) and Dual-Energy X-ray Absorptiometry (DEXA). 
DEXA is, like air-displacement and skinfold measurement, an indirect technique with 
the added disadvantage of involving exposure to X-rays. In teenagers, this is an 
exposure to radiation at a time when the human body is rapidly growing and therefore 
as a technique it is hard to justify when non-radiation alternatives are available. BIA is 
also subject to predictive equations but has an even wider margin of error than 
skinfold measurement (+/-6 to 8kg in one individual adult) in estimating total fat 
mass(Piers et al., 2000). For these reasons, we did not choose to use either of these 
methods in assessing body fat in our study.  
Direct Measurement of body fat: MRI assessment of compartmental body fat  
As described above, the literature suggests that potential mechanisms of reduced 
insulin sensitivity are correlated to the compartmentalisation of lipids and, specifically, 
the presence of intrahepatic lipid. The only tool we consider to be currently 
appropriate for use in a cohort of healthy adolescents, both ethically and practically, to 
assess intra-hepatic lipid (also called Intrahepatocellular lipid; IHL or IHCL) is magnetic 
resonance imaging. This is because it is non-invasive, involves not exposure to 
radiation and still gives quantifiable measurements of adipose tissue in both visceral 
and non-visceral compartments.  
Magnetic resonance imaging scanners detect the signal released by magnetic nuclei in 
chemical compounds after application and removal of a magnetic field to a specific 
area of tissue. The signal generated depends on the type of magnetic nuclei (e.g. 1H, 
31P, 23Na), and the compounds in which they sit. This determines the deflection that 
occurs when the magnetic field is applied and thus the energy release when the field is 
removed and the nucleus returns to its original position. When used for ‘plain’ imaging 
the average signal returned from any given area is Fourier transformed to give a grey-
scale image for clinical interpretation. This does not differentiate between individual 
compounds in the tissue. It is possible, however, to use a subtractive technique to 
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leave the residual image showing only compounds of interest. In identifying fat 
compartments, the main other molecule contributing to the picture generated will be 
water. As there is not much water in adipose tissue, it is possible to take a sequence of 
images generated using application of a magnetic field at a frequency which will target 
water molecules, applied at 0° and 180° to the subject in sequential applications. At 
release of the magnetic field, the different applications produce equal but opposite 
signals from any tissue containing large amounts of water. When the images generated 
are subsequently combined, the water signal effectively cancels itself out so anything 
left has a low water content (i.e. is mainly fat). This is the Dixon method (Dixon, 1984). 
Processing subsequently can generate a quantifiable cross-sectional area of adipose 
tissue in which it is easy to delineate compartments as the water rich tissue between 
compartments is absent.   
A similar approach can be used to interrogate a much smaller voxel (sampling window) 
and by looking at the frequency of the received MR signal in relation to a reference 
(known) frequency, the chemical compounds within the voxel can be identified. The 
signal intensity can be measured at any given frequency and so quantification in 
comparison to the reference can also be made. In essence, for any voxel sampling 
tissue, a chemical spectrum can be generated which identifies compounds within the 
voxel and how much is there. This is magnetic resonance spectroscopy (MRS)(Qayyum, 
2009). MRS can be used to measure chemical composition of any tissue in vivo at any 
given time and so repeated application of the magnetic field and capture of the 
resulting signal can measure chemical flux over time. Thus MRS has superseded many 
techniques reliant on biopsy or in-vitro cell culture to follow metabolic processes at a 
cellular level.  
MRS is not without problems, however. It requires more intense signal concentration 
and is much more susceptible to heterogeneity across the voxel disrupting the signal. 
Similarly, the signal to noise ratio (SNR) needs to be as wide as possible to accurately 
identify small concentrations of compounds. For example, the predominance of water 
in cells (which contains magnetic H nuclei) can mask trace compounds unless the SNR 
is optimised. In 1H-MRS (which is used to identify IHL) this optimisation is done by 
selecting a voxel within a major lobe of the liver avoiding blood vessels if possible, 
using a higher rated scanner (3T instead of 1.5T improves frequency separation of the 
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compounds on the spectrum generated) minimising respiratory movement during 
signal acquisition (by employing breath-holds by the subject) and using a PRESS (point 
resolved spectroscopy) sequence which trades voxel definition for greatly improved 
SNR. Water is the reference peak generated in 1H-MRS and by comparison of the area 
under the peaks, a percentage of lipid can be calculated for that subject’s liver. The 
literature shows that in cooperative subjects, the technique can be used at most ages. 
It has been successfully used in preterm infants at term(Uthaya et al., 2005), term 
infants (Thomas et al., 2008) and older children/adults(Thomas et al., 2005; Brambilla 
et al., 2006; Petersen and Shulman, 2006). 
1.9 Measurement of insulin sensitivity 
Measurement of glucose homeostasis and specifically sensitivity to insulin requires 
serum sampling and so in looking through the literature when designing a paediatric 
study, a method which is accurate but minimally invasive is desirable. Historically the 
‘gold standard’ euglycaemic hyperinsulinaemic clamp study was used to obtain the 
relevant measurements: insulin sensitivity was measured by quantifying how much 
intravenous glucose was required to maintain serum glucose levels when 
administering an insulin infusion: the greater the glucose amount needing to be 
infused to maintain serum levels, the more insulin sensitive the subject(Sinaiko and 
Caprio, 2012). This method is, however, quite intensive and requires repeated 
sampling with the concomitant risks of administering insulin intravenously. Other 
methods have been validated against this ‘gold standard’ and provide a better 
alternative. Some studies have used a fasting insulin level and serum glucose to 
estimate baseline sensitivity to insulin, but this gives no indication of response to a 
glucose challenge. Normal indices at baseline may mask a blunted response to glucose 
loading in the early stages of decreasing sensitivity to insulin(Weiss et al., 2013). 
However, the Homeostasis Model Assessment (HOMA2-IR) method is widely used to 
do this in both adults and children, and correlates reasonably well with the clamp 
method (Yeckel et al., 2004).  
To provide a glucose challenge in a structured way, a glucose tolerance test is most 
common in paediatric studies (both clinical and research), and the oral glucose 
tolerance test (OGTT) is most common due to ease of administration. This technique 
requires only one serum glucose/insulin measurement before giving the glucose load, 
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then one measurement afterwards (usually between 30 minutes and 2 hours)(Colley 
and Larner, 1990). From these measurements, an assessment of glucose disposal can 
be made and a higher than expected glucose level (≥7.9mmol/L at 2 hours) indicates 
reduced insulin sensitivity. It is also possible to calculate the ‘Matsuda Index’ from 
these values which has also been validated alongside the ‘clamp’ glucose disposal rate 
(though it does make assumptions about the area under the curve during calculation 
and is optimised with an intermediary measurement at 30 or 60 minutes)(Matsuda 
and DeFronzo, 1999; Yeckel et al., 2004). From a paediatric study perspective, the 
OGTT with a fasting and 2 hour sample is the best compromise in measuring insulin 
sensitivity.   
1.10 Effect of exercise and diet on insulin sensitivity 
As has been outlined above, the liver appears to be central in reduction of insulin 
sensitivity and development of metabolic syndrome. While some of the biochemical 
processes are undoubtedly contributed to by genetic or early life programming, the 
literature review conducted suggests that with age, the influence of the environment 
and lifestyle becomes more important in insulin sensitivity. In simple terms, the chance 
of hepatic steatosis increases with an excess of energy. The surfeit of energy comes 
from one of only two alternative origins: too much intake or not enough energy 
used(Wiskin et al., 2011)  
1.10.1 Exercise in modifying health outcomes 
One half of the energy balance equation is exercise (i.e. energy use). Kajantie et al 
(Kajantie et al., 2010) researched the activity levels of adults who had been born 
preterm. They showed that even amongst those who had not got any sort of 
impediment from their preterm background (either neurological or respiratory 
conditions) those born preterm were less likely to take regular or prolonged exercise 
than their term-born peers. When leisure time spent in physical activity is examined, 
those born preterm and low birth-weight take less exercise than their term-born peers 
(Kaseva et al., 2012). It is clear from direct measurements of their capacity for aerobic 
exercise that those born preterm are not at a disadvantage or significantly less capable 
of exercise than their peers(Clemm et al., 2012).  
27 
 
Reinehr (Reinehr et al., 2010) offered an intriguing glimpse into the link between 
programming and environment with an exercise intervention in a child population 
when they showed that the ability to achieve reduction in adolescent obesity was not 
linked to prematurity or SGA/AGA status but that being previously SGA was more 
significant in improving insulin sensitivity within the group during weight loss than the 
degree of weight loss itself. Work with the Helsinki Birth Cohort showed that young 
adults born preterm have a higher directly measured resting energy expenditure than 
those born at term (Sipola-Leppanen et al., 2011). It is one possibility that until early 
adulthood, this is part of the process that contributes to maintenance of energy 
balance in the face of intake of dietary energy in ex-preterms (protective against 
obesity). However, if this means that less energy expenditure is required by exercise 
and a habit is established, it may be that at some point the balance tips towards 
accrual of energy: at that point apparently reduced exercise becomes a potential 
causal mechanism for becoming obese.  
 It is not possible to say what proportion of metabolically disadvantageous body 
compositions are due purely to environmental exposure and what proportion are a 
combination of programming during early growth priming a metabolic ‘time bomb’ 
unmasked by the changes of puberty and beyond. However, there is clearly a residual 
link and opportunity to beneficially modify body composition, the metabolic effects of 
which may still be strongly linked to early life. 
In the wider paediatric population there are studies which have explored structured 
intervention in school-age children (Kriemler et al., 2010; Puder et al., 2011) which on 
the face of the results show improvements in aerobic exercise capacity and reduction 
in adiposity. However, the changes are measured immediately after the intervention 
and therefore the longevity of the change is not clear. The changes in fat mass are also 
very small and not of statistical significance. In addition there is some evidence to 
suggest that increased activity done at school leads to a concurrent reduction in 
exercise at home so that the overall effect of a structured intervention is minimised 
unintentionally (Wilkin et al., 2005). It is also well known that a simple increase in 
exercise to reduce obesity is usually ineffective as the body upregulates appetite to 
take in more calories in compensation. 
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In adults with proven NAFLD (IHL >5%), resistance exercise has been shown to reduce 
IHL and improve glycaemic control independent of measured weight loss, with possible 
better sustainability than programmed aerobic exercise (Hallsworth et al., 2011). This 
has not been examined in a paediatric population. 
Measuring activity in children can be achieved in two ways: by reporting (either parent 
or child) or by accelerometric assessment. Evidence clearly shows that reported 
exercise overestimates the true amount of exercise done(Basterfield et al., 2008) when 
measured directly. For this reason, the accepted standard is now direct measurement 
using accelerometers worn by study subjects. These devices measure acceleration in 
anything from one to three axes depending on the sophistication of the device. They 
monitor a number of counts per minute (one count representing a detected 
movement in a monitored direction/axis) which then allows stratification of the level 
of activity into (commonly) sedentary, mild, or moderate-to-vigorous activity 
(MVPA)(Metcalf et al., 2002) using cut-off points. Once defined, a 24 hour period can 
be interrogated and the time at any given level of activity defined. Accelerometery has 
some limitations. Compliance (wear-time) is potentially an issue but use of an activity 
diary and clear instructions on use can maximise wear time. In addition, use of cut-offs 
allows definition of a minimum wear time above which the validity of the data is 
acceptable and representative of the level of activity done(Basterfield et al., 2011b). 
Certain activities preclude the wearing of the accelerometer (e.g. swimming) and so on 
rare occasions, the measured activity may underestimate the actual physical activity 
done. Similarly, some types of activity measured on uniaxial devices may not trigger 
the accelerometer reliably (e.g. cycling whilst wearing a vertical-axis displacement 
accelerometer). Again, a well completed diary can aid interpretation of the data 
recorded. 
Using accelerometers to assess activity in the Gateshead Millennium Cohort (another 
cohort of children from North Eastern England, born in 2000a.d.) it has been shown 
that a reduction in MVPA is associated with increased BMI(Basterfield et al., 2012; 
Pearce et al., 2012) and importantly for our cohort, the amount of time in MVPA 
decreases as children enter adolescence(Basterfield et al., 2011a). Therefore, to help 
address influencing factors on energy balance in our cohort, accelerometery provides a 
method of reliably and accurately measuring direct activity. 
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1.10.2 Assessment of skeletal muscle oxidative capacity 
When considering activity, energy expenditure and metabolic flexibility, it immediately 
draws attention to the skeletal muscle and, more particularly, mitochondrial oxidative 
capacity. As noted evidence from adult populations shows that a primary 
mitochondrial defect is unlikely to be a primary cause for reduced muscle insulin 
sensitivity (Lim et al., 2010; Lim et al., 2011c) and the presence of IMCL is most likely to 
result from overload of hepatic capacity, at the tipping point into illness. However, the 
ability of the muscle to respond to glucose and the oxidative capacity under exercise is 
something that influences the global metabolic flexibility in an individual (Kelley, 2005) 
which may be influenced by many factors such as number of mitochondria and the 
ability to transport glucose into cells. In adolescents born preterm these are factors 
that could relate to gestation, nutrition and growth or later environmental influences. 
As the evidence shows, reduced time in MVPA and increased BMI appear to be related 
in the wider paediatric population and so when considering insulin sensitivity in 
adolescents born preterms it is sensible to have some measurement of skeletal muscle 
oxidative capacity as an objective measure of exercise capacity in the study group. In 
addition, part of the rationale for this study (see section 1.8.4) was to look at potential 
assessments that could be used in a serial fashion to assess an intervention (either 
lifestyle of diet) that might measure improved metabolic outcomes. Measurement of 
oxidative capacity would allow an assessment of improvement of metabolic flexibility 
in this situation. 
Non-invasive measurement of mitochondrial oxidative capacity is well described using 
the same MRS principles as outlined for IHL measurement. The technique is modified 
to detect the 31P nucleus which is present in the compounds which flux during 
exercise (ADP, ATP, Pi and PCr) to maintain ATP levels for the muscle to keep working. 
If the spectra are collected during exercise and afterwards, the level of 
phosphocreatine (which is the intrinsic muscle store for high-energy phosphate) can be 
measured as it depletes releasing high energy phosphate (measurable as an increasing 
Pi peak), then replenishing afterwards by mitochondrial oxidation. The half-time of 
replenishment is then a quantitative measure that is indicative of the oxidative 
capacity of the muscle which is being sampled in the MRS voxel (Chance et al., 2006; 
Boesch, 2007; Kemp et al., 2007). The method has been shown to be acceptable to 
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subjects and very reproducible making it a robust comparison across, and within, 
groups (Bendahan et al., 2003; Befroy et al., 2007; Layec et al., 2009; Lim et al., 2010). 
It has all of the advantages outlined for 1H-MRS (non-invasive etc.) and therefore in 
measuring skeletal muscle oxidative function in children, is the most acceptable 
method available.  
There are some recognised limitations of the technique which could be relevant to a 
paediatric population. Firstly the exercise protocol needs to be standardised across the 
cohort and younger participants might find it more difficult to comply with this. 
Secondly, the technical placement of a voxel aims to sample a single muscle group. If 
more than one group is sampled, the PCr in different groups may deplete and recover 
at different rates and the loss of a unified recovery (known as inorganic phosphate 
splitting) precludes accurate interpretation of the results. Lastly, the minimum pH of 
during exercise has been shown to affect the rate of recovery of PCr and therefore in 
analysis consideration of standardised post-hoc corrections has to be made. This has 
potential, therefore, to affect comparisons across groups and generalisability of the 
results to other patient groups(Iotti et al., 1993). 
1.10.3 Vitamin D  
Vitamin D is a steroid hormone produced in the skin from 7-dehydrocholesterol. UV 
light passing through the skin creates pre-vitamin D3 which then undergoes a 
temperature sensitive rearrangement to produce vitamin D3. Vitamin D3 then 
undergoes hydroxylation twice over (once in the liver and then in the kidney) to 
produce dihydroxylated vitamin D. 25-hydroxyvitamin D3 is the most abundant form of 
vitamin D in the circulation and is mostly found bound to vitamin D binding protein. 
The enzyme in the kidney responsible for producing 1,25-dihydroxyvitamin D3 (the 
active form of vitamin D) is a mitochondrial enzyme (CYP27B1). Alternative 24-
hydroxylation of the 25-hydroxyvitamin D3 can also occur in the kidney to produce the 
inactive 24,25-dihyroxyvitamin D3. Production of this alternative form of 
dihydroxyvitamin D is induced by the presence of 1,25 dihydroxyvitamin D and part of 
the mechanism for regulating itself. Some vitamin D can be acquired through dietary 
sources but the vast majority is generated in the skin.  
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The effects of vitamin D are mediated throughout the body by vitamin D receptors. 
The vitamin D receptor is a nuclear steroid receptor and highly conserved across 
species of vertebrate (mammal, fish, bird). The human vitamin D receptor joins with 
the retinoid X receptor (RXR) ligand  in order to form a working complex which can 
then bind with co-regulatory complexes known as vitamin D response 
elements(Haussler et al., 2013). The vitamin D response elements are specific genomic 
DNA sequences which bind the activated vitamin D receptor and promote 
transcription. Once bound, the effectiveness of transcription appears to be dependent 
on recruitment  of co-activators, and the diversity in this process may partly explain 
the diversity of effects seen with vitamin D/vitamin D receptor interactions(Christakos 
et al., 2016). 
Vitamin D is described as having ‘classical’ actions through involvement with skeletal 
homeostasis(Shaw and Mughal, 2013a), but in recent years it has been appreciated 
that there are vitamin D receptors in many non-skeletal tissues throughout the human 
body(Shaw and Mughal, 2013b; Wacker and Holick, 2013). As this knowledge has 
progressed, given the high prevalence of vitamin D deficiency in the western 
hemisphere, vitamin D replacement and supplementation has become the focus of 
therapeutic investigation in many different clinical disciplines, from treatment of 
psoriasis, hypertension and myalgia, to reduced muscle strength and glucose control in 
diabetes(Girgis et al., 2013).  
The association with high BMI and reduced serum vitamin D levels is well 
known(Samuel and Borrell, 2013): in those who are vitamin D deficient and obese, 
standard supplementation is less effective in raising serum vitamin D levels than in 
non-obese subjects(Forsythe et al., 2012; Saliba et al., 2013). It is also reported that 
young adults born preterm are less likely to have adequate intake of dietary vitamin D 
or calcium when compared to their term-born peers(Kaseva et al., 2013).  
Evidence in the literature also demonstrates that vitamin D deficiency in adults has a 
measurable and reversible impact on mitochondrial oxidative function when measured 
using the 31P MRS technique (Sinha et al., 2013). The mechanism behind this observed 
phenomenon is unknown, but it is methodologically essential now when using the 31P 
MRS technique to control for, or at least measure, vitamin D status in volunteers.  
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Serum Vitamin D levels have been investigated in relation to insulin sensitivity in 
adults, adolescents and children, though the results are mixed (Girgis et al., 2013). In 
recent studies there appeared to be no difference in insulin sensitivity in obese 
children and adolescents who were vitamin D deficient and there was no difference in 
insulin sensitivity between obese and non-obese subjects (Torun et al., 2013). In 
healthy young adults who had vitamin D deficiency, supplementation into the normal 
serum range did not improve insulin sensitivity when measure using a euglycaemic 
hyperinsulinaemic clamp study (Grimnes et al., 2011). Some studies of 
supplementation of vitamin D, however, have reported improvements in glycaemic 
control and insulin sensitivity in type 2 diabetes (Mitri et al., 2011) and gestational 
diabetes (Asemi et al., 2013) where a pre-existing condition exists and improvement is 
desired. In adolescents who were obese and vitamin D deficient, high-dose 
supplementation of vitamin D  resulted in a return to normal serum vitamin D levels 
and in an improvement of insulin sensitivity measured using fasting insulin and HOMA-
IR modelling(Belenchia et al., 2013). It should be noted, however, that BMI did not 
change in the study period and no response to glucose loading by way of assessing 
metabolic flexibility was made. Kelishadi et al supplemented children who met their 
study definition of having metabolic syndrome with very high dose vitamin D 
supplements (300000iU) over 12 weeks and looked at whether this improved indices 
of glycaemic control(Kelishadi et al., 2014) such as the HOMA index. In the 
supplemented group there was measured improvement in these indices, but as with 
Belenchia’s group there was no measure of response to dynamic loading with glucose.  
The breadth of possible interactions of vitamin D with the areas of metabolic interest 
in this study suggest that investigation of vitamin D levels in this cohort would be both 
novel and important in order to interpret any metabolic findings. 
1.10.4 Diet 
Balancing against energy expenditure in examining whether there is a net energy 
accrual or loss, is dietary intake. The literature is clear about how important diet is as a 
contributory factor in development of NAFLD both in terms of direct excess of calories 
and exposure to substances which trigger deposition of IHL such as fructose and 
alcohol(Bremer et al., 2012; Lustig, 2013; Weiss et al., 2013) and, as outlined in 1.7.3, 
in some instances of dietary deficiency. In adults with type-2 diabetes, dietary intake is 
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central to the dual cycle hypothesis of development and persistence of the 
condition(Taylor, 2008). In newly diagnosed type 2 diabetes, the beta cell dysfunction 
(previously regarded as irreversible) can be interrupted and reversed by adherence to 
a highly calorie restricted diet. During this process, the first measurable changes that 
occur are pancreatic and IHL clearance (well before other adipose compartments 
reduce in size) (Lim et al., 2011a). 
Diet, however, is hard to robustly assess due to recall bias, intentional intake bias 
(when the subject knows they are commencing a period of monitoring) and non-expert 
variation in interpretation/estimation of components (e.g. fat, carbohydrate, protein) 
of the food during analysis of what has been reportedly consumed. The standard 
options for assessment include prospective food diaries, weighed-food records and 
recall questionnaires. In designing a paediatric study where access to a dietician would 
be limited, and not available until data analyses, it was important that the technique 
used was robust, reproducible and, ideally, removed some of the analysis work by 
having pre-set values for reported intake.  
The SCRAN24 program chosen for this study is a piece of laptop-based software which 
engages children to input types of food and portion size from provided photographs 
for the previous 24 hours food intake. It has been validated for use against 
conventional methods of dietary assessment and, if anything, tends to slightly 
underestimate intake for total energy(Foster et al., 2013a). It uses division of the day 
into epochs and prompts throughout to improve recall, and is simple enough for 
children in primary school to use it successfully. The database attached to SCRAN24 
has 98% of the most common foodstuffs consumed by children in the North East of 
England accessible in such a way that, by selecting a food type and portion size, it 
generates automatic output files with a nutritional breakdown for that item. This 
means that only a limited number of foods will ever have to be assessed by a dietetic 
expert and therefore the time and cost of producing valid results is greatly diminished. 
In these respects it has great advantage over the other methods which could have 
been used. 
34 
 
1.11 The study cohort 
The Growmore Study is the latest review of the Newcastle Preterm Birth Growth Study 
cohort (children who were born preterm in Newcastle in the 1990’s) (Wood et al., 
2013). The children were recruited soon after birth into two separate studies looking 
at nutrition in preterm infants. The Growth Study (Cooke et al., 1998; Cooke et al., 
1999) recruited infants who were ≤1750g birth weight and ≤34 weeks gestation. They 
were randomised to be fed specific preterm- or term- formula from discharge to 6 
months of age, or the specific preterm formula until term corrected age, then term 
formula until 6 months old. The Protein Study (Embleton et al., 2001; Embleton and 
Cooke, 2005) used similar methods and randomised recruited infants (≤1750g birth 
weight and ≤34 weeks’ gestation) into 3 groups. The groups were then given one of 
three milk formulas which had different protein concentrations (2.7g, 3.0g and 
3.3g/100ml formula) but the same calorie density. They were fed the selected formula 
from time that they began enteral feeding until 12 weeks after term (corrected 
gestational age). There was a small time period of overlap between recruiting for the 
two studies and thought the recruitment criteria above were clear, one set of low 
birthweight (but 36 weeks GA) triplets were include as breastfed controls, as were 
siblings of eligible infants whose birthweight was >1750g.  
Both studies looked at outcome measures including body composition (by Dual Energy 
X-Ray Absorptiometry [DEXA] and skinfold thickness), anthropometry (height, weight, 
length, head circumference) and involved taking serum samples to assess body 
biochemistry (including lipids). Extended follow-up visits, when other measures of 
development were assessed (mental and psychomotor developmental indices), were 
undertaken until 24 months of age. In total, more than 200 infants took part in the 
initial studies.  
At the age of 10-12 years, the cohort was revisited in a further study looking at growth 
and insulin sensitivity. In this study, the anthropometric measures were repeated and 
further blood samples taken to examine insulin sensitivity with respect to 
contemporary body composition, growth in the intervening years and early (infant) 
growth patterns. Of the original cohort, 153 children consented to assessment, 139 
had assessment including DEXA and of these, 109 had blood sampling done. 
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Figure 2: NPTBG Study Cohort: recruitment and studies chronology  
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1.11.1 Protein Study 
The protein study looked at the differences that occur when preterm infants are fed 
iso-caloric formulations with different protein concentrations. It demonstrated that 
both weight gain and nitrogen accrual were improved in children who were fed the 
high-protein formula once enteral feeding had been established (Cooke et al., 2006). 
This was without any of the feared side-effects of a high protein formulation expressed 
in contemporary literature such as acidosis and excess nitrogen compounds in the 
blood. The study also showed that on the high-protein formulation, the rate of growth 
was greater than that which would have been expected in utero: this demonstrated 
that the protein intake (not calorie density) of the formulation was responsible for 
good catch-up growth. It also showed that weight gain was best in boys fed the high 
protein formula, suggesting that even high protein formula may not be meeting the 
growth needs of girls in this critical period. The study also demonstrated that a high 
protein formulation would promote better growth prior to hospital discharge 
(Embleton and Cooke, 2005). 
1.11.2 Growth Study 
The growth study looked at the differences that occur in preterm infants when fed 
different ‘whole’ formulas (rather than altering a single component in the protein 
study). Specifically, there was inclusion of a preterm formula group (higher calorie, 
protein and mineral contents). This demonstrated that differences in very early growth 
persisted to 6 months of age and that, dependent on the calorie density of the milk, 
children would up- or down-regulate their intake (volume) to get the calories they 
required for growth (Cooke et al., 1998). By 12 months, those fed on the preterm 
formula consistently had increased lean and fat mass (therefore no increase in % fat 
mass)(Cooke et al., 1999; Cooke et al., 2010) which is at odds with the suggestions of 
some authors (Ong, 2007) who have suggested preterm infants are more likely to 
deposit ‘central’ fat mass disproportionately to lean tissue mass. In the ‘preterm’ 
formula group the magnitude of catch-up growth shown was greatest, and boys grew 
more than girls (Cooke et al., 1998; Cooke et al., 1999; Cooke et al., 2010). This 
disparity between the sexes was not previously reported in preterm infants.  
Developmental outcomes were studied in the growth cohort at 18 months of age 
(Cooke et al., 2001). It was found that girls have better psychomotor and mental 
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developmental indices than boys but there did not seem to be any difference in the 
cohort ascribable to the formula given to the children. Differences in the growth 
patterns observed previously were also maintained. 
1.11.3 Most recent assessment 
The cohort was seen last at the ages of between 10 and 13 years of age. Children from 
both the protein and growth study were reviewed. Data taken at the time (as yet 
unpublished) showed that the development of reduced insulin sensitivity was not 
associated with rapid growth and weight gain in infancy. However, the change in BMI 
since infancy was correlated with contemporary fat mass and level of insulin sensitivity 
(Korada, M. et al. Presented at PAS, Baltimore, 2009). A small number of the cohort 
also had epigenetic analysis which showed that ‘patterns of weight gain or body 
composition are related to gene expression, and differences in DNA methylation of 
specific genes’ (Groom, A. et al. Presented at DoHAD, Chile, 2009). These data 
suggested strongly that in the cohort, there had been strong influences on health 
which were not directly attributable to infancy despite the marked difference in 
growth that had been demonstrated by nutritional manipulation started prior to 
discharge home.  
1.12 Study design 
It is important to acknowledge that this study sits within a larger piece of research 
following up the Newcastle Preterm Birth Growth Study (NPTBGS) cohort (Wood et al., 
2013) longitudinally since birth. While there is a degree of opportunism in the study 
design (i.e. there is a ‘bigger picture’ imperative to try to optimise the amount of data 
collected to enrich the longitudinal dataset) all of the assessments used were planned 
in order to minimise the inconvenience to the families and children who volunteered. 
To this end, serious consideration was given to the merits of spending some of the 
limited funds for the study on age-matched controls to perhaps place the data in a 
more generalizable context. While this would have provided an interesting comparison 
for some of the MR studies and serum data, the control group would not have been 
big enough to match the spread of ages within the study cohort nor provide enough 
power for the control group data to be robust (due to lack of numbers). The study, 
therefore, remained an observational cohort study. This model offers most 
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opportunity for investigation of the cohort group at this time, while preserving the 
longitudinal data collection ethos underpinning the research as a whole. 
When planning this study, it was also acknowledged that it might be the last time that 
a significant number of the cohort could be recruited into a study episode. The 
NPTBGS study group felt, therefore, that it was an important opportunity to look at the 
use of different and novel modalities of investigation (e.g. MRS, BODPOD, SCRAN24, 
accelerometers) from the perspective of how they could be used, closely integrated 
within single study visits, to provide data. This would then perhaps go on to inform 
future study planning for longitudinal (serial visits), multimodal assessment in 
interventional studies with future cohorts of children born preterm. This is reflected in 
some of the data presented in the results chapter. 
1.13 Study Aims and Hypotheses 
1.13.1 Growmore Study Hypotheses 
From the data collected at previous visits from the study cohort and the evidence in 
the literature, there are four hypotheses underpinning the current study. These are 
presented below as null hypotheses regarding a cohort of adolescents born preterm: 
1) In adolescence, muscle mitochondrial oxidative capacity quantified by 31P MRS 
will show no association with physical activity levels, adipose tissue 
distribution, sensitivity to insulin, or vitamin D status. 
2) In adolescence, IHL accumulation will show no association with nor be 
determined by insulin sensitivity, serum lipid profile and compartmentalisation 
of body fat deposits. 
3) In adolescence, there will be no measurable association between body 
metabolic outcomes (specifically insulin sensitivity) and body composition, 
nutritional intake or directly measured physical activity. 
4) Auxological methods (specifically skinfold thickness measurement techniques) 
of assessing body composition will not correlate well with gold standard 
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‘research methods’ for quantifying body composition (BODPOD), nor will they 
correlate with directly measured lipid deposition in the cohort (1H-MRS). 
1.13.2 Growmore Study Aims 
The study had the following aims which guided the study design, the investigative 
methods chosen and the data analysis: 
 To investigate whether contemporary fat mass, lipid distribution and 
compartmentalisation in adolescents, who were born preterm, is related to 
directly measured metabolic outcomes. 
 To investigate associations between reduced insulin sensitivity, exercise, 
prematurity and mitochondrial function in the cohort. 
 To determine the potential interactions between adipose tissue 
compartmentalisation, lipid deposition, reduced insulin sensitivity and other 
specific factors (such as diet and measured physical activity). 
 To determine the feasibility of using the study visit protocol as repeated 
assessments in a future, controlled interventional trial. 
 To collect serum samples for future epigenetic/RNA and metabolomic analyses. 
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Chapter 2. Methods 
2.1 Cohort selection and recruitment 
As described, this observational cohort study recruited from a cohort of individuals 
who have previously been involved in research studies.  The study participants 
recruited attended a single visit to the Newcastle Magnetic Resonance Imaging Centre 
(NMRC), on the Campus for Ageing and Vitality at Newcastle University, during which 
all but one of the investigations were completed within a four-hour timeframe. At the 
end of the study visit, the participants were issued with a pre-programmed 
accelerometer (Actigraph) and instructions for using it in the three days immediately 
after the study. Due to the cost of the multiple tests the study was limited to 60 
participants. The protocol for the study has been peer reviewed and published (Wood 
et al., 2013) as part of a broader-spectrum article discussing the research in which the 
study cohort have participated since birth. 
2.1.1 Recruitment 
153 of the original cohort participated in the most recent study. We had previous 
contact details and permission to contact 247 of the children from the original NPTBGS 
cohort. It was anticipated, therefore, that recruiting 60 children from the same cohort 
would be feasible in the timescale allowed for the study. No active selection process 
was used (i.e. no discriminators based on previous study results were applied to the 
selecting participants from the cohort to avoid bias in the process of recruitment).  
In line with the previous studies involving the cohort, we used a standard, paper-based 
recruitment with three phases:  
1) The NHS Summary Care Record (SCR) was accessed in a strictly limited fashion 
by me (as per ethical approval) to obtain current General Practitioner (GP) 
details for the cohort using the NHS number for each child, which we held 
already from participation in previous research. For those with a registered GP, 
who were listed as alive on the SCR, we contacted the children’s GPs to ensure 
the contact details we had were correct and that the children were alive and 
well. The GP was required to reply with a standard form stating that either the 
details we held were correct, or providing any updated details as appropriate. 
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Of the 247 previously-contacted children, we were able to find current 
complete details for 235. The relevant GPs universally returned the information 
slips within the time frame of recruitment and we contacted everyone for 
whom information was confirmed by the GP as correct or updated during the 
recruitment period. 
2) Once we had a response from the GP (final n=235), we contacted the parents 
by mail (enclosing the project information sheets) to ascertain interest in the 
study. We required a response by mail using a standard reply sheet and 
stamped, addressed envelope. A maximum of two invitations were sent to each 
traceable cohort member.  
3) Once the family confirmed interest in the study, a follow-up contact to provide 
any extra required information and to arrange a visit date was made.  
The study visits were then assigned on a first-come first served basis according to the 
parental replies.  
Written consent for participation was taken at the study visit, after a review of the 
information sheet and verbal briefing about the process. Both parent- and child-
specific forms were used and the both had the option to accept or decline any part of 
the testing, at any time during the study visit.   
2.2 Investigative methods  
Participants attended the visits following an overnight fast with no food after midnight 
prior to the morning of the visit. All visits were carried out in the morning to facilitate 
this. Participants were allowed a small drink of water up to two hours before the study 
visit start time.  
The following methods for data collection were used during the study visit. The visit 
flow chart can be seen in figure 3. 
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Figure 3: Study protocol flowchart 
2.2.1 Anthropometry 
Each participant had measurement of: height (to the nearest 0.1cm) using a telescopic 
stadiometer (SECA, Birmingham, UK) with the head positioned so that the Frankfort 
plane was correctly attained and the stadiometer arm was resting on the crown of the 
head (to ensure standardisation between participants); weight (to nearest 0.1kg) taken 
from the BOD POD™ (COSMED, USA) during plethysmography; waist circumference (to 
the nearest 0.1cm) using a self-retracting, soft, plastic measuring tape (BMI measuring 
tape, model no. CWSG26852, CTO group, China) with the waist taken as the transverse 
plain midpoint between the lower margin of the ribs and the upper edge of the 
superior iliac crest; and blood pressure (mmHg; sitting, right arm) using an automated 
oscillometric sphygmomanometer (Carescape vital signs monitor, GE Healthcare 
systems, UK) with appropriately sized cuff (to cover the upper arm as much as 
possible, but not including the elbow nor impinging on the axilla. Each measurement 
was taken up to three times (if two concordant readings, this was recorded; otherwise 
three were averaged) with the exception of the BODPOD which took two concordant 
readings of body weight during its use. From these measurements, body mass index 
was also calculated. Height readings were also used in analysis to generate fat-mass 
and fat-free mass indexes, as well as indexing the intra-abdominal lipid measurements. 
Standard deviation (z) scores (SDS) were calculated for height, weight and BMI using 
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standard UK reference data (Cole, 1997; Cole et al., 1998) 
(http://www.cdc.gov/growthcharts/percentile_data_files.htm) and an online 
calculation tool to generate the score (Quesgen Systems: 
http://www.quesgen.com/tools/BMIPedsCalc). The accuracy of this tool was checked 
during analysis and cross-referenced to another online tool which generated the same 
values as the chosen tool (http://www.stokes.chop.edu/web/zscore). 
2.2.2 Body composition 
Holtain (Crymych, UK) calipers were used to measure skin-fold thickness in four areas 
following the techniques published by Durnin, Womersley and Rahman (Durnin and 
Rahaman, 1967; Durnin and Womersley, 1974): biceps, triceps, subscapular and 
suprailiac. Each measurement was repeated up to three times: if two concordant 
readings were obtained, this was recorded; otherwise three were taken and the 
average recorded. The investigator was trained in the technique of skinfold 
measurement by members of the Diet and Nutrition Survey of Infants and Young 
Children prior to the study commencing.  
From these measurements, a measure of body composition was calculated using the 
logarithm of the sum of four skinfolds to generate a body density estimate. The body 
density formulae used (Durnin and Rahaman, 1967) are sex-specific and age 
dependent (<18 or ≥18 years old). The density estimate was then used in age-specific 
formulae to calculate percentage body fat (see below). In addition, the equations for 
estimate of body fat used by Slaughter (Slaughter et al., 1988) from two skinfold 
measurements (triceps and subscapular) were calculated. These measures are 
commonly used in North America. Six different equations were required as per 
Slaughter’s research, specifically one for each group within the cohort defined as: pre-
pubescent (Tanner Stage 1+2), pubescent (Tanner Stage 3) and post-pubescent 
(Tanner Stage 4+5) white males with sum of two skinfolds <35mm; all females with 
sum of two skinfolds <35mm; any males with sum of two skinfolds >35mm and any 
females with sum of two skinfolds>35mm. 
Air-Displacement Plethysmography was used to provide a second measure of body 
composition using the BOD POD™ system (COSMED, USA). This non-invasive method 
measures the density of the test subject and has been validated in children (Fields and 
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Goran, 2000; Fields et al., 2002; Fields et al., 2004a; Fields et al., 2004b; Ball, 2005). 
The BODPOD used has also been validated ‘in-house’, in adults, in comparison to the 
electric bioimpedance technique also used at the NMRC. 
All volunteers who underwent BODPOD measurement were in a fasted state to try to 
standardise hydration status and density measurements. The measurement process 
involved calibration of the measurement chamber (empty, then with a standard 
cylinder of known volume) then the participant sits in the measurement chamber. The 
difference in volume by comparison with the calibration volumes allows calculation of 
the participant volume and thus, in conjunction with the measured mass of the 
participant, the body density can be calculated. The software programme that controls 
the BODPOD measurement requires two consistent readings. In the event of disparate 
readings, it takes a third to produce a usable measurement. Our participants wore a 
tight-fitting swimsuit or equivalent (to minimise the loose clothing which might 
interfere with the reading) and a tight-fitting hat to prevent hair-volume isothermic 
interference with the measurement. The biggest difficulty that was faced was ensuring 
the children sat still during the measurement, but all who agreed to be measured in 
the BODPOD (n=58/60) managed to achieve a measured density.  
Unlike the method used by Fields (Fields and Goran, 2000; Fields et al., 2004a; Fields et 
al., 2004b) we did not directly measure the children’s thoracic gas volume. The 
BODPOD software gives an estimated thoracic gas volume based on the height of the 
participant. Data from a preliminary study by Holmes et al. suggests that, compared to 
hydrodensitometry and air-displacement plethysmography using measured thoracic 
gas volume in those aged 8-12 years old, use of the estimated thoracic gas volume is 
acceptable(Holmes et al., 2011). Using this estimate meant that we minimised the 
length of time in the BODPOD for the participants in order to minimise any discomfort 
associated with being exposed in a swimsuit. In a study with adolescents where there 
were many different measurements being done, we decided that the evidence 
supported this pragmatic approach to minimise the length of time spent in the 
BODPOD. It should also be noted that direct measurement of thoracic gas volume as 
described is difficult to achieve in paediatric subjects (Fields et al., 2004b). As such, 
while using the predicted thoracic volume might introduce error in any individual 
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measurement, it should be a consistent error across the cohort which therefore 
minimises impact on the correlation analyses. 
Converting body density into percentage body fat 
For both the skinfold thickness (sum of four) and BODPOD techniques, a body density 
measurement is generated. In order to convert this to a percentage body fat 
measurement the density measurement is entered into an equation of body 
composition: either that by Siri(Siri, 1956; Siri, 1961), applicable to those aged 18 or 
over; or Lohman (Lohman, 1989) which is a modified version of the Siri equation to 
take account of the age of the child (by using age-stratified constants in place of the 
fixed values in Siri’s equation). This was done manually for the skinfolds results, but 
was calculated automatically by the BODPOD software and a percent fat reading 
supplied (in addition to the fat mass and fat-free mass readings in kilograms). For the 
skinfold and BODPOD techniques, a fat mass was calculated using the percentage 
result and known bodyweight, then indexed to produce an FMI and FFMI comparable 
to that generated by the BODPOD technique. This ensured that there was some 
correction for body habitus and allowed better within-group comparison (VanItallie et 
al., 1990). 
2.2.3 Blood sampling and oral glucose tolerance testing 
The study participants fasted for around 8 hours overnight prior to attending the study 
visit. This allowed a standardised fasting-state oral glucose tolerance test (OGTT) to be 
performed (Colley and Larner, 1990) 
For those participants who consented to this investigation a venous cannula was 
inserted (22G Jelco, Smiths Medical, Kent, UK) prior to the administration of the 
standard oral glucose load (2.6ml/kg of Polycal™ [Nutrica Clinical Care, Wiltshire, UK] 
up to a maximum of 113mls, equivalent to a maximum of 75g anhydrous glucose). A 
series of baseline blood tests (for lipid profile, liver function, glucose, insulin, sex 
hormones, RNA, cellular DNA and serum to store) were taken at insertion of the 
cannula. Those participants in whom it was possible to site a cannula had a repeat 
sampling (for serum glucose and insulin) two hours after the oral load was finished. 
The whole-blood samples taken for glucose were immediately tested using the glucose 
oxidase method glucose analyser (Yellow Springs Instrument [YSI] 3000, Yellow 
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Springs, OH). They were then centrifuged (at 3000 rpm for 10 minutes) to isolate 
serum which was then tested using the same machine. Prior to use and at regular 
intervals throughout the visits, the YSI3000 was calibrated using a 10mmol/L quality 
control solution and variance of ±0.2mmol/L was considered acceptable. Attempts 
were made to spin the samples for glucose within minutes of collection but this was 
not always possible because of demand for use of the centrifuge. Therefore, due to the 
extra processing step and the sometimes unavoidable delay in centrifuging samples, 
the whole blood sample glucose readings were used in the final analyses in preference 
to the serum glucose.  
The samples for insulin analysis were collected in a preservative free vacutainers and 
allowed to coagulate before centrifugation within 30 minutes of collection. The serum 
was then pipetted and stored separately at -70°C. Once the study cohort visits were 
finished the samples were transported from NMRC to the laboratories, frozen, and 
analysed immediately once thawed in the laboratories. The insulin samples were 
analysed as a batch, together, (courtesy of Annette Lane, Institute of Cellular Medicine, 
Newcastle University) using the Dako Insulin ELISA Kit (Dako Denmark, Glostrup, 
Denmark) with the final plates read photometrically. Repeat measures were carried 
out every seventh sample to ensure quality control and all were within acceptable 
tolerances (accepted coefficient of variation for this ELISA is 7.5%). For analysis, the 
fasting insulin and glucose measurements were used to estimate insulin sensitivity and 
resistance using the Homeostasis Model Assessment (HOMA) method (Matthews et 
al., 1985; Levy et al., 1998; Wallace et al., 2004). In addition, the index pioneered by 
Matsuda et al (Matsuda and DeFronzo, 1999; Yeckel et al., 2004) was also used to 
examine the disposal of glucose after OGTT in analysis, as it offers the advantage of 
quantifying the physiological response to a glucose load (not offered by the HOMA 
method).  
The blood for lipid profile and, liver function was analysed off-site at the Royal Victoria 
Infirmary (RVI) Biochemistry laboratories immediately after the study visit finished. In 
between sampling and delivery to the laboratories, the samples were stored in a 4°C 
fridge, on site. Samples were transferred from NMRC to the RVI on ice in a freezer bag 
by the investigator. 
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Spare serum was separated from using the same methods as for the glucose samples 
and stored frozen -70C freezer on site at the NMRC) for potential future metabolomic 
analysis, at the Newcastle Biomedicine Biobank facility. During the final stages of our 
study data collection, Sinha et al (Sinha et al., 2013) demonstrated a clear association 
between skeletal muscle mitochondrial oxidative function and serum vitamin D levels 
in patients with Growth Hormone deficiency using the same 31-P MRS methodology as 
we had in our participants. Preterm infants in infancy and later in life may be 
nutritionally disadvantaged compared to their term peers and we therefore decided to 
use some of the saved serum to assess fasting vitamin D levels in our cohort. We felt 
that this would be important in correct interpretation of our MR data. The frozen 
serum was transported to Manchester (courtesy of Dr. Jacqueline Berry, Manchester 
University) where it was assayed using the Liquid Chromatography-Tandem Mass 
Spectrometry (LC-MS/MS) method to obtain a 25-OH Vitamin D quantitation. This was 
then included in the analysis of the 31-P MR data (see later methods).  
2.2.4 Epigenetic sampling 
Participants who consented to blood sampling were asked to provide two samples for 
later epigenetic analysis: RNA collected in a PAXgene™ Vacuum sample tube 
(PreAnalytiX GmbH, Switzerland), and an EDTA vacutainer sample from which a cellular 
‘pellet’ was extracted. All participants were also asked to provide 2ml of saliva into an 
Oragene™ Pot (DNA Genotek, Canada) from which DNA analysis could be done. Once 
collected, these samples were stored in a 4°C fridge until the end of the study visit and 
then transferred to the International Centre for Life (ICFL) in Newcastle, in a freezer 
bag, by the investigator.  
As all three samples types contained cells, they were subject to the Human Tissue Act 
(HTA), 2004(Human Tissue Act 2004). In compliance with this and the local HTA licence 
(no. 12534, held by Newcastle Biomedicine Biobank) the samples were processed at 
the International Centre for Life (ICFL, Newcastle, UK) to extract the genetic material 
using standard methods(Groom et al., 2012; Relton et al., 2012; Turcot et al., 2012) 
within 7 days of the sample being taken. Once extracted, the genetic material was no 
longer subject to the HTA and was prepared for storage on site at the ICFL for future 
epigenetic analysis. Study participants were made expressly aware that they were 
providing genetic samples for future analysis and given the opportunity to opt out of 
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this process. All genetic samples were labelled and stored anonymously using study 
numbers to ensure that there was no potential for misuse of any genetic information 
found in the future analysis. 
2.2.5 Pubertal staging 
All study participants were asked to self-assess their pubertal status using a booklet 
outlining the standard Tanner staging (Tanner et al., 1966b; Tanner et al., 1966a) of 
pubertal development. Female participants were also asked whether they had 
undergone menarche and, if they have an established menstrual cycle, to estimate 
what day of their cycle it is at the study visit. This information was used to control for 
pubertal status when assessing insulin sensitivity. 
2.2.6 Magnetic Resonance Imaging studies 
All of the Magnetic Resonance Imaging (MRI) studies were carried out by the Research 
Radiographers at NMRC, who ensured the safety and comfort of the participants in the 
MR suite. A separate, NMRC-specific MRI consent and safety questionnaire was 
administered by the Radiographers (in parallel with the Study Consent Forms) for all of 
the children prior to starting the MR sequences. The children were allowed to be 
accompanied by a parent into the scanner room if they wanted, but none took up this 
opportunity. Of the 60 participants, one was deemed to be unsuitable for scanning as 
they had permanent metallic cosmetic implants in their anterior abdominal wall that 
would have posed a thermal injury risk and also have degraded the study images. The 
59 children who underwent the scan protocol all provided images of suitable quality 
for analysis. 
The MR study protocol was trialled with the investigator as a test subject prior to any 
participants being scanned to ensure that the scan protocol could be completed within 
one hour (as stipulated by the Study Protocol submitted to, and approved by, the 
Ethics Committee). The 3-Tesla Achieva MRI scanner (Philips, Andover, Massachusetts) 
was used in conjunction with in-house modified coils to generate the images and data 
for analysis (Trenell et al., 2008; Lim et al., 2010; Lim et al., 2011c). Analysis of the 
results was undertaken by the investigator after tuition in the methodology by 
Professor M. Trenell and Dr K. Hollingsworth (NMRC). 
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The scan protocol for each participant started with abdominal scanning (head into the 
MR scanner). After approximately twenty minutes, the participants changed position 
under the guidance of the radiographers and went feet-first into the scanner for the 
exercise scans. 
Measurement of intrahepatic lipid 
Two methods for measurement of intrahepatic lipid (IHL) were used to collect  data in 
the study: the Dixon method (Dixon, 1984; Glover and Schneider, 1991; Hardy et al., 
1995) and 1H-Magnetic Resonance Spectroscopy (MRS)(Hallsworth et al., 2011; Lim et 
al., 2011a).  
For both techniques, the participant was laid supine, head first into the scanner, and a 
Philips Sense Cardiac 6 Channel coil (Philips, Andover, Massachusetts) placed over 
them, centred a the xiphisternum. Standard survey and reference scans were then 
carried out to ensure correct positioning of the subject prior to data collection. 
Dixon Sequencing 
A 3-point Dixon sequence was then taken from mid- to superior-liver in 6 cross-
sectional slices, 10mm thick with single-slice gaps) to provide the images required. The 
Dixon method uses in- and out-of-phase images to produce a ‘pure water’ image of the 
scanned structure, with the difference compared to the original image (non-water 
area) being pure fat. Thus an amount of intrahepatic lipid can be estimated. In our 
participants, however, the levels of intrahepatic lipid were found to be so low that we 
were unable to obtain accurate results from analysis of the scan data. There was 
insufficient fat content in the liver to allow reproducible estimation of fat content 
using the available software. This method was, therefore, discontinued after interim 
review of the data obtained. 
1H-MRS 
Following the Dixon sequence, the participants underwent point-resolved 
spectroscopy (PRESS) imaging to determine the levels of fat in the liver by generating 
1H-liver spectra(Qayyum, 2009). The participants were required to perform several 
breath-holds in order to accurately place the sampling voxel (30x30x30mm) in the 
superior portion of the right lobe of the liver, avoiding any large liver vessels. They 
were then required to perform a further 16.8 second breath-hold during which T2 
50 
 
PRESS scanning was performed to measure the relaxation times of the spectroscopy 
peak signals over time. This was done in all subjects who underwent MR scanning. 
Individuals required coaching and encouragement during the scan to maintain a 
suitable breath-hold as failure to do so gave distorted results during the PRESS T2 scan.  
Initial analysis of the 1H spectra (for an example see figure 4) was done using the 
Advanced Method for Accurate, Robust, and efficient Spectral fitting (AMARES) 
algorithm in the jMRUI v3.0 software package(Vanhamme et al., 1997). Once this was 
complete, further processing was done to calculate the %IHL. This is, by convention, 
the % of CH2 lipid peak signal amplitude relative to the water peak signal amplitude 
after correction for T1 and T2 relaxation times(Naressi et al., 2001; Thomas et al., 
2005; Gardner et al., 2012). This method, however, was found to be inaccurate for a 
number of children at the interim review because their IHL levels were so low that the 
AMARES program could not be used to accurately plot the fat peak during relaxation in 
the T2 sequence. In order to overcome this, the area under the curve at the  beneath 
the water peak (at 4.26ppm) and lipid peak (between 0.9 and 2.2ppm) was 
integrated(Qayyum, 2009) using a Matlab (The Mathworks Inc, MA, USA) algorithm 
designed by Dr Kieren Hollingsworth, after AMARES processing of the PRESS T1 scan. 
By using the assumption of a standard relaxation time for the water peak (26ms) and 
fat (71ms) this then allowed, as outlined above, expression of the lipid peak as a % 
relative to the water peak. While this method did not use directly derived water or fat 
relaxation times, it did allow reproducible estimates of IHL content for all of the 
participants who had a scan. It is this data that is included in the subsequent analysis.  
Measurement of intra-abdominal fat 
While in position for abdominal imaging, the participants also had a further Dixon 
sequence taken to determine intra-abdominal fat content. The 3 point Dixon sequence 
was centred anatomically around the L2/3 junction in order to allow reproducibility 
between participants and give some measure of centrally located, intra-abdominal fat. 
This level was also chosen as it allowed the scan to be commenced without the need 
or repositioning of the body coil, which contributed to the scan protocol being 
achievable within the specified time frame of 1 hour. 
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Figure 4: An example of 1H-MRS spectra in a normal and fat-loaded liver (courtesy of 
NMRC) 
 
The abdominal Dixon sequence took 6 cross-sectional slices (as for that outlined for 
the intra-abdominal lipid content) with the third slice corresponding to the L2/3 
landmark. Once taken, the fat percentage data was converted using Matlab from .PAR 
to .hdr format which could be read by imageJ software (opensource image reading 
program, National Institutes of Health). Using imageJ the fat percentage image was 
converted to a binary representation (pixels containing fat or not) and then the total 
area of fat was calculated (cm2). This was then further classified as either visceral 
adipose tissue (VAT; i.e. that which was found inside the abdominal cavity) or 
subcutaneous adipose tissue (SAT; adipose tissue outside the abdominal cavity). These 
values were then converted into a VAT/SAT ratio (Brambilla et al., 2006) and also 
indexed against height to provide some reference to body habitus given that the area 
was of a single cross-section only. These data were then used in analysis. 
Measurement of mitochondrial oxidative function 
Once the abdominal sequences were finished, the children were repositioned, feet 
first into the scanner and with their left foot placed in a custom-made exercise rig as 
described previously in the literature (Jones et al., 2010; Sinha et al., 2013) to allow a 
standardised exercise protocol during which 31P-MRS was carried out to assess 
mitochondrial oxidative function. 
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Figure 5a: A typical spectrum (top right) generated using 31P-MRS techniques, and 
stacked spectra demonstrating the change in PCr levels over time during exercise 
(depletion) and recovery. 
 
 
 
Figure 5b: an example of 31P-MRS spectra generated using the custom-built rig 
(courtesy of NMRC, Newcastle University) 
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The custom-built exercise rig allows plantar flexion movement between 0° to 30° with 
the foot starting in the anatomical position for the left leg only. This effectively isolates 
the calf muscles during the plantar flexion without other muscle groups being 
involved. Resistance to plantar flexion can then be programmed into the exercise rig at 
any level the operator sets. The participants were supine (as with the abdominal scans) 
and leg restraints were used to prevent deliberate use of thigh muscles in assisting 
work against the resistance rig during exercise (particularly quadriceps). The exercise 
rig was used prior to the exercise testing to quantify the calf muscle group maximum 
voluntary contraction (MVC) for each participant.  
In order to generate the 31P spectra (figure 5a), a 10cm diameter 31P surface coil was 
placed over the calf muscles, centred on the widest part of the gastrocnemius/soleus 
complex, for transmission and reception of the signal. Once the MVC was recorded and 
the participants had had time to recover, the exercise rig (figure 5b) was set to provide 
resistance of 35% of MVC, and 31P spectra were recorded over a three minute time 
window to assess resting mitochondrial function. This was immediately followed by a 
three-minute exercise period during which the participants were required to perform 
plantar flexion against the set resistance at a frequency of 0.5Hz. An audible cue at this 
frequency was provided to ensure regular rhythmic flexion. It was reinforced by 
tapping on the shoulder if the children were unable to match the frequency with 
rhythmic plantar flexion in time to the audible cue alone. With these measures, all of 
the children who attempted the exercise were able to accomplish the task. After the 
three-minute exercise, there was a rest period. MR phosphorous spectra were 
gathered every 10 seconds during the rest-exercise-rest protocol using adiabatic One-
Dimensional Image-Selected In-vivo Spectroscopy (1D-ISIS). This protocol has been 
shown to robustly measure mitochondrial oxidative function during recovery from 
exercise (Jones et al., 2010; Sinha et al., 2013). Using a 35% MVC protocol alone 
(rather than a 25% then 35% in sequence) also allows collection of pH change data by 
spectroscopy without the need for a longer time in the scanner. This allowed us to 
ensure that PCr readings are representative with respect to pH influence on the Pi-PCr 
flux and also calculate τ ½ ADP from the measured data without unnecessarily 
prolonging the scan time for the children.  
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The phosphorus spectra were analysed in batches using the AMARES algorithm in 
jMRUI using a prior knowledge base, and from this quantifications of PCr, inorganic 
phosphate (Pi) and pH throughout the protocol were obtained. The data were then 
processed to calculate the various components of oxidative metabolism as described 
by Kemp and Radda(Kemp and Radda, 1994). Change in pH was calculated by 
measurement of the changing horizontal displacement of the Pi peak from the PCr 
peak on the 31P MR spectrum(Kemp and Radda, 1994). A single exponential fit was 
then used to estimate the half-time to recovery within the muscle represented by 
recovery of equilibrium of PCr (τ½PCR) and ADP (τ½ADP) as described by Jones et al 
(Jones et al., 2010). Occasionally, this technique did not yield properly fitted ADP 
curves due to inorganic phosphate splitting. This phenomenon occurs when the 
sampling voxel crosses two or more muscle fibre groups such that the flux being 
measured is effectively two or more independent groups, hence no clear single peak is 
registered: instead there are several smaller, asynchronous peaks which cannot be 
analysed in the standard fashion. On the few occasions when this was observed during 
data analysis, the results had to be excluded from correlation analysis.  
In the post data-collection processing it became clear that the end exercise pH reached 
by our volunteers varied considerably. It is recognised that the pH can have an effect 
on the τ½PCr values and there is a well-established post-hoc correction that can be 
made(Iotti et al., 1993) which references the results to the mean minimum pH 
achieved across the cohort. This changes the absolute half-time results but allows 
referenced comparison within the group for comparison and correlation to other 
measured variables. 
2.2.7 Dietary recall: SCRAN24 
To assess the participants’ diets, we used the SCRAN-24 programme developed by the 
team at the Human Nutrition Research Centre (HNRC) at Newcastle University(Foster 
et al., 2013a; Foster et al., 2013b). It is a computer-based, guided software program 
which took around 30 minutes to complete, on a laptop computer, per participant. It is 
a recall diary tool.  
SCRAN-24 uses a series of steps to determine the times of food/drink intake over the 
24 hours prior to using the program. It asks the user to list chronologically the items of 
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food or drink consumed in the 24 hour period under a series of headings (breakfast, 
mid-morning snack, lunch etc.). It then breaks down each intake into their component 
parts. For the majority of foodstuffs (98% of those) regularly consumed by children in 
the North-East of England, the program contains a listed item. Non-listed items have to 
be entered in free-text. Once the items are selected for the full 24 hour period the 
program then revisits each episode of food intake and prompts the participant to 
assess and log portion size based on a series of photo-based choices. A final step 
prompts the user to try to link food and drink intake with activity through the day and 
highlights any times of the day during which nothing was ingested as particular areas 
to focus on. This is done to try to improve recall and thus improve the sensitivity of the 
diary. Once the participant has completed the portion sizes for all chosen items, the 
program saves this information in a database file.  
The database file contains pre-programmed nutritional information for all of the listed 
items chosen and based on the quantities selected (portion size) for each item. As 
these have been seen and selected by the participant, it removes some of the 
interpretive steps that might have occurred in a traditional written recall diary. It also 
avoids the bias of a prospective diary which occurs when dietary modification occurs 
due to observation. For the free text items entered in the program, significant dietetic 
experience is still required to accurately assess and enter the required data into the 
database. SCRAN-24 has been validated for use in children in the North-East of England 
aged 11 years of age or over.  
The SCRAN data was only collected on one occasion (during the study visit). Data from 
the recall would be more robust if repeated on 2-3 separate occasions per child, but 
due to the extensive nature of the tests at the study visit and the fact that the logistical 
framework to conduct follow-up home assessments was not available, it was decided 
to restrict this to a single assessment. This was approved by the REC who felt that 
minimising interruption to the participants’ lives was important. It was accepted that 
natural variation in dietary intake due to extrinsic factors (e.g. weekend vs. school day; 
after-school activities etc.) may therefore have had an impact on the reliability of the 
results based on one recall session alone. However, it is not unreasonable to assume 
that those with high-fat, high-carbohydrate diets are unlikely to have changed to a 
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healthy diet the day before the study visit. Other sources of bias such as failed recall 
are equally applicable to SCRAN-24 as a written recall diary. 
2.2.8 Direct Measurement of Physical Activity 
The children were given the opportunity to take home an accelerometer at the end of 
the study visit in order to directly measure their physical activity for a period of three 
days. The process was explained and wearing of the accelerometer demonstrated prior 
to the candidate agreeing to take it home. All of the children agreed to try the process. 
A pool of six, calibrated accelerometers were used to collect the data. Accelerometers 
have been used for many years to measure directly physical activity in children(Metcalf 
et al., 2002) and they are well validated for use being practical to use, reliable, 
calibrated to ‘gold standard’ techniques (such as indirect calorimetry) and more 
accurate than self-reporting of exercise(Basterfield et al., 2008; Evenson et al., 2008; 
Basterfield et al., 2011a; Trost et al., 2011). 
The accelerometers used were ActiGraphs™ (GT1M model, MTI, Pensacola, USA). 
These are small and light-weight, uniaxial accelerometers. They were pre-programmed 
to begin and stop recording activity prior to issues to participants. They measured 
acceleration of different intensities in one (vertical) plane during sequential, pre-
defined, short epochs (10 seconds) which were then downloaded onto a laptop 
computer and analysed after completion of the data collection. They were worn by 
convention on the right hip, during waking hours, and the participants were instructed 
as to how to wear them correctly to ensure accurate data collection. During wearing, 
any displacement of the hip (i.e. pelvis tilt or changing body position) during activity 
causes vertical displacement of the accelerometer which is recorded, and thus 
quantitative measure of activity (‘counts per minute’, cpm) can be calculated. It is 
recognised (and was explained to the participants) that the ActiGraphs were not 
waterproof and therefore were not wearable during activities such as swimming. They 
are also not reliable at recording exercise intensity during cycling (Evenson et al., 
2008).  The accelerometers also measured the number of steps taken. The 
accelerometers were worn for three consecutive days including at least one weekend 
day and one weekday as described in the literature as this provides a reliable 
assessment of activity as long as there is a minimum of 6 hours weartime per day 
recorded (Basterfield et al., 2011b; Pearce et al., 2012). We decided, given the age 
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group (12 years and upwards), the requirement from the REC to ensure disruption to 
the participants lives was minimised and the fact that we only had a few 
accelerometers to use on a rolling basis, that a 72 hour data collection period starting 
at 7am the morning after the study visit would be in keeping with the aims of the 
study. We assumed that most of the participants would be able to adhere to this.   
The participants kept a written diary to keep track of the time the accelerometers 
were put on and taken off through the day in order to aid analysis and identification of 
non-wear periods (Basterfield et al., 2008; Basterfield et al., 2012). The accelerometers 
were returned after the period of wear by either drop-off to the researcher or by post, 
in pre-paid envelopes.  
Analysis of the activity data was done using the Actilife program (version 5, MTI, 
Pensacola, USA) under the supervision of Dr Laura Basterfield (Human Nutrition 
Research Centre, Newcastle University). Using pre-defined, calorimetrically-referenced 
cut-offs (Evenson et al., 2008) the data recorded over three consecutive days was 
classified into sedentary, light, moderate to vigorous physical activity (MVPA). The cut-
points used were: Sedentary ≤100cpm; Light Activity 101-2295cpm; Moderate Activity 
2296-4011; Vigorous activity ≥4012cpm. MVPA therefore was any activity ≥2296cpm. 
These cut points are slightly lower than those used by other studies (Puyau et al., 
2002; Basterfield et al., 2008) but they are calorimetrically referenced and because 
Evenson used ROC curves in her analysis, when compared to other cut-off points by 
Trost (Trost et al., 2011) these cut-points performed best across a wide range of ages 
of children. It is also notable that adult cut-offs for moderate to vigorous activity are 
generally lower than those of children and so in an adolescent cohort, using these cut-
points is appropriate.  
 From this, it was possible to calculate the time spent (minutes) and percentage time in 
sedentary or MVPA. MVPA was chosen rather than looking individually at different 
activity levels as it has been shown in non-preterm children in the North East that 
MVPA seems to be most closely associated with body habitus change when followed 
longitudinally(Basterfield et al., 2012) Non-wear periods were defined manually during 
analysis cross-referenced to the weartime diary kept by the children and any long zero-
count periods (no activity recorded for >1 hour) removed from the analysis. Any 
complete record which had wear on less than 3 days, or less than 6 hours of weartime 
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per day, was rejected. Of the 60 children who agreed to participate in this part of the 
study, 2 participants failed to wear the device (one not returned), 5 did not wear it for 
three consecutive days and one failed to achieve 6 hours weartime per day. This 
equated to a satisfactory completion rate of 84%.  
2.2.9 Questionnaires 
The study participants completed a paper questionnaire during the study visit 
regarding their view on what children would prefer for structured activity within a 
programme designed to encourage a healthier lifestyle in children and their families. A 
total of ten choices were presented as statements and the participants were asked to 
rate each one on a ten point Likert scale. The median and interquartile ranges were 
calculated for each outcome. A free text box was included to allow suggestions for 
other interventions which the children thought might be used. This data was collected 
in order to inform potential future interventional studies about which interventions 
might be most accepted by a similar teenage cohort and is presented in section3.5. 
As part of good research practice, each family who came to a study visit was given a 
feedback questionnaire asking them to tell us what we did well, what they didn’t 
enjoy, and what we could do to improve the study. This was filled in anonymously and 
they were given the opportunity to return them on the day or at a later date. The 
information from this allowed us to make minor changes in approach to improve the 
experience during the study visit (for example ensuring accompanying parents knew 
that they would have a period of ‘downtime’ while their children were being scanned 
or that the glucose drink for the GTT was best drunk in one go rather than sipped due 
to its viscous consistency). 
2.3 Ethical Approval 
A favourable ethical opinion for the Growmore study was gained (after amendments) 
on 9th February 2011 from Sunderland Regional Ethics Committee (study number 
10/H0904/67). Following this, the Newcastle Hospitals NHS trust Research and 
Development department confirmed approval on 23rd March 2011 (study number 
5530). One substantial amendment was approved during the course of the study (2nd 
September 2012) for a ‘young adult’ consent form (where a participant >18 years old 
living with parents might attend alone). This was not, in the event, needed. 
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2.4 Statistical analysis 
As this is an observational study with many different measured variables, calculating a 
required number of study volunteers needed for the results to have standard statistical 
power to achieve significance is difficult. To this end, the following sample size 
estimates were made after discussion amongst the NPTBGS study group members: 
1. Based on effect size data from the cohort, at the last visit, relating fat mass 
index to insulin sensitivity (R2=0.12), an 80% power at 5% significance level 
would require approximately 60 study subjects to detect any significant within-
cohort difference.  
2. The work using 31P-MRS by Sinha et al showed that to demonstrate a 
reduction in τ½PCr of 10% with supplementation of vitamin D to the same 
power level as required in this study (of 80% at 5% significance) required only 
10 subjects (Sinha et al., 2013). 
Based on these data, it was decided that a study size of 60 individuals would be 
appropriate as a target for recruitment in order to detect significant within-cohort 
variation within the variables measured.  
It was decided that the data generated would be analysed in various ways suitable to 
the comparisons being made (Wood et al., 2013). Comparison between the volunteers 
making up the study cohort and the cohort as a whole at the last visit was made using 
student t-tests or Mann-Whitney U tests to examine whether the study cohort (fewer 
in number) were representative of the overall cohort for key variables such as 
gestation and birth weight. Bland-Altman plots were used to compare and assess 
agreement between different methods examining body composition (Bland and 
Altman, 1986; Bland and Altman, 1995; Krouwer, 2008).  
Correlation analysis (either Spearman’s Rho or single variable linear regression) was 
used to examine relationships between pairs of variables such as IHL and insulin 
sensitivity, and oxidative function and vitamin D status. More complex linear 
regression were then developed using insulin sensitivity, fat deposition and tau½PCr 
(as a measure of oxidative function) as dependent variables. When constructing these 
models, adjustment was be made for confounding factors such as sex, gestation, 
pubertal stage and birth weight z-score.  
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Primarily the data was analysed using the Stata data analysis program (v11/13, 
StatCorp LP, Texas USA) available through Newcastle University Computing Services. 
Specific analysis of MRS, dietary and exercise data was made using some open source 
programs and some bespoke software as outlined above, prior to statistical analysis.
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Chapter 3. Results 
As outlined previously, the cohort who volunteered for the current study were part of 
the NPTBGS cohort, formed by amalgamation of two original study cohorts. The 
recruitment for this study was non-selective to try to minimise bias at entry to the 
study (i.e. the traceable members of the original cohort (n=235) were all sent two 
invitations which contained a response form and a patient information letter). The first 
60 to respond and volunteer were recruited, so it was necessary to consider whether 
these individuals were representative of the original NPTBGS cohort. If the current 
study cohort was broadly representative of the NPTBGS cohort, the study results 
would be more translatable to a wider, ex-preterm cohort outwith the study group.  
3.1 The study cohort: representativeness of overall preterm cohort 
When comparing the current cohort to the original cohort, data from the previous 
time that the cohort was assessed was used (Wood et al., 2013). Gestational age and 
birthweight SDS were used as variables representative of the growth status at birth of 
the individuals being compared. The dates of birth of the NPTBGS were used to 
confirm that the current study cohort was representative of the original cohort in age 
(and that the current cohort was not an older or younger sub-group). 
In order to make some comparison of the metabolic status of the current study cohort 
with the other members of the NPTBGS cohort, at the time of the last study, the 
recorded data for body mass index (BMI), fat mass index (FMI) and percentage body 
fat (the latter two measured by DEXA and BIA) were compared. There was no way to 
confirm that the NPTBGS individuals who were compared to the current study cohort 
would have taken the same life course trajectory in terms of metabolic outcomes, so it 
was only possible to make an assessment of whether the current cohort was 
‘metabolically’ similar to the overall group at the last assessment. The comparisons 
were made using either t-tests (for normally distributed data) or Mann-Whitney U 
tests (for skewed data). Chi-squared testing was used for categorical data analysis. 
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3.1.1 Comparison of birth weights and gestation 
The characteristics of the current study cohort at the time of this study are shown in 
table 1.  
Characteristic Mean (range) 
Gestation at birth (weeks) 31 (26+1 to 34+4) 
Birth weight (kg) 1.37 (0.84 to 1.87) 
Age at study (years) 15.5 (12.1 to 18.8) 
Male:Female (n) 25 : 35 
Table 1: cohort characteristics 
The inclusion of a maximum weight cut-off in the original study enrolments leads to an 
intrinsic bias which cannot be overlooked when considering the generalisability of the 
results, such that the older the gestational age (GA) of the individual at birth, the 
lighter they had to be in comparison with their peers (as measured by birthweight SDS) 
in order to be recruited into the original studies (figure 6). 
 
Figure 6: birth weight SDS plotted against gestational age at birth in the current study 
cohort. 
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Gestational Age at birth (days) 
Mean SD 95%CI 
Complete NPTBGS cohort (1) 216 14.87 ±1.85 
NPTBGS cohort without current 
cohort included (2) 
216 15.40 ±2.20 
Current Study (Growmore) cohort (3) 217 13.14 ±3.39 
Table 2: Comparison of gestational age at birth between NPTBGS cohort and the 
Growmore Cohort. (2) vs. (3): p = 0.89 (NS); (1) vs. (3): p = 0.92 (NS) using two-tailed 
Student t-test 
 Birth weight SDS score 
Median Interquartile range 
NPTBGS cohort without current 
cohort included (1) 
-0.75 -1.58 to -0.15 
Current Study (Growmore) cohort (2) -0.715 -1.41 to -0.195 
Table 3: Comparison of birth weight SDS between NPTBGS cohort and the Growmore 
Cohort; (1) vs. (2): p = 0.95 (NS) using Mann-Whitney U test 
 Age at time of current study (years) 
Median Q1 Q3 Range  
Complete NPTBGS cohort (1) 14 12 15 11 to 17 
NPTBGS cohort without current 
cohort included (2) 
14 12 15.75 11 to 17 
Current Study (Growmore) cohort (3) 14 12 15 11 to 17 
Table 4: comparison of cohort members’ age at start of the Growmore Study 
recruitment period; p = 1.0 (NS) using Chi Squared test 
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Tables 2 to 4 show that when comparing the current study cohort with the remainder 
of the NPTBGS cohort, there is no significant difference for gestational age, birth 
weight SDS or age at the start of the current study recruitment period 
3.1.2 Comparison of BMI, FMI and percentage total body fat 
Table 5 shows the comparison of BMI, FMI and percentage (total) body fat (measured 
at the last study visit), between those tested who subsequently volunteered for this 
study and those who did not. Of note, not all of the NPTBGS cohort who were not 
recruited for the current study had all of the above indices measured at the last visit. In 
addition, not all of the 60 who took part in the current study had all of the indices 
measured at the previous study. 
These data show that there was no significant difference between those who 
subsequently volunteered for this study and those who did not, in the group who had 
their BMI, FMI and percent body fat measured at the last study visit. 
 BMI FMI % body fat 
NPTBGS cohort without 
current cohort included 
(1) 
n* 100 89 89 
 
Median 18.1 5.57 30.6 
IQR 
16.1 to 
20.8 
4.07 to 
7.96 
24.3 to 
38.9 
Current Study 
(Growmore) cohort (2) 
n* 52 46 46 
 
Median 17.5 5.24 28.3 
IQR 
15.9 to 
19.7 
3.67 to 
6.84 
24.3 to 
35.4 
Mann-Whitney U p (1)vs.(2) 0.23 0.22 0.16 
Table 5: comparison of BMI, FMI and % body fat. (*the number of volunteers who had 
these measurements made at the previous study i.e. not the whole NPTBGS cohort) 
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Investigation undertaken n (%) 
MRI scan 59 (98) 
MR results suitable for post-hoc analysis (Aτ½PCr) 50 (83) 
Activity Monitor (completed and returned) 44 (73) 
BODPOD 58 (97) 
Auxology 60 (100) 
Serum sampling 46 (77) 
Table 6: number of volunteers who underwent the aspects of multimodal assessment 
during this study 
3.1.3 Participation in multimodal assessment in the current study 
As was observed in the previous studies, not every volunteer in this study consented to 
taking part in every aspect of the study. Table 6 outlines the number of subjects out of 
the total volunteers (n = 60) that consented to, and took part in, the different aspects 
of the current study. Of these, not all the data collected was of sufficient quality to 
analyse. 
3.1.4 Comparison between ‘original’ study groups. 
Within the current study cohort there was a mix of children recruited to the original 
protein (n=29) and growth (n=31) studies. This could possibly lead to confounding. 
Analysis was done on those variables reflecting status at birth and those that were 
thought to be important with respect to the study aims. Mann-Whitney U tests were 
used to assess the difference within variables, categorised by original study (table 7). 
There were no statistically significant (P≤0.05) differences detected, but IHL measured 
by MRS was approaching significance between those enrolled into the different 
studies. The significant difference for age at study visit reflects the fact that the 
66 
 
children enrolled into the protein study, which recruited after the growth study, were 
younger as a subgroup within the cohort. 
Variable  
Z value  
(Growth vs. Protein 
Study) 
p value 
Birth Weight SDS 0.488 0.63 
Gestational Age at Birth -0.23 0.82 
Age at Study Visit 6.18 <0.001** 
Intrahepatic Lipid (IHL) -1.78 0.07 
Fat Mass index (from 
BODPOD data) 
0.15 0.88 
BMI SDS 0.38 0.70 
VAT/SAT ratio -0.75 0.45 
HOMA (% insulin 
sensitivity) 
0.40 0.69 
Matsuda Index -0.19 0.85 
Vitamin D (total) -0.44 0.65 
Moderate to Vigorous 
Physical Activity 
-1.02 0.31 
Table 7: Mann Whitney U test comparison between growth and protein studies within 
the GROWMORE cohort 
3.1.5 Comparisons between Boys and Girls 
Within the study cohort there was an increased number (n=35; boys n=25), and 
increased proportion of girls, compared to the original NPTBGS cohort. Comparison 
was therefore made in the current study cohort to assess whether there was a 
demographic difference between the boys and girls at time of study (table 8). The only 
significant difference in the comparison variables describing the two groups was age at 
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study: the girls were on average 1 year older than the boys (boys mean: 14.8yrs; girls 
mean: 15.8; p=0.036).  
 
Variable  Z value (M vs. F) p value 
Birth Weight SDS 0.488 0.63 
Gestational Age at Birth -0.23 0.82 
Age at Study Visit -2.09 0.04 
Tanner Stage -0.87 0.38 
BMI SDS -0.43 0.67 
Table 8: Mann Whitney U test comparison between boys and girls within the 
GROWMORE cohort 
3.1.6 Discussion 
The analysis of these data shows that the cohort which volunteered for this study is 
representative, in a broad sense, of the NPTBGS cohort using metrics which reflect 
uterine and neonatal status as well as limited representation of metabolic status in late 
childhood/early adolescence. There were no significant differences arising from 
children being in different studies originally, and there was minimal difference in 
baseline measures between the male and female cohort members. The original cohort 
were all selected for being in good health in the context of preterm birth, in order to 
minimise the effects of ‘acquired’ morbidity having been born preterm. These 
individuals, from a population perspective, are those most likely to be those who 
subsequently lead lives in society which are outwardly least distinguishable from their 
term born peers. Under such circumstances, delayed or programmed adult metabolic 
health problems may have a profound effect on their lifetime need for use of 
healthcare resources, when compared to their term born peers. The results of this 
study specifically arise from a small group of individuals who are representative of the 
wider NPTBGS cohort: this, in turn, means that the results will have some 
generalisability with reference to preterm infants who pass through neonatal care 
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apparently unscathed. Further analysis of measured variables by male/female or 
original study enrolment is discussed in the relevant sections of the results (section 3.2 
to 3.4). 
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3.2 Body composition and lipid distribution in body compartments 
As described earlier, one of the intentions of this study was to look at some of the 
different methods that might be used in future studies to monitor efficacy of any 
lifestyle or research intervention over an extended period. When looking at body 
composition, it was of particular interest to compare skinfold measurements with air 
displacement plethysmography (ADP) as methods for estimating total body fat. A 
reduction in total body fat would be a simple measurement useful in monitoring 
progress of an intervention, as well as quantify any relapse after an intervention was 
stopped.  ADP is measured using the BODPOD™ as described. While it is more 
convenient than using other research methods such as immersion, it is still expensive 
and remains the domain of research studies. For a future study with larger numbers 
use of skinfold measurement would potentially allow more rapid data collection, but 
only if the data generated were accurate.  
The other outcome of interest was comparing the general measures of body 
composition with the directly measured MRS and Dixon method outcomes for IHL and 
visceral/subcutaneous adipose tissue distribution, to see if they held any associations.  
3.2.1 Comparison of methods for measuring body composition 
When using the four-skinfold method as outlined in the methods, and the BODPOD™, 
a body density is generated which can then be converted to a percentage body fat 
using the equations of Siri and Lohman, depending on age. The calculations for the 
two-skinfold technique produces a ‘percentage body fat’ without using these 
equations directly. The total body fat-mass and fat-free mass was then calculated (kg) 
from the volunteer’s weight, and then indexed against height (VanItallie et al., 1990) as 
a means of adjustment for body habitus and to improve comparability across the 
group. Table 9 shows the descriptive summary for the data generated using these 
techniques. Table 10 shows the correlation between these body composition 
techniques and each other, and also the correlation between these measures and 
other auxological measures commonly used to track changes in body composition. 
Table 10 also compares all of these measures to the directly measured lipid deposits 
from 1H-MRS and Dixon imaging. While it appears that all of the auxological and body 
composition measures have a good correlation with the directly measured visceral and 
subcutaneous adipose tissue, there is not a good correlation with the lipid content as 
70 
 
measured in the liver using 1H-MRS: only fat mass index measured using the BODPOD 
or 2-skinfold technique appears to be correlated with the measurement of intrahepatic 
lipid.  
 
 
Technique FMI BP FMI 2S FMI 4S FFMI BP FFMI 2S FFMI 4S 
5% 1.37 1.62 1.82 13.39 13.19 13.02 
50%  3.43 3.60 4.47 15.89 16.42 15.70 
95% 10.82 10.02 9.01 19.73 19.08 19.38 
Mean 4.75 4.54 4.83 16.12 16.32 16.02 
Standard 
Deviation.   
3.29 2.79 2.33 1.84 1.78 1.97 
 
Table 9: Descriptive data for the three techniques from which Fat Mass Index can be 
generated. All data in kg/m2. (FMI: Fat Mass Index; FFMI: Fat Free Mass Index; BP: 
BODPOD™; 2S: two skinfold technique; 4S: 4 skinfold technique) 
 
While the correlation statistic would suggest that the measures obtained by BODPOD 
and the 2-skinfold technique are potentially correlating well enough to be used 
interchangeably, this must be formally tested. Figures 6 to 11 show Bland-Altman plots 
generated to compare the results from the methods for Fat-Mass Index (FMI, kg/m2) 
and figures 12 to 17 show the same comparisons for Fat-Free Mass Index (FFMI). For 
each comparison, there are two plots: one showing the differences plotted against the 
mean of the two techniques (as recommended by Bland and Altman(Bland and 
Altman, 1995) and one showing the differences plotted against the ‘reference’ method 
(Krouwer, 2008) which was assumed to be air displacement plethysmography (or the 
two-skinfold measurement when directly comparing the skinfold techniques, based on 
the correlation analysis). 
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 FMI  BP FMI 2S FMI 4S BMI WC MAC BMI SDS 
FMI  BP        
FMI 2S 0.92 
<0.001 
      
FMI 4S 0.90 
<0.001 
0.96 
<0.001 
     
BMI 0.81 
<0.001 
0.82 
<0.001 
0.87 
<0.001 
    
WC 0.77 
<0.001 
0.76 
<0.001 
0.79 
<0.001 
0.91 
<0.001 
   
MAC 0.53 
<0.001 
0.58 
<0.001 
0.68 
<0.001 
0.87 
<0.001 
0.78 
<0.001 
  
BMI SDS 0.79 
<0.001 
0.79 
<0.001 
0.79 
<0.001 
0.94 
<0.001 
0.88 
<0.001 
0.77 
<0.001 
 
% IHL 0.29 
0.03 
0.28 
0.03 
0.18 
0.17† 
0.19 
0.15† 
0.25 
0.06* 
0.07 
0.59† 
0.24 
0.07* 
VAT 0.41 
0.001 
0.43 
<0.001 
0.38 
0.002 
0.49 
<0.001 
0.59 
<0.001 
0.33 
0.01 
0.56 
<0.001 
SAT 0.91 
<0.001 
0.92 
<0.001 
0.93 
<0.001 
0.86 
<0.001 
0.84 
<0.001 
0.62 
<0.001 
0.82 
<0.001 
VATi 0.44 
<0.001 
0.45 
<0.001 
0.38 
0.003 
0.45 
<0.001 
0.53 
<0.001 
0.24 
0.06* 
0.55 
<0.001 
SATi 0.9295 
<0.001 
0.9329 
<0.001 
0.9178 
<0.001 
0.8253 
<0.001 
0.7962 
<0.001 
0.5448 
<0.001 
0.8154 
<0.001 
Table 10: Spearman’s correlation analysis for the three techniques from which Fat 
Mass Index can be generated, and other auxological techniques used to track body 
composition. Values shown are: Rho; p-value. †Not significant; *p<0.1 (FMI: Fat Mass 
Index; BP: BODPOD™; 2S: two skinfold technique; 4S: 4 skinfold technique; %IHL: % 
Intrahepatic lipid content; VAT: visceral adipose tissue; SAT: subcutaneous adipose 
tissue; i: indexed against height-squared) 
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Figure 6: Comparison of Fat Mass Index (BODPOD [BP] vs. Two Skinfold Technique 
[2S]); Differences vs. Mean 
 
Figure 7: Comparison of Fat Mass Index (BODPOD [BP] vs. Two Skinfold Technique 
[2S]); Differences vs. FMI BP 
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Figure 8: Comparison of Fat Mass Index (BODPOD [BP] vs. Four Skinfold Technique 
[4S]); Differences vs. Mean 
 
Figure 9: Comparison of Fat Mass Index (BODPOD [BP] vs. Four Skinfold Technique 
[4S]); Differences vs. FMI BP 
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Figure 10: Comparison of Fat Mass Index (Two Skinfold [2S] vs. Four Skinfold Technique 
[4S]); Differences vs. Mean 
 
Figure 11: Comparison of Fat Mass Index (Two Skinfold [2S] vs. Four Skinfold Technique 
[4S]); Differences vs. Two Skinfold method 
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The Bland-Altman plots of the test differences plotted against the means, for skinfold 
measurement compared to BODPOD (figures 6 & 8) suggest that, when compared to 
the BODPOD, both skinfold-measurement techniques produce a slightly higher FMI 
than that from the BODPOD. However, the line of equality lies within the 95% 
confidence intervals for the bias (mean of the differences) suggesting overall there is 
no mean difference. More significantly, both skinfold techniques also trend towards 
‘over-reading’ relative to the mean when the FMI is low and then ‘under-reading’ 
when the FMI is higher. This is shown by the marked downslope of the data trend 
across the line of equality from positive to negative differences, on both plots, as the 
FMI increases. This appearance is highly suggestive of systematic error in one of the 
methods used.  
The use of quadratic elements within the skinfold equations which generate body 
density or percentage body fat (originating during the generation of the equations in 
the original research) may be a cause of this. As the two-skinfold (2S) equations are 
not reliant on the equations of Lohman or Siri (and also the BODPOD uses these) it 
does not seem likely that the error is within these conversions, as the same pattern is 
also seen in the four-skinfold data (which does use Lohman/Siri).  
The other possibility is that within the algorithms for predicting thoracic volume by 
BODPOD, as used in this study, there is a similar error: if BODPOD overestimates lung 
volume in lean individuals it will produce a positive difference in the plot for lower 
actual FMI when compared to either skinfold method. A smaller residual body volume 
for measured body weight equates to higher density, thus lower fat content in the 
model, lower FMI and thus underestimate (positive difference) when compared to the 
other methods. To produce the linear error seen, BODPOD would also have to 
underestimate lung volume in obese individuals in order to underestimate body 
density (give higher FMI readings) in those with a higher FMI. As the FMI is indexed 
against height and the BODPOD uses height as a predictor in estimated thoracic gas 
volume, it is also possible that there could be a confounding interaction generated 
here.  
When the plot (figure 10) comparing both skinfold methods is reviewed, the same 
trend towards over- and under-estimate is suggested, albeit in a less pronounced way. 
The mean of the differences is altered towards a positive mean difference bias, but the 
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line of equality is not found within the confidence intervals of this bias. This suggests 
that overall, the four skinfold technique under-reads density relative to the two 
skinfold thus giving a higher FMI and points to the error being in the skinfold equations 
rather than BODPOD volume estimates. 
When examining the limits of agreement for these three plots, it is clear that the 
agreement between methods is clinically significantly different outwith a narrow range 
of FMI where the data trend crosses the line of equality. As would be expected, the 
two skinfold techniques are in closest agreement with each other (1.5 to 2.2kg/m2) 
either side of the line of equality from the mean of the differences). When compared 
to FMI as measured by BODPOD, the limits of agreement are much wider (between 2.5 
and 2.7kg/m2). When the group data is examined, the data can be seen to be skewed 
in all groups with the median fat mass ranging from 3.43 to 4.47kg/m2 [range 1.37 to 
10.82kg/m2]. In this group of individuals, therefore, a difference between techniques 
of 2.5kg/m2 is a large potential difference. Correlation analysis against FMI measured 
with BODPOD using Spearman’s correlation generated a rho value of 0.898 
(4S)/0.923(2S) [p<0.001], but when  the measured differences between the methods 
are considered proportionally to what is being measured, they are too great to say 
anything other than that the tests are not suitable to be used interchangeably in a 
research setting.  
Figures 7, 9 and 11 differ from the three discussed above as they compare the 
difference between methods to the ‘reference method’. For this, we chose BODPOD as 
the reference method as it directly measures body volume rather than extrapolates a 
density or body fat percentage from a proxy measure. Based on the fact that the two-
skinfold method stratifies the calculation by pubertal status and other factors (thus is 
perhaps more tailored within a given population) it was chosen as the reference 
method for the comparison between the two skinfold methods. Using this method did 
not alter any of the findings outlined above.  
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Figure 12: Comparison of Fat Free Mass Index (BODPOD [BP] vs. Two Skinfold 
Technique [2S]); Differences vs. Mean 
 
Figure 13: Comparison of Fat Free Mass Index (BODPOD [BP] vs. Two Skinfold 
Technique [2S]); Differences vs. FMI BP 
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Figure 14: Comparison of Fat Free Mass Index (BODPOD [BP] vs. Four Skinfold 
Technique [4S]); differences vs. Mean 
 
Figure 15: Comparison of Fat Free Mass Index (BODPOD [BP] vs. Four Skinfold 
Technique [4S]); Differences vs. FMI BP 
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Figure 16: Comparison of Fat Free Mass Index (Two Skinfold [2S] vs. Four Skinfold 
Technique [4S]); Differences vs. Mean 
 
Figure 17: Comparison of Fat Free Mass Index (Two Skinfold [2S] vs. Four Skinfold 
Technique [4S]); Differences vs. Two Skinfold method 
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The same analysis was used to examine the techniques in the prediction of Fat-Free 
Mass Index (FFMI). Unsurprisingly, the bias directions were reversed but the pattern of 
distribution was more scattered and did not seem to show the same linear trend as 
seen in the FMI plots. For all three comparisons the 95% limits of agreement were 
similar in magnitude (kg/m2) as the FMI plots but because the FFMI is a larger number 
(as most humans are more lean than fat) the relative error compared to the measured 
FFMI was reduced. However, the fact that the maximum FFMI generated was around 
20kg/m2 (with the median between 15 and 16) the percentage error is still potentially 
(at best) 12.5% for any given measurement. As such, it is not possible to say that these 
tests could be used interchangeably in future studies.  
3.2.2 Lipid compartments and content measured using MRS and Dixon 
methods 
As discussed in my introduction, evidence from the literature suggests that the 
compartmentalisation of lipids is important in determining their eventual physiological 
effect. During the study the percentage of intrahepatic lipid present was measured 
directly using MRS, as were visceral/subcutaneous adipose tissue (at a single 
abdominal level) and serum lipids, in addition to the anthropometric body composition 
measures. We also had a measure of dietary energy, carbohydrate and fat intake from 
the SCRAN24 data. In order to examine the relationship of these variables correlation 
analysis was used, and then a model to examine associations was constructed using 
the significant variables.  
Table 11 shows the measured variables that were thought to be likely to be related 
clinically to intrahepatic lipid content. Spearman’s correlation analysis was used 
initially for this analysis as there is no requirement for normality in the distribution of 
the dataset. Once this was done, a second correlation analysis was done using 
univariate regression. For this, any non-normally distributed data were transformed to 
a normal distribution where possible. Pre- and post-transformation, the variables were 
tested for normality using the Shapiro-Wilk test of normality. The analysis showed that 
the percentage of intrahepatic lipid was most strongly associated with current body 
habitus (measured by current weight SDS, BMI SDS, FMI and percentage body fat), 
visceral adiposity, and serum lipids (most strongly circulating triglycerides). There is 
also a strong association with raised ALT levels: raised ALT is biochemical marker of 
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hepatocyte damage which can happen in the presence of raised intrahepatic lipid, but 
the lipid theory as discussed previously would not suggest it is a cause of raised IHL. In 
fact, when examined using linear regression, the results suggested that the ALT 
increased with lower levels of IHL, which is not physiologically explicable other than 
within the majority of the population studied there is a generally low level of 
intrahepatic fat and normal variation of ALT (within normal laboratory limits). Thus the 
association is likely to be spurious (type 1 error).  
Using combinations of the variables with the strongest association to IHL, models were 
then tested using multivariate linear regression to assess their associations against IHL 
(as the dependent variable). Sequential removal of non-significant terms was carried 
out until a final model was left. Care was taken to avoid using closely related terms 
within the final model (e.g. FMI generated by BP was used but not that generated by 
skinfold measurement). The models used to generate the final model (A-C) are 
outlined below (table 12 to 14).  
 
 
 
 
 
 
 
Table 11 (next page): Spearman’s Correlation Analysis of measured variables against 
percent IHL (correlation coefficient) and Correlation using univariate linear regression 
[*p<0.1; **significant (p<0.05)] Note: Birth weight SDS was not transformable to a 
normal distribution  
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Measurement (vs. IHL) Corr.Coeff. 
(Rho) 
P value R2 P value 
Birth Weight SDS 0.02 0.88 N/A N/A 
Gestational age  -0.18 0.16 0.02 0.32 
Age at study visit -0.10 0.44 0.01 0.56 
Current weight SDS 0.22 0.09* 0.14 0.004** 
Percentage Body Fat 0.30 0.02** 0.10 0.02** 
Percentage Lean  -0.30 0.02** 0.11 0.01** 
Fat Mass Index (BODPOD™) 0.29 0.03** 0.10 0.02** 
Fat Mass Index (4 Skinfold) 0.18 0.17 0.05 0.10* 
Fat Mass Index (2 Skinfold) 0.28 0.03** 0.11 0.01** 
Body Mass Index SDS 0.23 0.07* 0.14 0.004** 
Waist circumference (cm) 0.25 0.06* 0.17 0.001** 
Mid-arm circumference (cm) 0.07 0.59 0.03 0.20 
Visceral adipose tissue (VAT) 0.21 0.11 0.23 <0.001** 
Subcutaneous adipose tissue 
(SAT) 
0.25 0.05* 0.10 0.02** 
VAT/SAT ratio -0.03 0.82 0.01 0.58 
VAT index (cm2/m2) 0.22 0.09* 0.21 <0.001** 
SAT index (cm2/m2) 0.26 0.05** 0.06 0.06* 
Tanner Stage  -0.19 0.14 N/A N/A 
Serum Cholesterol 0.25 0.10* 0.19 0.003** 
Serum Triglyceride 0.33 0.02** 0.24 <0.001** 
Low Density Lipoprotein-C 0.27 0.08* 0.20 0.002** 
Serum Alanine Transferase  0.32 0.03** 0.25 <0.001** 
Total Energy intake (in 24 hours)  0.09 0.49 0.002 0.77 
Carbohydrate intake (in 24 hours) 0.09 0.49 0.005 0.58 
Fat intake (in 24 hours) 0.04 0.75 0.0001 0.93 
Protein intake (in 24 hours) 0.0017 0.99 0.001 0.79 
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Variable Model 1 Model 2 Model 3 Model 4 
Triglyceride 0.022 0.018 0.001 <0.001 
LDL-C 0.467 0.056 - - 
Cholesterol 0.666 - - - 
Tanner St 1-3 - - - >0.05 
Tanner St 4 - - - 0.007 
Tanner St 5 - - - 0.04 
R2 0.31 0.30 0.24 0.39 
Adjusted R2 0.25 0.27 0.22 0.31 
p value (for 
model) 
0.002 <0.001 <0.001 0.001 
Table 12: Multivariate model (A): Serum markers and significance in model where IHL 
is the dependent variable (p value of each component of model shown). Adjusted 
model for Tanner stage shown: Likelihood ratio testing of model excluding Tanner 
Stage shows Tanner Stage is significant in the complete model (p=0.04). 
Variable Model 1 Model 2 Model 3 Model 4 Model 5 
Waist Circumference 0.18 0.03 0.03 0.001 <0.001 
% Bodyfat (BODPOD) 0.54 0.54 0.81 - - 
FMI (BODPOD) 0.56 0.57 - - - 
BMI SDS 0.89 - - - - 
Tanner St 1-3 - - - - >0.1 
Tanner St 4 - - - - 0.02 
Tanner St 5 - - - - 0.04 
R2 0.17 0.17 0.17 0.17 0.27 
Adjusted R2 0.11 0.12 0.14 0.15 0.20 
p value (for model) 0.04 0.02 0.007 0.001 0.004 
Table 13: Multivariate model (B): body composition measurements and significance in 
model where IHL is the dependent variable. Adjusted model for Tanner stage shown: 
Likelihood ratio testing of model excluding Tanner Stage shows Tanner Stage is not 
significant in the complete model (p=0.09) 
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Variable Model 1 Model 2 Model 3 Model 4 
Visceral Adipose Tissue (VAT) 0.35 0.03 <0.001 <0.001 
Subcutaneous Adipose Tissue  0.68 0.64 - - 
VAT index 0.74 - - - 
Tanner St 1-5 - - - >0.1 
R2 0.23 0.23 0.23 0.26 
Adjusted R2 0.19 0.20 0.22 0.19 
p value (for model) 0.002 <0.001 <0.001 0.005 
 
Table 14: Multivariate model (C): Lipid compartmentalisation and significance in model 
where IHL is the dependent variable. Adjustment for Tanner stage is not significant 
 
 
Variable Model 1 Model 2 Model 3 
Triglyceride  0.008 0.005 0.001 
VAT 0.05 0.009 0.017 
Waist 
Circumference 
0.85 - - 
Tanner St 1-3 - - >0.05 
Tanner St 4 - - 0.007 
Tanner St 5 - - 0.03 
R2 0.35 0.35 0.47 
Adjusted R2 0.31 0.32 0.40 
p value (for model) 0.0004 0.0001 0.0002 
Table 15: Multivariate model (D): Significant variable from models A-C and significance 
in final model where IHL is the dependent variable. Adjusted model for Tanner stage 
shown: Likelihood ratio testing of model excluding Tanner Stage shows Tanner Stage is 
significant in the complete model (p=0.047) 
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Models A to C show that compared to IHL, serum triglyceride is the most strongly 
associated of the serum measures, waist circumference is the most closely associated 
body composition/habitus measure and visceral adipose tissue is the most strongly 
associated direct adipose tissue measure (not indexed for height).  
The final model (D; table 15) shows that a combination of serum triglyceride level and 
visceral adipose tissue explain at least 32% of the variance seen in IHL levels. 
Adjustment for Tanner Stage did not show any reduction in statistical significance in 
the variables most closely associated with IHL deposition (they remained p<0.05), but 
was found to be significant when added to the model in association with triglyceride 
level (model A) thus also in the final model (models D and E). The correlation 
coefficients for Tanner staging were consistently negative (i.e. the higher the stage, 
more negative the association with IHL). There was no evidence of a significant 
contribution from Tanner staging to the association between VAT and IHL or waist 
circumference and IHL.  
Further analysis using Spearman’s test of correlation showed that there was no 
significant direct correlation between Tanner Stage and any of the serum variables 
(triglyceride, LDL-C, cholesterol or ALT: all p>0.1), body composition assessments or 
measured adipose tissue (VAT, SAT, VAT Index, SAT Index, FMI, % body fat: all p>0.1) 
but there was a correlation with waist circumference (P=0.005), mid arm 
circumference (p<0.001) and BMI SDS (p= 0.007). In the multivariate analysis there was 
a suggestion that the effect of Tanner Stage was strongest at self-assessed Stage 4 and 
5. A Kruskall-Wallis test was therefore used to assess variables by staging (Tanner St 1 
to 5) to see if these individual groups would show a difference. There was no 
demonstrable difference when stratified by these groups for IHL (p=0.36), VAT 
(p=0.91) FMI (0.44) or triglyceride (p=0.83). When the stages were grouped further 
(Tanner St 1-3 [pre-pubescent] vs. 4[pubescent] vs. 5[post-pubescent]) and tested 
using the same test, there was no significant difference in the groups in IHL (p=0.3), 
VAT (p=0.76) or triglyceride (p=0.68) though BMI SDS, mid-arm circumference and 
waist circumference were all still significantly different between the groups (p<0.05 for 
all).  
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When analysing the final model, it was found that there was significant 
heteroskedasticity in the data (i.e. it was not possible to say confidently that IHL and 
VAT/triglycerides were independent from a statistical perspective). The data was 
therefore reanalysed after transforming IHL to normalise the data (though 
theoretically this should not have affected the original model as IHL was the 
dependent variable). Transformation removed the heteroskedasticity and while it 
altered the p values for the individual terms, did not change the overall effect (see 
table 16). Including Tanner Staging did strengthen the model, as before. 
With these findings in mind, the three preliminary models (A-C) were re-analysed but 
the three variables chosen for the final model all remained the most significant in re-
analysis and therefore were used in the revised model. The original models (A-C) have 
been presented here as the use of a non-normally distributed independent variable is 
acceptable in the tests used.  
 
Variable Model 1 Model 2 
Triglyceride  0.01 0.001 
VAT 0.069 0.113 
Tanner St 1-3 - 0.08 
Tanner St 4 - 0.008 
Tanner St 5 - 0.004 
R2 0.26 0.45 
Adjusted R2 0.23 0.35 
p value (for model) 0.002 <0.001 
Table 16: final model recalculated (E) and adjusted to remove heteroskedasticity by 
transformation of dependent variable to normal distribution (IHL). Adjusted model for 
Tanner stage shown: Likelihood ratio testing of model excluding Tanner Stage shows 
Tanner Stage is significant in the complete model (p=0.01). 
87 
 
3.2.3 Discussion 
It is clear from the correlation analysis done between the auxological and body 
composition measures that there is a good correlation between them, i.e. all the 
measures tested report adiposity when it is present. It is also clear that they are well 
correlated with the visceral and subcutaneous fat deposition as directly measured in 
the study, but not so well with the intrahepatic lipid status. This raises the possibility 
that deposition of lipids in some compartments within the body is ‘linear’ in relation to 
overall adiposity (thus predictable from indirect measures of adiposity such as BMI or 
waist circumference) but (in the study cohort at least) the deposition of intrahepatic 
lipid may not be linear, and may only occur after a certain metabolic or adiposity 
threshold has been reached.  
The comparative analysis using Bland Altman plots to further interrogate the body 
composition measurements showed that, in this population, the accuracy of the 
skinfold equations in predicting body fat percentage was not within small enough 
limits of agreement to be able to say that they could be used in a clinic setting in a 
bigger study monitoring an intervention. This study, based on the literature has 
assumed that the BODPOD is the gold standard as it reportedly has good reliability (in 
reproducibility of results) and the estimate thoracic volume has been shown to be 
reliable in the age group which we were testing (Fields et al., 2002; Fields et al., 
2004b). It also has the advantage of directly measuring body volume and therefore 
should be prone to less error and extrapolation when compared to measurement of 
skinfolds. Within the use of the BODPOD, we have made assumptions about hydration 
status being equivalent in all the children (as all our volunteers had fasted overnight) 
and as noted in the comparative plots, one explanation for the systematic error seen 
might an error in the estimate of thoracic gas volume. It also uses the equations of Siri 
and Lohman which will introduce a degree of assumption due to the nature of their 
two-compartment models.  However, the skinfold measurements have a higher degree 
of mathematical extrapolation to arrive at a density and will therefore be prone to 
more error. In addition, the equations used for the two-skinfold technique has 
arbitrary cut-offs for age and pubertal status which will have an influence on their 
accuracy in any given population, whereas the BODPOD provides a measurement of 
density without categorisation at that stage. There is also the issue of population 
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specificity when using the skinfold techniques, which are now quite old. There has 
been a change in the levels of obesity in children in the last 30 years and as such, the 
original equations relating skinfold summation to a test population may well be out of 
date in relation to modern children by virtue of the original test population being very 
different to their modern counterparts. As such, air displacement plethysmography  
(using the BODPOD™) would have to be the recommended method for this type of 
assessment in a future intervention study in this age group. While correlation analysis 
shows some good correlations between IHL and auxometric measurements such as 
FMI, BMI and waist circumference the fat that none of these are predictively 
associated with IHL at regression suggest that if, in a future study, intrahepatic lipid is 
the measurement of interest, then it will need to be measured using MRI. While 
correlated, none of the other methods offer a suitably proxy measurement.   
When considering the measurement of intrahepatic lipid, the results which the study 
produced are largely in line with the literature published about metabolic outcomes in 
adolescents and older, namely that during this time any measurable effect of 
prematurity becomes harder to detect and influences from the environment seem to 
become predominant(Tinnion et al., 2014). It is only for a few specific adult health 
outcomes such as blood pressure and arterial wall stiffness that there is clear origin 
and persisting contribution from preterm birth, in the context of a structural change in 
the body (e.g. nephron number)(Parkinson et al., 2013). In this study, there was no 
demonstrable association between IHL and either birthweight SDS or gestational age. 
While these are crude measurements of the potential effects of preterm birth, any 
proportional programming events might be expected to be related directly to degree 
of prematurity or relative size at delivery. Their absence in this study does not preclude 
more subtle or ‘one-off’ programming events (or critical windows) but does suggest 
that variation in the cohort may be more as a result of postnatal environment.  
The current literature regarding visceral adipose tissue and intrahepatic lipid in 
children and adolescents covers a variety of measurement techniques both in imaging 
modality ( CT/MRI/ Ultrasonography/DEXA) and in vertebral level at which the image is 
taken (in those that use axial imaging)(Suliga, 2009). When looking at parameters 
derived independently of imaging, and associations which might explain the variance 
in VAT (in regression analysis), different authors have found that waist 
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circumference(Asayama et al., 2002; Asayama et al., 2005; Benfield et al., 2008) and 
trunk skinfolds(Fox et al., 2000) have been strongly, positively associated with VAT. 
Neither, individually, fully explained the variance. Some analyses extending data across 
different ages of child and ethnic sub-groups are less convincing about how predictive 
WC and BMI are for predicting VAT, though they correlate well at all ages with total 
adiposity(Bouchard, 2007; Katzmarzyk and Bouchard, 2014). There is also 
disagreement in the literature as to whether the site of measurement of waist 
circumference influences how well it correlates as a proxy for visceral adipose 
tissue(Bosy-Westphal et al., 2010) or cardiometabolic risk(Harrington et al., 2013). 
Visceral adipose tissue has been positively associated with triglyceride levels in obese 
adolescents(Caprio et al., 1996) as well as basal insulin levels(Caprio, 1999) but other 
fat compartments were not. As might be expected, some of the variation seen in VAT 
levels and distribution between populations can be explained by genetic and ethnic 
differences (summarised by Suliga (Suliga, 2009)). Work by Goran and co-
authors(Goran et al., 1997; Goran et al., 1998; Goran, 1999; Goran and Gower, 1999) 
sought to characterise some of the life course changes that might affect visceral fat 
and suggest that (as would be expected) age, level of development and pubertal status 
all have an influence on VAT, as well as those influences that are modifiable (also 
known as ‘lifestyle’ factors). The influence of gender and puberty is variable across 
ethnic origin(Staiano et al., 2013). However, when considering the contribution to 
disease it has to be remembered that in the majority of children the absolute levels of 
VAT remain small in comparison to subcutaneous adipose tissue(Benfield et al., 2008).  
Intrahepatic lipid is most often studied in the context of disease, especially non-
alcoholic fatty liver disease (NAFLD). In those born preterm, Modi’s group from London 
(UK) has demonstrated with MRI/MRS that, even as outwardly healthy adults, those 
born preterm have a higher level of intrahepatic lipid than their terms-born 
peers(Thomas et al., 2008; Thomas et al., 2011). The group have also suggested that 
intrahepatic lipid levels are primarily correlated to neonatal illness severity (rather 
than growth or nutrition) and this, therefore, has potential implications for all babies 
born preterm who require intensive care.  A cohort of Danish children, including lean 
and obese subjects, aged 8 to 18 years, showed that the prevalence of raised 
intrahepatic lipid was 31% in the obese group (vs 3% in the lean) and that where there 
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was hepatic steatosis, it was strongly associated with dyslipidaemia and increased 
glycosylated haemoglobin(Fonvig et al., 2015). Della Corte’s cohort of 60 children 
compared hepatic steatosis in children with NAFLD (n=30) and children with familial 
hypobetalipoproteinaemia (n-=30)(Della Corte et al., 2013). The degree of steatosis 
was similar between the two groups but the NAFLD group had worse insulin sensitivity, 
suggesting that the presence of lipid per se (like in skeletal muscle) is not necessarily 
the only factor in subsequent pathological processes within the liver. Similar 
associations have been shown in targeted, obese, paediatric populations (defined 
variably as BMI >90 or 95th centile for the local population). Bille’s cohort of those aged 
6 to 20 years old who were obese demonstrated increased total body fat and high 
levels of liver enzymes on serum testing (suggesting hepatocyte damage) and of these, 
gamma-glutaryltransferase and alanine transferase were predictive of high levels of 
hepatic lipid(Bille et al., 2012). VAT was also shown to be strongly associated with 
hepatic steatosis. Similarly, Duarte showed a significant positive association with waist 
circumference and hepatic lipid in a cohort of 77 children aged between 2 and 13 years 
old(Duarte and Silva, 2011). Though there is, therefore, evidence suggesting that there 
is a link between adverse metabolic phenotypes and hepatic lipid deposition, it is not 
yet clear how, exactly, hepatic lipid seen in children might then move on to cause 
problems in adulthood. While it is clear in adults with newly diagnosed T2DM that 
imposing a fasting diet has a marked effect in improving insulin sensitivity(Lim et al., 
2011a), and the authors of the research into increased IHL/VAT in children suggest that 
these are a sensible target for reduction during childhood to try to start adulthood 
with a ‘clean slate’, the studies to show sustained improvement in adult health 
outcomes by intervention in children with increased IHL/VAT have not yet been done.  
One theory which might help to explain why some populations are susceptible to lipid 
deposition in the liver and subsequent (or concurrent) metabolic dysregulation is the 
unfolded protein response (UPR) theory(Henkel and Green, 2013). Endoplasmic 
reticulum stress provokes the UPR as a protective mechanism. It in turn has a role to 
play in regulating lipid metabolism (especially as ectopic lipid deposition is a source of 
endoplasmic reticulum stress). Thus a defect in, or dysregulation of, the UPR may lie at 
the root of unwanted hepatic lipid deposition and form part of a vicious cycle therein. 
It is worth noting that (as discussed previously) inflammation and endoplasmic 
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reticulum stress may be contributory to worsened insulin sensitivity and it is possible, 
therefore, that such a reduced sensitivity might be present in parallel with hepatic lipid 
deposition. In addition, deposition of lipid and a direct effect on basal insulin sensitivity 
(i.e. the lipid induction theory) through interruption of expression of glucose 
transporters might also be present alongside these processes as a contributor to the 
cellular stress (as glucose deprivation also worsens endoplasmic reticulum stress).  
This study, of a cohort of adolescents born preterm, has shown that circulating 
triglyceride levels and visceral adipose deposits are positively associated with 
increasing levels of IHL in these children who were born preterm. Visceral adipose 
tissue levels do not appear to be directly associated with either resting insulin 
sensitivity of glucose disposal (see 3.4.4). It is not possible to say whether the 
circulating triglycerides are a causal agent or a symptom of hepatic lipid overload as 
some authors suggest. The presence of visceral adipose tissue in association with 
hepatic lipid deposition has already been shown in other study populations (the ‘portal 
drainage’ theory (Bjorntorp, 1990)). This study shows that it may also exists in the 
Growmore cohort, and regardless of aetiology, it importantly suggests a potential 
target for intervention. It is interesting that there is a strong association of a measured 
area of visceral adipose tissue at a single cross-sectional abdominal level, but when 
indexed to try to correct for body height, this association is less strong. These results 
sit alongside strong correlations seen between overall measures of obesity (e.g. waist 
circumference and BMI SDS) and amount of intrahepatic lipid, which do not translate 
into a direct association when using regression analysis. O’Connor(O'Connor et al., 
2015) found a strong association with waist circumference and visceral adipose tissue 
using the same vertebral level in females as we did, but slightly different in males (L1-
2). It is possible this reflects that overall obesity is not important when considering 
deposition of lipid in the liver (i.e. only the visceral compartment is active in 
contributing to intrahepatic lipid) but that where there are auxological markers for 
obesity there is increased risk of visceral lipid deposition. This may also reflect a 
genetic component (either inherited or epigenetic) which predisposes some individuals 
to visceral lipid deposition in the absence of marked overall obesity, and others to non-
visceral adiposity with relatively lipid-free organs. 
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In this population of adolescents pubertal status clearly makes a contribution to the 
level of IHL seen. The association is a negative one such that IHL decreases as puberty 
progresses through to completion. The data suggest that including Tanner Stage 
improves the strength of the models when considering IHL deposition, but there was 
not a clear correlation with other variables to suggest a simple mechanism through 
which this occurring (i.e. in isolation, Tanner stage did not clearly correlate with any of 
the key variables that were associated with IHL levels in the regression analysis). As 
might be expected, Tanner stage was associated with overall habitus, but only 
improved model strength in the regression models which had serum triglycerides as a 
variable. It may be that pubertal status is working through a mechanism related to lipid 
metabolism and adipose tissue elsewhere in the body through puberty (not viscerally) 
thus is related to triglyceride levels rather than IHL per se. However, as expected, 
increased circulating triglyceride levels are associated with increasing amounts of IHL 
which may be cause, effect, or both, in relation to hepatic lipid deposition.  
The data did not show any link between dietary intake of total calories nor, specifically, 
fat/carbohydrate intake as measured by SCRAN24, and IHL. This probably reflects that, 
in this group of individuals, the fasting prior to examination as part of the study 
protocol means that the liver will have returned to a ‘baseline’ amount of lipid in it. It 
could be speculated that this is probably more representative of an individual’s long 
term environment or diet than it is of the intake in the preceding 24 hours. Less 
metabolically flexible individuals would be expected to have higher baseline amounts 
of IHL compared to their metabolically health peers. However, other authors have 
noted a lack of correlation between visceral adipose tissue and 
diet/nutrition(Bouchard et al., 1993). 
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3.3 Directly Measured Physical Activity, Skeletal Muscle Kinetics and 
Vitamin D 
After each study visit the participants were offered the opportunity to wear 
accelerometers for three days to objectively measure their physical activity. This was 
done to allow comparison between the physiological measurements of muscle 
mitochondrial oxidative function taken by 31P-MRS and how active the volunteers 
were in the non-laboratory setting. In addition, Vitamin D was measured on any fasting 
serum samples taken, in order to factor this into the results, as it has been shown that 
vitamin D is associated with the muscle kinetics seen by this method (Sinha et al., 
2013). 
3.3.1 Objectively measured physical activity 
Accelerometers were used as described in the methods to measure physical activity 
during a three day period after the study. The cut-points used for counts per minute 
allowed the activity to be classified into sedentary, light or moderate-to-vigorous 
(Evenson et al., 2008) and for each, a sub-classification of daily mean percentage time 
or daily mean number of minutes in that degree of activity. Figure 18 clearly shows 
that the cohort as a whole were not achieving the nationally recommended 60 minutes 
per day of moderate-to-vigorous activity (Strong et al., 2005; Basterfield et al., 2008).  
 
Figure 18: Moderate to vigorous activity (daily mean) in the cohort. National 
recommended minimum shown by red line. 
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 Male vs. Female Growth vs. 
Protein study 
Total Minutes Activity (mean/day) 0.95 0.76 
MVPA (mean minutes) 0.07* 0.31 
MVPA (mean % total activity) 0.07* 0.29 
Sedentary activity (mean minutes) 0.28 0.76 
Sedentary activity (mean % total) 0.02** 0.09* 
Light activity (mean minutes) 0.15 0.25 
Light Activity (mean % total) 0.02** 0.11 
Mean Step-count/day 0.14 0.43 
Table 17: Within-cohort analysis of directly measured activity using accelerometers. 
Table shows p-values for Mann Whitney U test [*p<0.1; **p<0.05] 
Valid results (>6 hours per day wear-time) from the cohort were obtained in a total of 
44/60 who took the devices home. Reasons for not meeting the criteria were diary-
validated wear-time too short, failure to return the device, periods of unexplained low 
level activity which did not correspond with the written diaries where it was not 
possible to confirm that the device was being worn.  
 
Figure 19: Percentage of time in light activity (daily mean) in the cohort: comparison of 
girls vs. boys. 
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Table 17 shows the main activity categories assessed for differences between sexes 
and shows that the boys in the cohort were more active than the girls (see figures 19 
and 20) but this was only significant for light activity and sedentary activity. There was 
a trend observed for MVPA but this was not significant. There was no statistical 
significance between those individuals recruited into either the original growth study 
or the protein study. 
 
Figure 20: Percentage of time in sedentary activity (daily mean) in the cohort: 
comparison of girls vs. boys. 
 
 
Table 18 presents a correlation analysis between the different categories of activity, 
total activity and mean daily step count, and other variables which it was thought 
could influence the activity. As these are associations, there is no comment on 
causality and though the exercise measures are presented as the dependent variables, 
if causality exists, they may be the independent variable. [*p<0.1;**p<0.05]  
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 Total 
Mins 
(mean/
day) 
MVPA 
(mean 
mins) 
MVPA 
(mean 
%) 
Sedy 
act. 
(mean 
mins) 
Sedy 
act. 
(mean 
%) 
Light 
act. 
(mean 
mins) 
Light 
act. 
(mean 
%l) 
Mean 
Step-
count/
day 
Birth weight 
SDS 
0.49 0.68 0.52 0.86 0.39 0.08* 0.06* 0.75 
Gestational 
age at birth 
0.83 0.09* 0.17 0.90 0.50 0.78 0.79 0.24 
Age at 
Study visit 
0.76 0.07* 0.07* 0.78 0.13 0.63 0.38 0.17 
Height SDS 0.26 0.47 0.66 0.25 0.99 0.94 0.85 0.77 
Current Wt 
SDS 
0.33 0.59 0.99 0.11 0.30 0.45 0.22 0.72 
Current 
BMI SDS 
0.89 0.99 0.71 0.46 0.24 0.39 0.21 0.55 
Visceral 
Adipose 
Tissue (cm2) 
0.42 0.84 0.47 0.18 0.60 0.88 0.97 0.78 
Subcutaneo
us Adipose 
Tissue (cm2) 
0.89 0.23 0.16 0.33 0.05* 0.23 0.09* 0.15 
VAT/SAT 
ratio 
0.73 0.49 0.42 0.39 0.11 0.27 0.05* 0.44 
VAT Index 
(cm2/m2) 
0.61 0.84 0.55 0.35 0.79 0.75 0.86 0.92 
SAT Index 
(cm2/m2) 
0.93 0.31 0.21 0.34 0.07* 0.29 0.11 0.22 
Fat-free 
mass index 
(BODPOD) 
0.45 0.46 0.72 0.56 0.52 0.49 0.37 0.93 
Fat mass 
index 
(BODPOD) 
0.34 0.27 0.26 0.84 0.10 0.18 0.13 0.18 
Waist 
Circumfere
nce 
0.62 0.34 0.24 0.45 0.05* 0.09* 0.08* 0.09* 
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Mid-arm 
Circumfere
nce 
0.75 0.37 0.21 0.23 0.053* 0.21 0.08* 0.12 
HOMA%S 0.36 0.84 0.63 0.51 0.98 0.40 0.48 0.77 
Matsuda 
Index 
0.09* 0.51 0.68 0.50 0.12 0.01** 0.02** 0.11 
Serum 
Vitamin D 
0.95 0.25 0.18 0.30 0.09* 0.20 0.09* 0.15 
Tanner 
Stage1 
0.57 0.25 0.43 0.99 0.34 0.22 0.28 0.22 
Q1 vs. Q4 
Matsuda 
Index2 
0.10* 0.50 0.63 0.57 0.10 0.02** 0.02** 0.07* 
Q1 vs. Q4 
HOMA%S2 
0.051* 0.56 0.43 0.17 0.85 0.14 0.44 0.70 
Season 
(March to 
Sept vs. Oct 
to Feb)2 
0.43 0.79 0.73 0.23 0.55 0.93 0.58 0.82 
Table 18: Correlation analysis of directly measured physical activity using 
accelerometers, (Spearman’s Correlation Analysis unless stated). Table shows p-values. 
Note: within cohort analysis shown for Tanner Stage, quartile and season 
comparison.1: Kruskall-Wallis Test; 2: Mann Whitney U test [*p≤0.1;**p<0.05] 
 
Total Activity Time 
This measure of activity was most closely associated with the Insulin Sensitivity (IS) 
measures, in particular the Matsuda Index which is an estimation of glucose disposal. 
More daily activity would fit with a better baseline metabolic flexibility, but in those 
volunteers who achieved a minimum of six hours wear-time it is not possible to say 
whether they were worn for the full duration of the waking hours. The near-significant 
correlation (figure 21) with the HOMA modelling quartile analysis must also be viewed 
with caution for this reason, though the analysis showed that those in Q1 (least IS) had 
fewer total minutes of activity per day than those in Q4 (most IS).  
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Moderate to Vigorous Physical Activity 
None of the variables examined in association with measured activity was significant 
for MVPA, but there was a trend towards age at study being associated: the younger 
the individual, the greater the time spend in MVPA. This finding is well described in 
other groups of children (Basterfield et al., 2012). One recent study found an increase 
in fat-free mass index (in children who were younger and born small for gestational 
age at term) with increased moderate activity(Kennedy et al., 2013), but this is not 
seen in our cohort. 
 
Figure 21: Total daily activity (mean minutes/day): comparison of most and least 
insulin sensitive by HOMA modelling (% sensitivity shown).  
Sedentary Activity 
The correlation analysis showed that there was a trend towards increased percentage 
time in sedentary activity associated with some markers of adiposity (Subcutaneous 
Adipose Tissue (SAT) Index, waist circumference, mid-arm circumference). This is 
consistent with other childhood cohorts (Basterfield et al., 2012).  
Light Physical Activity 
The most striking finding in the analysis for light activity was the association with the 
measured Matsuda Index (see figure 22). For both percentage of time in light activity 
and the daily minutes in light activity the association was statistically significant 
99 
 
(p<0.05) suggesting that those who did more light exercise were also more insulin 
sensitive when given a glucose load. The absence of this association for IS measured 
using the HOMA method suggests that it is specifically related to metabolic flexibility 
as described by Kelley (Kelley, 2005) rather than ‘baseline’ fasting IS. This is discussed 
more in section 3.4. Trends towards a reduction in adiposity (SAT, waist circumference 
and mid-arm circumference) are also seen with an increase in time in light activity. 
Surprisingly, birthweight SDS score also seems to trend towards an association with 
time in light activity: time spent in light activity increases with lowered birthweight 
SDS. It is possible this is not a true effect as there is no association with gestational age 
at birth which is highly correlated with birthweight in terms of maturity (i.e. the 
birthweight SDS decreases with increased gestational age due to recruitment criteria 
from the original studies).  
 
 
Figure 22: Significant correlation between Matsuda Index and light activity measured 
using accelerometry 
 
Total Step Count (mean/day)  
In line with the findings for light activity, there were trends seen associating increasing 
total step count/day with a reduction in waist circumference. The difference between 
highest and lowest quartiles for Matsuda Index when comparing total step count 
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within the cohort also showed a trend towards increased IS with higher daily step 
counts. 
 
Figure 23: Trend towards increased daily step count between most and least insulin 
sensitive (Matsuda Index quartiles) 
 
3.3.2 Skeletal Muscle Kinetics and mitochondrial oxidative capacity measured 
by 31P-MRS 
One of the main investigative techniques used in this study was Magnetic Resonance 
Spectroscopy (MRS). To assess in-vivo mitochondrial function, 31P-MRS was used. A 
total of 59 of the cohort had an MRI scan and raw data was obtained from all of these. 
The raw data was subject to post-collection analysis as outlined in the methods and 
tables 19 to 21 present this data. There are two measures for phosphocreatine 
recovery (τ½PCr) which is the measure used here as a direct assessment of 
mitochondrial oxidative capacity in skeletal muscle. The better the oxidative capacity 
(measured by PCr recovery), the shorter the half time seen. Both datasets have both 
been processed using the Iotti correction to adjust the half times around the mean pH 
of the group, in order to allow within group comparisons (Iotti et al., 1993). For this 
group, those participants who did not fully deplete their PCr store during the exercise 
were removed from analysis (leaving n=50). The τ½ADP is also presented. This 
measure gave a reciprocal measure of the process ongoing during the exercise and 
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also gave information about the quality of the MRS not always available by looking at 
the PCr results. The ADP curves were sensitive to inorganic phosphate splitting where 
the voxel crossed across two muscle groups, which then recovered at different rates. 
While this gave an overall τ½PCr, it could not necessarily be considered as accurate as 
those individuals who had no splitting (n=38). Therefore, the affected individuals were 
removed to give the data set presented here as ‘Iotti-adjusted PCr recovery (τ½PCr) 
adjusted for non-split τ½ADP’.  
Tables 19 and 20 show that there was no significant within cohort difference for either 
boys vs. girls, original study enrolment or the extremes of measured insulin sensitivity. 
Spearman correlation analysis of recorded minimum pH during standardised exercise 
showed no correlation between nadir pH and insulin sensitivity measured by either 
HOMA%S (Rho:  -0.10; p=0.64) or Matsuda Indices (Rho: 0.07; p=0.75). Serum 
triglyceride levels were also analysed with respect to the measured muscle kinetics 
and no correlation was found (p=0.65). 
 Male vs. Female Growth vs. Protein 
study 
Iotti-adjusted PCr recovery (τ½PCr) 0.26 0.09* 
Iotti-adjusted PCr recovery (τ½PCr) 
adjusted for non-split τ½ADP  
0.48 0.63 
τ½ADP 0.36 0.99 
Table 19: Comparison of 31P-MRS measured muscle kinetics by group within the 
cohort. (Mann-Whitney U test); Table lists p-values for the comparisons. *p<0.1 
 
 HOMA%S Q1 vs. Q4  Matsuda Index Q1 
vs. Q4  
Iotti-adjusted PCr recovery (τ½PCr)  0.62  0.85 
Iotti-adjusted PCr recovery (τ½PCr) 
adjusted for non-split τ½ADP  
0.85 0.44  
τ½ADP 0.41   0.12  
Table 20: Comparison of 31P-MRS measured muscle kinetics by groups within the 
cohort: comparison of most (Q4) and least (Q1) insulin sensitive. (Mann-Whitney U 
test); Table lists p-values for the comparisons.  
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 Iotti-adjusted 
PCr recovery 
(τ½PCr) 
Iotti-adjusted 
PCr recovery 
(τ½PCr) 
adjusted for 
non-split 
τ½ADP 
τ½ADP 
Birth weight SDS 0.59 0.97 0.87 
Gestational age at birth 0.079* 0.054* 0.07* 
Age at Study visit 0.26 0.69 0.67 
Tanner Stage 0.12 0.45 0.71 
Height SDS 0.46 0.09* 0.15 
Current Wt SDS 0.64 0.99 0.87 
Current BMI SDS 0.62 0.52 0.75 
Fat mass index (BODPOD) 0.47 0.55 0.80 
Fat-free mass index (BODPOD) 0.37 0.58 0.92 
Visceral Adipose Tissue (cm2) 0.58 0.41 0.29 
Subcutaneous Adipose Tissue 
(cm2) 
0.91 0.91 0.74 
VAT/SAT ratio 0.66 0.75 0.44 
VAT Index (cm2/m2) 0.41 0.25 0.24 
SAT Index (cm2/m2) 0.67 0.60 0.93 
Total Minutes Activity 
(mean/day) 
0.59 0.82 0.92 
MVPA (mean minutes) 0.52 0.33 0.25 
MVPA (mean % total activity) 0.52 0.47 0.34 
Sedentary activity (mean 
minutes) 
0.44 0.91 0.74 
Sedentary activity (mean % 
total) 
0.15 0.38 0.39 
Light activity (mean minutes) 0.29 0.34 0.57 
Light Activity (mean % total) 0.12 0.43 0.55 
Mean Step-count/day 0.57 0.49 0.46 
Wt SDS change [term to 2yr] 0.85 0.12 0.097* 
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Waist Circumference 0.85 0.91 0.78 
Mid-arm Circumference 0.63 0.87 0.94 
Serum Vitamin D 0.03** 0.44 0.26 
Table 21: Spearman Correlation analysis for muscle kinetics (τ½: half time for recovery; 
PCr: Phosphocreatine; ADP: adenosine diphosphate). MVPA: moderate-to-vigorous 
physical activity. For activity measures, mean (either minutes or % of total activity) is 
calculated over 3 days total data collection with minimum of 6 hours per day recorded. 
Wt. SDS: weight standard deviation (z) score. *p<0.1; **p<0.05 
 
 
Table 21 shows correlation analysis of non-transformed variables using Spearman’s 
correlation in relation to τ½PCr and τ½ADP. Univariate linear regression was also 
performed for these variables and yielded similar results, but required extensive 
transformation of the variables to normalise the data for regression. For this reason, 
the univariate regression data is therefore not presented here. There is a consistent 
association with gestational age and the length of half time during recovery (p=0.05 to 
p=0.07) with longer times seen in those individuals who were more preterm when 
born (see figure 24). In the Iotti-adjusted PCr recovery (τ½PCr) dataset, vitamin D is 
also significantly associated with the half time: the greater the vitamin D level, the 
quicker the half-time recorded (figure 25). This is not seen when those individuals with 
inorganic phosphate splitting are removed. 
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Figure 24: correlation between τ½PCr and gestational age at birth.  
 
 
Figure 25: correlation between τ½PCr and Serum Vitamin D levels 
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Vitamin D 
As other work has shown (Sinha et al., 2013), vitamin D is associated with muscle 
kinetics measured with 31P-MRS and potentially a reversible cause of worsened 
mitochondrial oxidative capacity. Therefore, analysis was done to assess what factors 
might be influencing serum Vitamin D levels. In line with findings published in the 
literature, the Vitamin D levels in the cohort were significantly negatively associated 
with measures of adiposity (see table 22) and there was a similar negative association 
trend with sedentary activity. There was a trend towards a positive association with 
the percentage of time spent in light activity, and vitamin D was strongly positively 
associated with improved insulin sensitivity by both measures used in the study (see 
section 3.4). Unsurprisingly, serum vitamin D levels correlated with the month of the 
year, and time of year when considered as a dichotomous variable. These results are 
shown in figures 26 to 29. Multivariate analysis was attempted to refine causation for 
Vitamin D levels but none of the models generated were valid as the terms used were 
not found to be independent. This is perhaps in keeping with the fact that vitamin D 
has many effects across many body systems (Girgis et al., 2013).   
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 Serum Vitamin D level 
Male vs. Female1 1.11; 0.27 
Growth vs. Protein study1 -0.44; 0.66 
Tanner Stage2 1.66; 0.80 
HOMA%S3 0.34; 0.02** 
Matsuda Index3 0.42; 0.005** 
Season (March to Sept vs. Oct to Feb)1 3.24; 0.001** 
Month of Visit2  14.5; 0.07* 
Birth weight SDS3 -0.20; 0.19 
Gestational age at birth3 -0.025; 0.87 
Age at Study visit3 0.002; 0.99 
Height SDS3 -0.20; 0.18 
Current Wt SDS3 -0.34; 0.02** 
Current BMI SDS3 -0.30; 0.04** 
Fat mass index (BODPOD)3 -0.27; 0.07* 
Fat-free mass index (BODPOD)3 -0.13; 0.39 
Waist Circumference3 -0.28; 0.06* 
Visceral Adipose Tissue (cm2)3 -0.36; 0.02** 
Subcutaneous Adipose Tissue (cm2)3 -0.35; 0.02** 
VAT/SAT ratio3 0.08; 0.59 
VAT Index (cm2/m2)3 -0.33; 0.03** 
SAT Index (cm2/m2)3 -0.33; 0.03** 
Total Minutes Activity (mean/day)3 -0.01; 0.95 
MVPA (mean minutes)3 0.20; 0.25 
MVPA (mean % total activity)3 0.23; 0.18 
Sedentary activity (mean minutes)3 -0.18; 0.30 
Sedentary activity (mean % total)3 -0.29; 0.09* 
Light activity (mean minutes)3 0.22; 0.19 
Light Activity (mean % total)3 0.29; 0.086* 
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Mean Step-count/day3 0.25; 0.15 
Table 22: Analysis of factors associated with serum Vitamin D levels and within cohort 
groups. 1: Mann Whitney U test (z value; p); 2: Kruskall-Wallis Test (Chi-Squared Value; 
p); 3: Spearman Correlation (Rho; p) [*p<0.1; **p<0.05] 
 
 
 
 
 
 
 
 
 
 
Figure 26: correlation between current weight SDS and Vitamin D 
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Figure 27: correlation between vitamin D and glucose disposal estimate as 
representation of IS (measured by Matsuda Index). Dashed lines represent accepted 
thresholds for Vitamin D deficiency (50nmol/L) and reduced IS (Matsuda Index <3) 
 
Figure 28: correlation between vitamin D and fasting IS (measured by HOMA 
modelling). Dashed lines represent accepted thresholds for Vitamin D deficiency 
(50nmol/L) and arbitrary reduced IS (HOMA%S<100) 
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Figure 29: correlation between month of study visit and measured serum Vitamin D 
levels 
3.3.3 Multivariate Analysis  
Multivariate analysis was performed with both τ½PCr datasets to try to establish 
whether there were any strong associations that might explain some of the variance 
seen in the results. The larger dataset was used as it would have more power by virtue 
of increased numbers, but the smaller dataset was theoretically more accurate in 
terms of what was occurring. With both (tables 23 to 28), variables for activity 
measures and IS were considered separately before inclusion into the final models. 
Early life growth (see section 3.4) was also included in the analysis in light of 
gestational age being a potentially important variable. In the final models, both were 
considered using the different measures of IS. For each final model, non-significant 
terms were removed until the minimum number of significant variables remained.  
For both Iotti-adjusted τ½PCr datasets, the final models showed that gestational age at 
birth was the most significant predictive factor for mitochondrial oxidative capacity. 
The earlier the gestational age at birth, the longer the half time for recovery seen. The 
two other factors that were predictive were fasting insulin sensitivity (measured by 
HOMA%S) and vitamin D status, with improved (shorter) half times where insulin 
sensitivity was higher and vitamin D levels higher.   
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 Model 1 Model 2 Model 3 Model 4 Model 5 
Sedentary activity 
(mean % total) 
0.40 0.33 0.325 0.098 0.009 
Mean Step-
count/day 
0.11 0.14 0.03 0.04 0.03 
Light Activity 
(mean % total) 
0.40 0.33 0.33 0.69  
MVPA (mean % 
total activity) 
0.41 0.33 0.33   
MVPA (mean 
minutes) 
0.59 0.92    
Total Minutes 
Activity 
(mean/day) 
0.83     
Sedentary activity 
(mean minutes) 
0.81     
Light activity 
(mean minutes) 
0.98     
R2 0.26 0.22 0.22 0.20 0.19 
Adjusted R2 0..04 0.09 0.12 0.12 0.14 
p value (for model) 0.35 0.17 0.09 0.07 0.03 
Table 23: Multivariate regression analysis (model A) for Iotti-adjusted PCr recovery 
(τ½PCr) with directly measured activity subgroups. Non-normal data was log 
transformed before regression analysis. 
 
 
 Model 1 Model 2 
HOMA%S 0.368  0.166  
Matsuda Index 0.852  
R2 0.06 0.057 
Adjusted R2 0.000 0.03 
p value (for model) 0.385 0.166 
Table 24: Multivariate regression analysis (model B) for Iotti-adjusted PCr recovery 
(τ½PCr) with directly measured insulin sensitivity. Non-normal data was log 
transformed before regression analysis. 
111 
 
 Model 1 Model 2 Model 3 Model 4 Model 5 
Gestational age at 
birth 
0.053 0.178 0.04 0.009 0.005 
Serum Vitamin D 0.225 0.084 0.20 0.124 0.045 
Sedentary activity 
(mean % total) 
0.196 0.175 0.19 0.479  
Mean Step-
count/day 
0.19 0.151 0.26   
HOMA%S 0.291 0.259    
Wt SDS change 
[term to 2yr] 
0.45     
R2 0.80 0.44 0.41 0.37 0.28 
Adjusted R2 0.64 0.30 0.30 0.29 0.24 
p value (for model) 0.03 0.03 0.02 0.01 0.004 
Table 25: Multivariate regression analysis (model C) for Iotti-adjusted PCr recovery 
(τ½PCr), Final model; testing for heteroskedasticity showed that the final terms 
(Vitamin D and Gestational Age) were independent. Inclusion of Tanner Staging was 
not significant by likelihood ratio testing of this model with or without Tanner Staging 
included. Substitution of Matsuda Index for HOMA%S did not improve the model, 
leaving only gestational age as the final term and increased heteroskedasticity (p=0.07 
with Matsuda Index i.e. less independence of terms; p=0.59 with HOMA%S). Non-
normal data was log transformed before regression analysis. 
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 Model 1 Model 2  Model 1 Model 2 
Total Minutes 
Activity 
(mean/day) 
0.305  HOMA%S  0.436 0.115 
MVPA (mean % 
total activity) 
0.087 0.088 Matsuda 
Index 
0.497  
Sedentary activity 
(mean % total) 
0.086 0.088    
Light Activity 
(mean % total) 
0.086 0.088   
Mean Step-
count/day 
0.029 0.041   
R2 0.31 0.27 R2 0.12 0.10 
Adjusted R2 0.13 0.12 Adjusted 
R2 
0.04 0.07 
p value (for model) 0.18 0.16 p value 
(for 
model) 
0.25 0.12 
Table 26: Multivariate regression analysis (model D) for Iotti-adjusted PCr recovery 
(τ½PCr) adjusted for non-split τ½ADP. Directly measured activity subgroups and insulin 
sensitivity. Non-normal data was log-transformed before regression analysis. 
 
 Model 1 Model 2 Model 3 Model 4 
HOMA%S 0.566 0.037 0.008 0.103 
Gestational age at birth 0.002 0.012 0.007 0.002 
Wt SDS change [term to 2yr] 0.174 0.063 0.085  
Serum Vitamin D 0.112 0.391   
Mean Step-count/day 0.855    
R2 0.99 0.69 0.67 0.43 
Adjusted R2 0.96 0.59 0.60 0.37 
p value (for model) 0.006 0.004 0.002 0.002 
Table 27: Multivariate regression analysis (model E) for Iotti-adjusted PCr recovery 
(τ½PCr) adjusted for non-split τ½ADP, Final model; including HOMA%S as the IS term. 
Testing for heteroskedasticity showed that the final terms (HOMA%S and Gestational 
Age) were independent. Inclusion of Tanner Staging was not significant by likelihood 
ratio testing of this model with or without Tanner Staging included. 
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 Model 1 Model 2 Model 3 Model 4 
Gestational age at birth 0.008 0.002 <0.001 0.001 
Serum Vitamin D 0.08 0.327 0.16 0.25 
Mean Step-count/day 0.495 0.70 0.65  
Matsuda Index 0.48 0.96   
Wt SDS change [term to 2yr] 0.69    
R2 0.99 0.65 0.66 0.41 
Adjusted R2 0.98 0.51 0.59 0.36 
p value (for model) 0.02 0.02 0.002 0.003 
Table 28: Multivariate regression analysis (model F) for Iotti-adjusted PCr recovery 
(τ½PCr) adjusted for non-split τ½ADP, Final model; Including Matsuda Index as the IS 
term. Testing for heteroskedasticity showed that the final terms (serum Vitamin D and 
Gestational Age) were independent. Inclusion of Tanner Staging was not significant by 
likelihood ratio testing of this model with or without Tanner Staging included. 
 
 
3.3.4 Discussion 
The results obtained by objective measurement of daily activity and 31P-MRS 
interrogation of in-vivo muscle kinetics was interesting, if for no reason other than 
there appeared to be no direct correlation between the two. It might reasonably have 
been expected that habitual activity levels would be associated with the oxidative 
capacity of the mitochondria if it were very modifiable by training the muscles with 
exercise. However, absence of such a link may reflect the fact that the standardised 
test is designed to deplete the PCr stores completely to measure recovery, and thus is 
perhaps more extreme than usual low-level aerobic exercise experienced at the 
cellular level.  There were, however, three key predictive variables which were 
exposed in multivariate testing, relating to the PCr half-time results.  
The finding that gestational age at birth was consistently predictive of τ½PCr is 
important because it is most likely a variable that will not be modifiable by 
intervention later in life. Work by Uauy and colleagues previously (Bertocci et al., 1992) 
has shown that infants born preterm have a smaller PCr signal than their term born 
counterparts, using a similar MRS technique to that used in this study. The authors 
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speculated that these hypotonic preterm infants may have had limited phosphate 
reserves such that when challenged by even a small increase in activity they depleted 
their reserves very quickly and took a long time to recover. However, this would not 
explain persistence of this effect once the infants become ambulant, active children 
and adolescents. Using other methods to measure oxidative capacity (aerobic fitness 
score), Rogers and colleagues (Rogers et al., 2005) demonstrated that at age 17, 
adolescents born preterm have reduced oxidative capacity and are more likely to 
become fatigued. The other finding that may be relevant in these children comes from 
post-mortem specimens from the skeletal muscle of infants born preterm which 
demonstrate that in preterms, there is a predominance of type 2 (low-oxidative) 
muscle fibres which have, relatively, a low density of mitochondria (Keens et al., 1978; 
Schloon et al., 1979; Vogler and Bove, 1985). In these studies which looked at muscles 
such as the diaphragm and intercostal muscles, it was demonstrated that the normal 
development towards term is to increase the density of type 1 (high oxidative) fibres. 
However, in surviving preterm infants who have experienced the normal preterm 
course of difficulty with deposition of lean tissue, there may be arrest or unchangeable 
alteration in the density of type 1 fibres. A permanent reduction in mitochondrial 
density may then be detectable in a prolonged PCr recovery. Aside from optimising 
protein nutrition in the preterm infant, which will always be attempted as long as it 
does not conflict with neuroprotective nutritional strategies, it does not suggest that 
this could be modified with intervention from term-equivalent age onwards.   
The second variable shown to be important in determining τ½PCr is insulin sensitivity; 
specifically fasting IS as measured by HOMA (% Sensitivity) modelling. % Sensitivity was 
specifically chosen as it reflects the physiological truth that IS is a continuum: insulin 
resistance is more analogous with a clinically defined quantity that allows physicians to 
quantify when a person may need intervention by defining a ‘normal’ cut-off. 
Physiologically, reduced IS leading to increased τ½PCr could be explained by reduced 
transit of glucose into the myocyte secondary to reduced expression of the insulin 
receptor and glucose transporting receptors at the myocyte membrane. This was 
demonstrated elegantly by Lim and colleagues using similar imaging techniques during 
a hyperglycaemic hyperinsulinaemic clamp study in diabetics (Lim et al., 2011c). In this 
study, the thing that does not fit with this possibility is that the Matsuda Index, which 
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is a better measure of glucose disposal than HOMA does not show any kind of 
relationship to τ½PCr. Reviewing the multivariate modelling, therefore, leads to the 
third, important variable: Vitamin D.  
In our study, as seen in Sinha’s work (Sinha et al., 2013), there is a relationship 
between decreasing serum vitamin D levels and increasing recovery times for τ½PCr. 
This effect is independent to that seen from gestational age at birth in our cohort. 
Vitamin D has many effects in many different tissues but it is not clear that it has a 
direct effect on muscle at the myocyte membrane. It is possible that it could have an 
effect, as a hormone-like substance, at the mitochondrial genome level upregulating 
either the cellular mechanisms and machinery needed to improve oxidative function, 
or more directly influencing ATP synthesis (Psarra et al., 2006). Vitamin D may also play 
a role in mitochondrial uptake of Calcium, needed for effective muscle function but 
also potentially important in stimulating ATP synthesis by the mitochondria. Sinha 
proposes this as potential mechanism of vitamin D action and cites work on vitamin D 
deficient chick muscles (Mukherjee et al., 1981) as an example where the muscle does 
not appear able to retain calcium.  
Our study also showed a very strong association between vitamin D and IS (see section 
3.4). It is possible, therefore, that the association seen in some of the multivariate 
models between HOMA sensitivity and mitochondrial oxidative capacity is, therefore, a 
statistical flaw which has occurred because of the underlying association between 
Vitamin D and IS. Thus HOMA sensitivity appears in the model in place of vitamin D 
due to the nature of the test, rather than because IS has a direct effect on τ½PCr.  
In his study, Sinha replaced vitamin D in his subjects and demonstrated an 
improvement in clinical, and MRS muscle kinetic, outcomes. For our cohort, therefore, 
it would be a potential intervention to supplement the cohort, and potentially those 
born preterm elsewhere, with vitamin D in order to try to improve mitochondrial 
oxidative function. Mize and colleagues cite an example of a child with muscle 
hypotonia and rickets where supplementation with vitamin D, calcium and phosphate 
improved muscle kinetics measured by MRS (Mize et al., 1988). We did not measure 
serum phosphate or calcium, but if vitamin D was used as a targeted intervention in 
our cohort, these other serum biochemical measures might also need checking. 
Intervention with supplementation also has to be considered in the clinical context: in 
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Sinha’s study he had objective measures of fatigue and weakness in his population 
where we have none. The muscle kinetics are not associated with measured of 
adiposity and therefore no clinical impact of the τ½PCr results can be assumed. In 
addition, our findings were that of a linear association: supplementing only those who 
were clinically vitamin D deficient (<25nmol/L or <50nmol/L depending on clinical 
threshold) would not necessarily encompass all of those who had relatively slow τ½PCr 
recovery. We would, therefore, not (in this study cohort) have any grounds on which 
to recommend supplementation, beyond the usual clinical thresholds. The data do 
show clearly, however, the potential need for supplementation through the winter 
months in the North East, though this might well readily apply to any age group. If in 
future studies there is evidence that there are clinical symptoms related to oxidative 
function impacting on quality of life, in children or adolescents similar to those in our 
cohort, then vitamin D supplementation may well be a good potential intervention to 
try to ameliorate these symptoms. However, Rogers’ work suggests that these 
adolescents do not perceive their differences in exercise capacity from term-born 
peers as impacting on their quality of life (Rogers et al., 2005). 
The data from the cohort from directly measured activity was, broadly speaking, 
similar to the data seen in the millennium cohort who are another North-East based 
cohort who have had accelerometric recording of their activity levels (Basterfield et al., 
2011b; Basterfield et al., 2012). In our cohort, as theirs, we saw that boys were more 
likely to be physically active than girls (Jimenez-Pavon et al., 2010) and that as the 
cohort aged, the amount of MVPA trended down. We also saw that increased time in 
sedentary activity was associated with a trend towards increase in some markers of 
adiposity. This has specifically not been found in some other authors work (Kennedy et 
al., 2013). The most striking new finding from the activity data was good evidence that 
light activity is most strongly associated with IS measures. This has been discussed in 
more detail in section 3.4. While there was no direct association between τ½PCr and 
any of the activity measures, it is possible that light activity may have an indirect effect 
on muscle oxidative function via either its positive association with IS, or via IS to 
vitamin D, which is associated with τ½PCr, as outlined above. Importantly, increasing 
light exercise seems to show a trend for reducing some of the markers of increased 
adiposity (waist circumference, mid-arm circumference, subcutaneous adipose tissue) 
117 
 
which we have shown are the things that might influence deposition of visceral and 
hepatic lipids. In terms of preventing progression of metabolic disease, light activity 
might be more acceptable as an intervention (less daunting and perhaps more 
sustainable than MVPA interventions) and therefore these are encouraging findings 
with respect to modifying the metabolic outcomes of those born preterm. 
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3.4 Insulin sensitivity  
One of the key determinants of metabolic outcomes in ‘pre-diabetes’, the metabolic 
syndrome and in type 2 diabetes is thought to be reduced insulin sensitivity (also 
described in the literature as insulin resistance). If there is a link between prematurity 
and later metabolic ill health, insulin sensitivity (IS) may be an important determinant 
or element which changes early in the process before actual ill-health occurs. It was 
therefore important to examine in the current study cohort.  
Two measures of insulin sensitivity were used. Firstly % Sensitivity calculated from the 
HOMA2 model (HOMA%S) was used as a measure of resting insulin sensitivity (it is 
calculated from fasting insulin and glucose levels). This was used in preference to the 
more often quoted HOMA IR (insulin resistance) measure, which is the reciprocal of 
%S: HOMA-IR = 100/%S. The choice was because it reflected the likelihood that in this 
relatively young cohort it is more appropriate to talk about a change in sensitivity to 
insulin (along a continuum) rather than an insulin ‘resistance’ which invites a cut-off or 
threshold assumption which may not apply. 100% sensitivity would be the expected 
sensitivity for any given individual, which allows some sub-group analysis if required. 
The second measure of IS used was the Matsuda Index which, as outlined in the 
methods section, is an index which was formulated to be closely related to glucose 
disposal as measured by a clamp study. It is one which lends itself to our methodology 
(i.e. an oral glucose tolerance test) and is different to the HOMA%S measure in as 
much as it looks at the body’s response to a glucose challenge. It is, therefore, useful in 
assessing current metabolic flexibility, which may not be reflected by a single HOMA%S 
value. 
As my literature review of factors influencing IS in the infant-to-adult time-course 
demonstrated, growth may be an important a factor in later IS. Therefore, the 
longitudinal data available for the cohort was examined to see which periods of 
growth could be included in the analysis.  
3.4.1 Growth in the cohort 
Examining the longitudinal cohort data (for the 60 adolescents involved in the current 
study), it was clear that the most data points available per participant were for the 
weight standard deviation scores (Wt. SDS). It was therefore possible to examine 
119 
 
change in Wt. SDS as a measure of growth velocity over time period as a proxy for 
growth. While this does not control for factors such as height, and includes no 
measure of lean tissue vs. fat deposition, it is a reasonable measure as it is indexed to 
the population mean for the age at the time of measurement.  
 
Figure 30: Changes in weight SDS over different time period in the current study 
cohort. ‘Last visit’: cohort aged 10-12yrs old. Box-plots show median, IQR.  
 
Figure 30 shows different epochs of growth within the current study cohort. It was 
clear from this that to look at the cohort in terms of changing growth velocities, it 
would be important to assess change between calculated Wt. SDS change in epochs, in 
a longitudinal fashion rather than from any given time-point to the current study, in 
order to capture accurately any periods of rapid growth. Figure 31 shows this 
graphically and suggests that the major periods of growth are from term equivalent to 
2 years and from 2 years to the last visit. However, there is little difference between 
the changes in the SDS score either between birth-to-term-equivalent, or from the last 
visit-to-current (p=0.89).  
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Figure 31: Change in weight SDS longitudinally in study cohort from recruitment to 
current study. Boxplot shows Median, IQR. P values are Mann Whitney U tests 
between epochs for SDS change across each epoch. 
 
 
Figure 32: Change in weight SDS longitudinally in study cohort from recruitment to 
current study. Boxplot shows Median, IQR. P values are Mann Whitney U tests 
between epochs for SDS change across each epoch. 
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Figure 32 illustrates the same longitudinal change but combines the middle two 
epochs to give a ‘term equivalent to last visit’ epoch. From the data it was not possible 
to say a-priori whether the change in Wt. SDS between term-equivalent to 2 years old 
would be more important to IS measurement than the change from term equivalent to 
the last visit. As the change seen between 2yrs old to last visit was not significant when 
compared to the change from last visit to current visit, the suggestion was that the 
initial change in Wt. SDS from term equivalent to 2 years would be most likely to be 
important, but for completeness, term equivalent-to-last visit was also used in the 
analysis of IS measurements.  
3.4.2 Insulin Sensitivity: correlation analysis 
From the 60 participants in the study, 46 had blood taken to allow serum analysis. In 
46, there was sufficient blood obtained to do a fasting HOMA %S calculation, and in 45 
there was sufficient to get a 2-hour sample to allow calculation of the Matsuda index. 
One participant (study number GM01) was excluded due to an extremely high 
calculated sensitivity which was thought to be due to an erroneous insulin 
measurement, using the HOMA2 model. Thus 45 results were available for the 
HOMA%S and 44 for the Matsuda Index analyses.  
Table 29 shows the results of Spearman’s correlation analysis for both HOMA%S and 
the Matsuda Index in the study cohort. This was done to assess whether there were 
any significant correlations between insulin sensitivity and potentially clinically 
significant variables in the general areas of: auxological measurement; overall body 
composition (BODPOD™); measured lipid compartments; serum measurements; 
dietary intake; and directly measured activity. Unsurprisingly, Spearman correlation for 
HOMA%S against Matsuda index was highly significant (Rho: 0.66; p<0.001) as both 
use the fasting insulin/glucose measurements in their calculations (figure 33).  
For correlation analysis against HOMA%S it was clear that, as with the data from the 
last study visit, the fasting insulin sensitivity was strongly correlated to current body 
composition (BMI SDS, p=0.01; Wt. SDS, p=0.02; total body fat, p=0.02; Fat Mass Index, 
p=0.01). HOMA%S was also seen to be associated with: body habitus (waist 
circumference, p=0.02); subcutaneous adipose tissue (cm2 and index, cm2/m2; p<0.01); 
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serum lipids (cholesterol, triglycerides, LDL-C; all p<0.05); and serum vitamin D 
(p=0.02).  
 
  HOMA % Sensitivity 
(Rho; p) 
Matsuda Index 
(Rho; p) 
Iotti-adjusted PCr recovery 
(τ½PCr) 
0.15; 0.38 0.09; 0.61 
Birth weight SDS -0.03; 0.83 -0.17; 0.26 
Gestational age at birth -0.02; 0.88 -0.01; 0.96 
Tanner Stage -0.10; 0.52 -0.07; 0.67 
Current Wt SDS -0.34; 0.02** -0.29; 0.06* 
Wt SDS change [term to 2yr] -0.37; 0.046** -0.15; 0.43 
Wt SDS change [term to last 
visit] 
-0.19; 0.28 -0.11; 0.55 
Intrahepatic Lipid (%) -0.11; 0.49 -0.11; 0.50 
Total body fat (%) -0.36; 0.02** -0.36; 0.02** 
Fat mass index (BODPOD) -0.39; 0.01** -0.37; 0.01** 
Fat-free mass index (BODPOD) -0.09; 0.52 -0.08; 0.58 
Waist Circumference -0.34; 0.02** -0.31; 0.04** 
Mid-arm Circumference -0.09; 0.55 -0.17; 0.28 
Current BMI SDS -0.37; 0.01** -0.39; 0.008** 
Visceral Adipose Tissue (cm2) -0.12; 0.45 -0.25; 0.11 
Subcutaneous Adipose Tissue 
(cm2) 
-0.46; 0.002** -0.41; 0.005** 
VAT/SAT ratio 0.38; 0.01** 0.24; 0.12 
VAT Index (cm2/m2) -0.13; 0.41 -0.25; 0.11 
SAT Index (cm2/m2) -0.46; 0.002** -0.43; 0.004** 
Serum Cholesterol -0.31; 0.04** -0.15; 0.34 
Serum Triglyceride  -0.50; <0.001** -0.49; <0.001** 
Serum LDL-C -0.38; 0.01** -0.19; 0.21 
Serum Vitamin D 0.34; 0.02** 0.42; 0.005** 
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Dietary Energy (in 24 hours) 0.10; 0.52 0.24; 0.12 
Carbohydrate intake (in 24 
hours) 
0.12; 0.43 0.23; 0.13 
Fat intake (in 24 hours) -0.01; 0.96 0.14; 0.38 
Protein intake (in 24 hours) 0.21; 0.17 0.35; 0.02** 
MVPA (mean minutes) 0.05; 0.79 0.12; 0.51 
MVPA (mean % total activity) -0.02; 0.90 0.07; 0.68 
Sedentary activity (mean 
minutes) 
0.19; 0.29 0.12; 0.50 
Sedentary activity (mean % total) -0.08; 0.66 -0.27; 0.12 
Light activity (mean minutes) 0.25; 0.15 0.44; 0.01** 
Light Activity (mean % total) 0.19; 0.28 0.41; 0.02** 
Table 29: Spearman Correlation analysis for variables and either HOMA %S or Matsuda 
indices. LDL-C: low density lipoprotein C; MVPA: moderate-to-vigorous physical 
activity; for activity measures, mean (either minutes or % of total activity) is calculated 
over 3 days total data collection with minimum of 6 hours per day recorded. [*p<0.1; 
**p<0.05] 
Those with measurements suggesting that they were overweight, or that had 
increased lipid deposition, had lower IS. There was no measurable association with 
intrahepatic lipid content (p=0.49) or visceral adipose tissue (p=0.45) which was 
surprising when considering the lipid hypothesis for reduced IS. For both, the direction 
of the correlation coefficient (Rho) did suggest that a lower lipid content (either IHL or 
VAT) was in that of improved insulin sensitivity but neither result was strong enough to 
consider a trend formed. Importantly, growth as indicated by change in Wt. SDS from 
term equivalent age to 2 years old was significantly correlated with measured IS (by 
HOMA%S, p=0.046) with the correlation coefficient suggesting that the smaller the 
change in Wt. SDS (i.e. the closer the SDS score was to staying the same between time-
points) the more insulin sensitive the participant would be. 
For Matsuda Index, there were significant changes in the profile of associated variables 
from that seen with HOMA%S. Current body composition variables were less 
significant or trending towards significance compared to HOMA%S (current Wt. SDS, 
p=0.06; total body fat, p=0.01; waist circumference, p=0.04; BMI SDS p=0.008) and 
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only serum triglycerides and Vitamin D levels were significant. Subcutaneous adipose 
tissue was also very significantly associated with the measured Matsuda Index and 
unlike the HOMA%S correlation, protein intake in 24 hours and light exercise also 
reached significance (p<0.05). Directly measured skeletal muscle oxidative capacity 
(adjusted τ½PCr) did not correlate with either measure of insulin sensitivity.  
 
Figure 33: HOMA%S results plotted against Matsuda Index.  
 
3.4.3 Insulin Sensitivity and Intrahepatic Lipid content 
The lack of correlation between either IS measurement and intrahepatic lipid (IHL) 
content was an unexpected result. In order to examine this further, both measures of 
IS were plotted against intrahepatic lipid content (figures 34 to 36).  
The plot of HOMA%S against IHL showed that while the majority of the cohort had 
clinically normal levels of intrahepatic lipid (IHL<5%) and a range of insulin sensitivities, 
there was subgroup of five individuals who appeared to have a high IHL content and 
low IS. When the same graph was plotted using the Matsuda Index, it could be seen 
that two of the low-IS/high-IHL individuals seemed to have a normal IS in terms of 
glucose disposal as measured by the Matsuda Index (i.e. an index >3). It was also clear 
that in the rest of the cohort there were some individuals who had reduced IS 
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measured by HOMA%S but normalised Matsuda Indices. This suggested that the 
resting IS did not necessarily equate to metabolic inflexibility in terms of coping with a 
glucose load and perhaps suggested that resting reduction in IS precedes reduced 
capacity to dispose of glucose in development of metabolic disease. In order to 
examine possible differences between these five low-IS/High-IHL individuals, subgroup 
analysis was completed (using Mann Whitney U tests) between the groups defined as 
IS<100%/IHL>5%, IS<100%/IHL<5% and IS>100%/IHL<5%.  
 
 
 
 
 
 
 
Figure 34: HOMA%S vs. Intrahepatic Lipid content 
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Figure 35: Matsuda Index vs. Intrahepatic lipid content 
 
Figure 36: Matsuda Index and HOMA%S vs. Intrahepatic lipid content to show changes 
from low insulin sensitivity to normal Matsuda indices after administration of a glucose 
load 
 
127 
 
Within the 5 individuals who had IHL>5%/IS<100%, the two who ‘normalised’ their 
Matsuda Indices were at the opposite ends of the pubertal spectrum (1 and 5) and the 
remaining 3 were stages 3, 4, and 5. As there were only 3 remaining who were 
consistently of low IS (by both HOMA%S and Matsuda index) the subgroup analysis 
was done using the HOMA%S values to see if there were any particular differences 
between the outlying individuals (n=5) and the remainder of the cohort. The results of 
the subgroup analysis are listed in table 30. The subgroup analysis also included the 
comparison of all individuals with IHL<5% divided into two groups based on IS >100% 
or <100%.  
Compared to the remainder of the cohort as a group, the 5 individuals with IHL>5% 
had universally raised serum lipids, higher indices for overweight/obesity (raised BMI 
SDS, waist circumference and Wt. SDS, p<0.05), evidence of higher lipid deposition 
across compartments (especially visceral adipose deposition, p=0.007) but were not 
significantly different with respect to vitamin D status or Tanner Stage. These findings 
are in line with the analysis looking at IHL and visceral adiposity presented in section 
3.2.  
When the five individuals with IHL>5% are compared to the cohort subgroup with 
IS>100% and IHL<5% there is the same pattern of results seen as when comparing 
them to the remainder of the cohort as a whole, but the significance is more marked. 
The five individuals, compared to this ‘healthy’ subset have increased lipid deposition 
measured by both auxological and body composition techniques (FMI, BMI [SDS], waist 
circumference, Wt. SDS) and direct measurement of lipid deposition (visceral [p=0.017] 
and subcutaneous [p=0.02]). They also have higher serum lipid content (p≤0.03).  
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IS<100%/IHL>5% 
vs. 
rest of cohort 
IS<100%/IHL>5% 
vs. 
IS<100%/IHL 
<5% 
IS<100%/IHL>5% 
vs. 
IS>100%/IHL<5% 
IS<100%/IHL<5% 
vs. 
IS>100%/IHL<5% 
Iotti-adjusted 
PCr recovery 
(τ½PCr) 
0.61 0.74 0.64 0.39 
Birth weight 
SDS 
0.96 0.53 0.77 0.98 
Gestational age 
at birth 
0.37 0.22 0.36 0.90 
Tanner Stage 0.79 0.85 0.70 0.61 
Current Wt SDS 0.03** 0.11 0.03** 0.40 
Wt SDS change 
[term to 2yr] 
0.62 0.59 0.70 0.046** 
Wt SDS change 
[term to last 
visit] 
0.71 0.79 0.71 0.58 
Total body fat 
(%) 
0.08 0.27 0.04** 0.02** 
Fat mass index 
(BODPOD) 
0.06 0.23 0.02** 0.02* 
Waist 
Circumference 
0.02** 0.04** 0.02** 0.27 
Mid-arm 
Circumference 
0.19 0.25 0.28 0.62 
Current BMI 
SDS 
0.02** 0.07* 0.02** 0.22 
Height SDS 0.11 0.22 0.16 0.54 
Visceral 
Adipose Tissue 
(cm2) 
0.007** 0.02** 0.02** 0.97 
Subcutaneous 
Adipose Tissue 
(cm2) 
0.04** 0.14 0.02** 0.01** 
VAT/SAT ratio 0.70 0.35 0.46 0.02** 
VAT Index 
(cm2/m2) 
0.008** 0.04** 0.01** 0.82 
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SAT Index 
(cm2/m2) 
0.07* 0.29 0.02** 0.008** 
Serum 
Cholesterol 
0.02** 0.05** 0.03** 0.01** 
Serum 
Triglyceride  
0.002** 0.004** 0.002** 0.01** 
Serum LDL-C 0.01** 0.03** 0.007** 0.01** 
Serum Vitamin 
D 
0.34 0.79 0.09* 0.12 
MVPA (mean 
minutes)† 
0.053* 0.11 0.31 0.24 
MVPA (mean % 
total activity)† 
0.04** 0.06* 0.07* 0.53 
Sedentary 
activity (mean 
minutes)† 
0.04** 0.06* 0.02** 0.13 
Sedentary 
activity (mean 
% total)† 
0.02** 0.01** 0.05* 0.24 
Light activity 
(mean 
minutes)† 
0.29 0.17 0.59 0.03** 
Light Activity 
(mean % total)† 
0.03** 0.01** 0.10* 0.19 
Table 30: Comparisons between groups within the cohort defined by Insulin sensitivity 
(HOMA % Sensitivity) and Intrahepatic Lipid levels. Small groups (n=3) defined by IS 
(<100%, >100%) or IHL (<5%, >5%). Mann Whitney U test used to assess differences 
between groups. †Activity measures: it should be noted that for comparisons involving 
the IS<100%/IHL>5% group, there are only n=3 out of 5 possible datasets that could be 
used (vs. up to n=41 for the rest of the cohort). [*P<0.1**P<0.05] 
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The final analysis was comparison between the halves of the cohort with IHL<5% who 
were IS>100%, and <100%, to see if there were any differences that could be detected 
as possible precursors for developing low HOMA%S. In this comparison the group with 
IS<100% had significantly higher fat mass index (p=0.02) and higher subcutaneous 
adipose tissue deposits (SAT index [cm2/m2], p=0.008), as well as higher circulating 
lipids. In this comparison, early growth again seemed to be important with those who 
were less insulin sensitive having had a higher change in Wt. SDS between term-
equivalent and 2 years old (p=0.046). Unlike the general Spearman correlation analysis 
for the HOMA%S measures, in this subgroup analysis, it was also shown to be 
significant that those who have a higher IS are more likely to spend a greater 
percentage of their activity in light activity than those with lower IS (p=0.03).  
Within the first three comparisons, table 30 lists the analysis of activity between the 
various groups, but there are only 3 out of the 5 with IHL>5% who completed wearing 
the accelerometers satisfactorily to produce comparable data. Thus, while the data for 
the comparison of IHL<5% but IS >100% vs. IS<100% is useable and produced a valid 
result for light exercise, the results for the other three comparisons cannot be 
meaningfully interpreted due to the tiny sample size.  
For the final comparison (all those with IHL<5% and IS measured by HOMA%S), Fisher’s 
exact test was also performed to see if the original study grouping (growth study vs. 
protein study) had any significant effect on whether the participants had HOMA%S 
above or below 100%. The two-tailed result showed p=1 and one tailed test had a 
p=0.59, showing that there were no significant effects in the study cohort with respect 
to HOMA%S, originating from their original study recruitment.   
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HOMA % Sensitivity 
Q1 vs. Q4; p value 
Matsuda Index 
Q1 vs. Q4; p value 
Iotti-adjusted PCr recovery (τ½PCr) 0.62 0.85 
Birth weight SDS 0.71 0.92 
Gestational age at birth 0.90 0.65 
Intrahepatic Lipid (%) 0.95 0.44 
Tanner Stage 0.45 0.56 
Current Wt SDS 0.13 0.14 
Wt SDS change [term to 2yr] 0.04** 0.24 
Wt SDS change [term to last visit] 0.35 0.31 
Total body fat (%) 0.12 0.09* 
Fat mass index (BODPOD) 0.08* 0.09* 
Waist Circumference 0.11 0.052* 
Mid-arm Circumference 0.85 0.39 
Current BMI SDS 0.08* 0.04** 
Height SDS 0.23 0.31 
Visceral Adipose Tissue (cm2) 0.67 0.07* 
Subcutaneous Adipose Tissue (cm2) 0.04** 0.04** 
VAT/SAT ratio 0.09* 0.38 
VAT Index (cm2/m2) 0.67 0.07* 
SAT Index (cm2/m2) 0.04** 0.04** 
Serum Cholesterol 0.28 0.67 
Serum Triglyceride  0.006** 0.007** 
Serum LDL-C 0.07* 0.41 
Serum Vitamin D 0.045** 0.005** 
MVPA (mean minutes)† 0.56 0.51 
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MVPA (mean % total activity)† 0.44 0.63 
Sedentary activity (mean 
minutes)† 
0.17 0.57 
Sedentary activity (mean % total)† 0.84 0.102 
Light activity (mean minutes)† 0.14 0.02** 
Light Activity (mean % total)† 0.44 0.02** 
Table 31: Comparison between most (Q4) and least (Q1) insulin sensitive quartiles 
within the cohort for both HOMA % Sensitivity and Matsuda indices. Comparisons 
done with Mann Whitney U tests. [*p<0.1,**p<0.05] 
 
The comparison excluding the five subjects with IHL>5% spanned a range of IS and did 
not include the Matsuda Indices. Therefore, to interrogate the extremes of the data 
further for potential clarification of factors which might predict IS, the HOMA%S and 
Matsuda data (excluding the five with IHL>5%) was split into quartiles to allow 
comparison of those subjects with the highest and lowest IS for both measures. Table 
31 shows the comparisons of the most (Q4) and least (Q1) sensitive subjects for both 
HOMA%S and Matsuda Index compared to the other measured variables. Common to 
both measures of IS were differences between the extreme quartiles for body 
composition (FMI, BMI SDS), adipose tissue deposition (subcutaneous) and serum 
triglyceride levels. Between the extreme quartiles in these measures, a tendency for 
increased adiposity was associated with reduced insulin sensitivity. Vitamin D level 
were also significantly different between Q1 and Q4 in both indices (p=0.045). Specific 
to HOMA%S, serum LDL-C levels were different between the two groups (with a 
tendency to higher levels in Q1) and change in Wt. SDS was also significant, as it had 
been in comparison involving all with IHL<5%. Specific to the Matsuda Index 
measurements, light exercise (absolute minutes and % of total daily activity) was 
significant with higher % in light exercise and higher absolute minutes associated with 
the higher IS in Q4. Visceral adiposity and protein intake trended towards significance 
(p<0.1 >0.05) with those in Q1 having greater visceral adipose deposits and lower 
protein intake in their diet.  
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 HOMA % Sensitivity Matsuda Index 
Corr 
Coeff 
R2 P  Corr 
Coeff 
R2 P  
Current Wt SDS -11.6 0.19 0.003** -1.0 0.15 0.01** 
Wt SDS change 
[term to 2yr] 
-7.3 0.09 0.105 -0.33 0.02 0.40 
Wt SDS change 
[term to last visit] 
-3.8 0.04 0.23 -0.13 0.005 0.70 
Total body fat (%) -17.2 0.16 0.006** -1.4 0.11 0.03** 
Fat mass index 
(BODPOD) 
-15.0 0.17 0.004** -1.3 0.13 0.02** 
Waist Circumference 1288 0.14 0.01** 118 0.12 0.02** 
Current BMI SDS -10.1 0.16 0.007** -0.94 0.14 0.01** 
Visceral Adipose 
Tissue (cm2) 
-6.16 0.02 0.38 -1.24 0.09 0.058* 
Subcut’ Adipose 
Tissue (cm2)† 
264 0.19 0.003** 23.3 016 0.009** 
VAT/SAT ratio 16.3 0.17 0.006** 0.86 0.05 0.16 
VAT Index (cm2/m2)† 20.0 0.005 0.65 6.76 0.062 0.11 
SAT Index (cm2/m2) -15.9 0.21 0.002** -1.43 0.17 0.006** 
Serum Cholesterol 590.1 0.12 0.02 24.3 0.02 0.34 
Serum Triglyceride  -34.4 0.28 <0.001** -3.1 0.25 <0.001** 
Serum LDL-C -52.2 0.22 0.001** -2.2 0.04 0.19 
Serum Vitamin D 25.9 0.13 0.01** 2.7 0.15 0.008** 
Protein intake (in 24 
hours) 
3.74 0.06 0.10 0.57 0.15 0.01** 
Light activity (mean 
minutes) 
0.18 0.11 0.06 0.03 0.24 0.004** 
Light Activity (mean 
% total) 
1.14 0.05 0.20 0.25 0.19 0.01** 
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Table 32 (previous page): Univariate linear regression analysis of variables found to be 
significant using Spearman’s correlation. Any non-normally distributed data log-
transformed for analysis, with exception that †: data normalised by inverse of SQRT 
before regression therefore direction of correlation coefficient reversed. 
[*p<0.1,**p<0.05] 
 
 
 Model 1 Model 2 Model 3 
Fat Mass Index 0.19 0.20 0.24 
Current weight SDS 0.19 0.20 0.16 
BMI SDS 0.67 0.56  
Waist Circumference 0.74   
R2 0.22 0.22 0.21 
Adjusted R2 0.14 0.16 0.17 
p value (for model) 0.036 0.016 0.007 
Table 33: HOMA % Sensitivity multivariate regression modelling (model A): body 
composition measures (table shows p values for individual components of model) 
 
 
 Model 1 
SAT index 0.001 
VAT index 0.168 
R2 0.24 
Adjusted R2 0.21 
p value (for model) 0.003 
Table 34: HOMA % Sensitivity multivariate regression modelling (model B): measured 
abdominal fat, indexed against height (table shows p values for individual components) 
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 Model 1 Model 2 
Cholesterol 0.67  
Triglyceride 0.02 0.02 
LDL-C 0.10 0.04 
Vitamin D (total) 0.03 0.03 
R2 0.43 0.42 
Adjusted R2 0.36 0.38 
p value (for model) <0.001 <0.001 
Table 35: HOMA % Sensitivity multivariate regression modelling (model C): measured 
serum lipids and vitamin D (table shows p values for individual components of model) 
 
 
 
 Model 1 Model 2 Model 3 Model 4 Model 5 
Fat Mass Index 0.24 0.11 0.03 0.048 0.02 
Triglyceride 0.009 0.004 0.001 0.002 0.001 
Vitamin D (total) 0.10 0.10 0.09 0.10  
Wt SDS change 
[term to 2yr] 
0.25 0.17 0.16   
LDL-C 0.31 0.28    
SAT index 0.69     
R2 0.59 0.59 0.57 0.42 0.37 
Adjusted R2 0.47 0.50 0.50 0.37 0.34 
p value (for 
model) 
0.002 <0.001 <0.001 <0.001 <0.001 
Table 36: HOMA % Sensitivity multivariate regression modelling (Final model [D]): 
Significant variables for predicting Insulin Sensitivity by HOMA % Sensitivity. Fat mass 
index used as significant body composition variable (table shows p values for individual 
components of model). 
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 Model 1 Model 2 Model 3 Model 4 
Triglyceride 0.02 0.01 0.04 0.02 
Vitamin D (total) 0.15 0.15 0.11 0.03 
LDL-C 0.18 0.10 0.05 0.039 
Current Weight 
SDS 
0.54 0.17 0.11  
Wt SDS change 
[term to 2yr] 
0.39 0.27   
SAT index 0.73    
R2 0.57 0.58 0.46 0.42 
Adjusted R2 0.45 0.48 0.40 0.38 
p value (for 
model) 
0.004 <0.001 <0.001 <0.001 
Table 37: HOMA % Sensitivity multivariate regression modelling (Final model [E]): 
Significant variables for predicting Insulin Sensitivity by HOMA % Sensitivity. Current 
Weight SDS used as significant body composition variable (table shows p values for 
individual components of model). 
 
Once the analysis of the data using extreme quartiles was performed, the most 
significant variables (both as per analysis and in clinical terms) were examined using 
linear regression. Where necessary the variables were normalised with log 
transformation to allow analysis. The results of the univariate analysis are shown in 
table 32.  
From these results, significant variables were modelled together for both the HOMA%S 
and Matsuda indices to give a final model for each. The process of modelling for 
HOMA%S is shown in tables 33 to 35. In these models, neither fat mass index nor 
current weight SDS reached significance as an individual term but both are clinically 
potentially important and so were included in final modelling (table 36, 37). When FMI 
is included in the model (table 36) for HOMA%S it is a significant term. With serum 
triglyceride, it accounts for nearly 40% of the variance seen in the measurement of 
HOMA%S after removal of non-significant co-variables. Importantly for our cohort, this 
suggests that intervention might be possible to modify HOMA%S through these 
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indices. For both FMI and serum triglyceride the correlation is negative, i.e. the lower 
the FMI or serum triglyceride, the better the IS.  
As current Wt. SDS was also identified as significant in the earlier correlation analysis it 
was used as a variable in this multivariate modelling (table 37) but when the model is 
pared down removing non-significant variables, it is lost to a final model involving only 
serum measures. Interestingly Vitamin D is left in this model but disappears from the 
previous one, suggesting that it is associated with FMI and Wt. SDS, being more 
important than current Wt. SDS in IS, but less so than FMI. In the second model, 
therefore, it is almost a ‘proxy’ measure for FMI.  
The same process was executed for the results from the Matsuda Index data, using 
modelling around similar variables to pick the most significant and then putting them 
into a single multivariate model, refined by removing non-significant terms (tables 38 
to 41). The final models were then constructed using the significant variables and, as 
with the HOMA%S modelling, both FMI and current Wt. SDS were used (tables 41 and 
42). Both processes left the same final model with serum triglyceride and mean 
minutes in light activity being most predictive of a glucose disposal (i.e. IS by Matsuda 
Index). The correlation coefficients showed that the more light exercise, the higher the 
Matsuda Index (IS) was, and the higher the serum triglyceride levels, the lower the IS 
as seen in the HOMA%S modelling. 
 
 Model 1 Model 2 Model 3 
Fat Mass Index 0.46 0.39 0.38 
Current weight SDS 0.49 0.35 0.20 
Waist Circumference 0.89 0.91  
BMI SDS 0.93   
R2 0.16 0.16 0.16 
Adjusted R2 0.07 0.10 0.12 
p value (for model) 0.13 0.07 0.03 
Table 38: Matsuda Index multivariate regression modelling (model F): body 
composition measures (table shows p values for individual components of model) 
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 Model 1 
SAT index 0.03 
VAT index 0.79 
R2 0.17 
Adjusted R2 0.13 
p value (for model) 0.02 
Table39: Matsuda Index multivariate regression modelling (model G): measured 
abdominal fat, indexed against height (table shows p values for individual components) 
 
 Model 1 
Triglyceride 0.002 
Vitamin D (total) 0.02 
R2 0.35 
Adjusted R2 0.32 
p value (for model) <0.001 
Table 40: Matsuda Index multivariate regression modelling (model H): measured 
serum triglycerides and vitamin D (table shows p values for individual components of 
model) 
 
 Model 1 Model 2 
Light Activity Mean (Total Minutes/day) 0.17 0.006 
Protein Intake (g in 24 hours) 0.08 0.08 
Light Activity Mean (percent of all activity/day) 0.94  
R2 0.31 0.31 
Adjusted R2 0.24 0.26 
p value (for model) 0.01 0.004 
Table 41: Matsuda Index multivariate regression modelling (model I): Activity and 
dietary intake (table shows p values for individual components of model) 
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 Model 1 Model 2 Model 3 Model 4 Model 5 
Triglyceride 0.007 0.004 0.003 0.03 0.001 
Vitamin D (total) 0.22 0.19 0.21 0.14 0.012 
Light Activity Mean 
(Total Minutes/day) 
0.09 0.08 0.02 0.01  
Fat Mass Index 0.32 0.35 0.33   
SAT index  0.57 0.66    
Protein Intake (g in 
24 hours) 
0.69     
R2 0.55 0.54 0.56 0.54 0.50 
Adjusted R2 0.42 0.44 0.49 0.49 0.46 
p value (for model) 0.004 0.002 <0.001 <0.001 <0.001 
Table 42: Matsuda Index multivariate regression modelling (Final model [J]): Significant 
variables for predicting Insulin Sensitivity by Matsuda Index. Fat mass index used as 
significant body composition variable (table shows p values for individual components 
of model). 
 
 Model 1 Model 2 Model 3 Model 4 Model 5 
Triglyceride 0.008 0.006 0.003 0.003 0.001 
Light Activity Mean 
(Total Minutes/day) 
0.08 0.03 0.02 0.01 0.012 
Vitamin D (total) 0.32 0.31 0.25 0.14  
Current Wt SDS 0.39 0.31 0.29   
Protein Intake (g in 
24 hours) 
0.60 0.67    
SAT index  0.74     
R2 0.54 0.57 0.56 0.54 0.50 
Adjusted R2 0.41 0.47 0.49 0.49 0.46 
p value (for model) 0.005 <0.001 <0.001 <0.001 <0.001 
Table 43: Matsuda Index multivariate regression modelling (Final model [K]): 
Significant variables for predicting Insulin Sensitivity by Matsuda Index. Current Weight 
SDS used as significant body composition variable (table shows p values for individual 
components of model). 
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For both of the ‘final’ HOMA%S multivariate models and the single, final, multivariate 
model for Matsuda Index, the models were tested for heteroskedasticity before and 
after adjustment for Tanner Stage. Inclusion of Tanner Stage did not alter any of the 
final models (the difference between models with or without Tanner Stage was 
insignificant on likelihood ratio testing) and there was no heteroskedasticity, 
suggesting that the terms included in the final models were independent.  
3.4.4 Discussion 
When considering the analysis of IS, the overall aim was perhaps to try to discern both 
whether there was any detectable correlation with preterm birth that may have 
influenced IS measured later in life, and also what other factors associated IS were at 
work, with a view to potential therapeutic intervention. As the logic model generated 
from the literature review showed (Tinnion et al., 2014), the suggestion is that the 
further on those who are born preterm are from infancy, the less the measurable 
effect of prematurity, low birthweight or rapid growth is. In the current cohort, there 
was no correlation at all between gestational age, birthweight SDS, and the original 
study enrolment (growth or protein study), and the measured IS by either method. 
In this study the different correlation analyses showed that for both methods of IS 
measurement, current body habitus is an important determinant of IS: the more 
‘adipose’ the body habitus (high fat mass, large waist circumference, high BMI SDS) the 
lower the insulin sensitivity. This was in keeping with the findings from the last study 
visit the cohort undertook (Wood et al., 2013) and the wider literature which suggests 
their influence over IS  increases with chronological age (Tinnion et al., 2014).  
It was unexpected that there was no correlation between IHL content and measured 
IS. The literature around the ‘lipid hypothesis’ of reduced IS would have suggested that 
hepatic lipid deposition would be related to measured IS. Examination of the 
correlation between IHL and IS identified a subgroup of adolescents with both above 
‘normal’ IHL (clinically significant levels are considered to be >5%) and an IS of less 
than 100%. The majority of the cohort had low (<5%) and so this analysis allowed the 
opportunity to examine whether there was anything that could predict development 
of an IHL>5%/low IS status, as well as look for differences between those with normal 
IHL and high or low IS. The analysis showed that at low IS, the differences between the 
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groups with IHL above or below 5% were related mainly to lipid deposition as found 
earlier in section 3.2 (visceral adipose tissue and serum lipids, especially triglycerides). 
There was little difference in body composition. However, when comparing the five 
individuals with high IHL to the individuals with IS>100% and low IHL, this ‘healthy’ 
subgroup were leaner and had less subcutaneous fat, in addition to reduced visceral 
adipose tissue. They also had lower levels of serum lipids. These results all fit with the 
observation that ’acquired metabolic changes’ over time have a big influence on IS. 
They also suggest that there may be opportunity for intervention during the childhood 
years that might move children towards a metabolically healthy phenotype and modify 
positively ongoing metabolic development.  
When comparing those with different IS (by HOMA%S) but IHL<5% (both whole group 
and highest/lowest quartile for IS) similar trends were found as between the five 
‘outliers’ and the ‘healthy’ subgroups, but the quartile analysis also allowed 
comparison within the Matsuda Index measurements. As HOMA%S is essentially a 
fasting state measurement and Matsuda Index is a measure of glucose disposal (in this 
study, over a two hour oral glucose tolerance test), it would be expected that there 
would be a difference in the factors influencing the measured IS. The initial graphing of 
IHL vs. IS suggested that even in those with high IHL and low IS, there was still a 
measurable degree of metabolic flexibility such that of the five individuals who had 
low IS by HOMA%S with IHL>5%, when given a glucose load, two recorded normal 
Matsuda indices suggesting an ability to cope with the glucose load. In the general 
cohort, this was also seen in a number of individuals with HOMA%S of <100% and 
IHL<5% who subsequently had normalised Matsuda Indices. This can be interpreted as 
a demonstration of functional metabolic flexibility despite reduced fasting IS. 
Importantly, when considering these results, there was no discernible effect from 
pubertal stage in any of the modelling. Examination of the highest and lowest quartiles 
showed some commonality of influence on IS between the two methods: both showed 
a trend towards significance for FMI and BMI SDS, and triglyceride was significantly 
associated with both.  
Low vitamin D was also significantly associated with reduced IS by both methods. The 
significance of triglycerides was not surprising as there are documented physiological 
mechanisms by which they can directly affect IS. Vitamin D has also been shown to be 
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lower in obese individuals, and in those born preterm, and this might explain the 
correlation seen. In other populations there is a well-documented association between 
reduced vitamin D and markers of reduced IS (Chiu et al., 2004; Forouhi et al., 2008; 
Liu et al., 2009a; Baz-Hecht and Goldfine, 2010)] Some studies with vitamin D 
replacement have claimed to improve insulin sensitivity (Belenchia et al., 2013; 
Kelishadi et al., 2014) and so there may be a direct mechanism at work between IS and 
Vitamin D levels in both the most and least insulin-sensitive individuals.  
The question of whether there is an in-vivo link between vitamin D and insulin 
secretion and action is not yet resolved. The PROspective Metabolism and ISlet cell 
Evaluation (PROMISE) study(Kayaniyil et al., 2011) reported associations in univariate 
analysis between baseline vitamin D status and progression to dysglycaemic states 
(diabetes, impaired fasting glucose or reduced glucose disposal) in an over-50 year old 
population, but not in longitudinal multivariate analysis. In an earlier paper(Kayaniyil et 
al., 2010) the same authors had presented results to suggest that in a cross-sectional 
study of individuals at risk of T2DM there was an association with vitamin D levels and 
both fasting insulin sensitivity (measured by HOMA) and glucose disposal (measured 
by Matsuda index) even after adjusting for sociodemographic factors, physical activity, 
supplement use, parathyroid hormone, and BMI. Rat studies involving induction of 
diabetic-like states by destruction of islet cells (by streptozotocin administration in 
vivo), followed by dietary supplementation of vitamin D, found upregulated 
transcription and expression of glutamatergic receptors in those animals who had 
been given the vitamin D supplement(Jayanarayanan et al., 2015). In rats, these 
receptors increased the calcium-mediated release of insulin and the authors postulate 
a role for them in the ‘antidiabetic’ actions of vitamin D seen in the experiment. 
Incubation of untreated, rat, islet cells with vitamin D for an hour resulted in increased 
glucose-stimulated insulin secretion in-vitro(Jeddi et al., 2015). In humans, the 
presence of the vitamin D receptor in pancreatic tissue and the vitamin D response 
element in the insulin gene promoter region, with evidence of transcriptional 
activation caused by vitamin D(Maestro et al., 2003) also strengthen the possibility 
that vitamin D may play an in-vivo role in insulin homeostasis. 
The presence of individuals who were: insulin sensitive by both measures with IHL<5%; 
insulin sensitive by Matsuda indices but not by HOMA%S with IHL<5%; and three who 
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had low IS by both methods and IHL>5%; suggests that there may be a metabolic 
progression from ‘normal’ to ‘functionally metabolically flexible’ to ‘metabolically 
inflexible’. The data do not give any answers as to what exact changes occur at each 
step, but they would suggest that the first changes are related to increased adiposity in 
body habitus, total fat and subcutaneous deposition of fat (which reduce resting IS), 
then an increase in serum lipids and visceral adipose tissue (which then leads to 
increased IHL). The fact that individuals could have IS above and below 100% despite 
IHL<5% would suggest that clinically high IHL is not a mandatory determinant of IS in 
these individuals and that the two may be ‘uncoupled’. However, it is also possible that 
there is a threshold effect beyond which IHL begins to accumulate and then begins to 
contribute to overall IS. No individual had IHL>5% and resting IS>100% suggesting that 
IHL follows IS, not the other way round. The lack of direct association between IHL and 
IS is also, perhaps, a reason to revisit the possibility of looking at intra- and extra-
myocellular lipid and seeing if there is a similar distribution to IHL, or whether it shows 
a relationship to IS in a more direct fashion. 
There was also the finding that some individuals retained functional flexibility, when 
faced with a glucose load, to explain. In the quartile analysis, the data suggested that 
individuals with higher levels of light exercise and lower levels of visceral adipose 
tissue had higher Matsuda Indices and therefore it may be that this type of exercise is 
protective, even if there is IHL>5%. Similarly, adopting a lifestyle which reduces the 
likelihood of developing visceral adipose tissue deposition may help improve metabolic 
flexibility.  
Quartile analysis also showed that early life growth was different between the most 
and least insulin sensitive individuals, measured by HOMA%S, with those who had 
greatest change in Wt. SDS from term equivalent age to 2 years old being least 
sensitive to insulin. This suggests that there is a degree of metabolic programming by 
early life growth involved in the difference between the most and least sensitive, but 
when introduced as a variable in multivariate modelling, it loses its significance 
compared to other contemporary variables. This univariate significance of early growth 
for IS becoming less significant through the life-course is in keeping with the published 
literature.  
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Multivariate analysis confirmed that IS was strongly related to fasting triglyceride 
levels in both HOMA%S and Matsuda calculations. The analysis produced two potential 
models for HOMA%S, one which included fat mass index and one based on serum 
measurements (triglyceride, LDL-C and Vitamin D), in addition to triglycerides. From a 
clinical perspective, the model with fat mass index is more relevant as it takes account 
of the changes in metabolic status leading to reduced IS that are suggested by the 
quartile and subgroup analysis. It is also more elegant because the process of 
generating the model with fat mass index involved inclusion of vitamin D and LDL-C 
(the other significant terms for the three-variable HOMA%S model) and fat mass index 
was more significant than either of the other terms. The multivariate model for 
Matsuda Index (consistently) suggested that the number of minutes in light activity 
was important in predicting the glucose disposal after loading, thus IS, alongside serum 
triglyceride levels: longer in light exercise was proportional to improvement in 
Matsuda Index (i.e. IS). This would provide a good potential target for intervention, 
and it is notable that it is light exercise that seems to have the beneficial effect: as such 
this might be more palatable as an intervention for health than one which required 
regular MVPA. Light exercise, which might be considered conditioning for skeletal 
muscle function, over longer periods, may have a specific effect on the skeletal muscle 
IS. This would explain why it is associated with disposal of glucose after a load (not the 
fasting IS) and also why two individuals with IHL>5% and IS<100% can have normal 
Matsuda Indices. In line with some of the research into type 2 diabetes which showed 
that reduced IS in skeletal muscle in type 2 diabetes was not secondary to a 
mitochondrial function issue (Lim et al., 2011c) (but probably more to do with glucose 
uptake into the myocyte) there was no association between oxidative function and IS 
in this analysis.  
Overall, the results for analysis of IS in the study cohort suggest that while there is no 
discernible link to prematurity or birthweight, early growth may have some bearing on 
an individual’s fasting insulin sensitivity. However, when contemporary variables are 
taken into account, its significance is greatly reduced. This is in keeping with the 
published literature. In general, the two different measures of IS show that there are 
some body composition and habitus variables which influence IS across both 
measurement techniques, but there is a difference in the flexibility with which a 
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glucose load can be tolerated. As such, the influences on this ability are different to 
those governing the baseline IS in any individual. Aside from interventions designed to 
improve baseline IS by reducing circulating lipids, reducing deposition of adipose tissue 
and (possibly) optimising vitamin D levels, the results also suggest that targeting at-risk 
individuals with light activity interventions might help preserve metabolic flexibility 
even when baseline IS is reduced. 
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3.5 Future Studies: cohort opinion on lifestyle intervention 
At the end of each study visit, the volunteers were given a questionnaire with ten 
options for interventions that could be used in a future intervention study. The 
intervention would be designed to be minimally intrusive to family life but be well 
adhered to, in order to try to improve lifestyle in children born preterm. In an 
intervention study, the current study protocol (or modified version thereof) would be 
used to assess progress over time. On the questionnaire, each intervention was scored 
on a Likert-style rating scale (from 0 to 10; 10 = most desirable; see page 162) 
3.5.1 Questionnaire results 
Option for intervention Mean SD Mode Median IQR 
‘one to one’ with dietician 6.89 2.19 8 7.0 5.4 to 8 
Wii fit and weekly coach 7.06 2.28 8 8.0 6.0 to 9 
Cooking lessons for whole 
family 
7.88 1.95 9 9.0 6.4 to 9 
Free access to local 
swimming pool 
8.45 1.68 10 9.0 8.0 to 10 
Weekend lifestyle and 
activity camps (children) 
7.03 2.21 9 7.0 5.0 to 9 
School holiday lifestyle and 
activity camps 
7.24 2.32 8 8.0 6.0 to 9 
Gym membership for 1 year 7.83 2.30 10 9.0 7.0 to 10 
Space on an allotment and 
teaching how to grow your 
own vegetables 
5.68 2.82 5 6.0 3.0 to 8 
Organised walks to/from 
school 
5.81 2.43 5 5.0 4.0 to 8 
Regular coaching in team 
sports of child’s choice 
7.99 1.91 9 8.0 7.0 to 9 
Table 44: Results of Lifestyle Intervention Questionnaire. Kruskall-Wallis test for 
difference between groups: Chi-squared: 74.2; p<0.001 
 
The results from the questionnaire (table 44 and figure 37) showed that there was a 
wide spread of preferences for which intervention would be most acceptable. There 
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was significant difference across the groups with the option for space on an allotment 
being least popular and the most popular being free access to a swimming pool. This 
would be the recommendation for a set lifestyle intervention from this study, for 
future studies, as it would fit with the observation that light activity is probably most 
beneficial in metabolic health outcomes. We have no evidence to suggest that a 
particular dietary pattern in the data collected, nor that mandating MVPA, would be 
most effective in modifying the metabolic outcomes within the cohort. However, it 
would have to be mandated for a longer session, frequently undertaken, at a gentle 
pace. This would possibly require supervision or coaching until a habit was formed, 
with a diary record kept to ensure consistency in the intervention. This approach 
would also fit observations from other studies that long term aerobic training is best in 
improving mitochondrial oxidative function as measured by τ½PCr using 31P-MRS 
(McCully et al., 1989). 
 
 
Figure 37: graphical representation of cohort preferences for lifestyle intervention. 
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Chapter 4. Study Strengths, Weaknesses and Confounding Factors 
The current study had areas of both strength and weakness, some by its design, some 
which are related to the methods, and some because of the nature of the cohort. 
4.1 Strengths 
The fact that the study cohort was drawn from the larger, original cohort, who have a 
good track record for participating in research, meant that within the study period it 
was possible to achieve the target recruitment of 60 participants. The study itself was 
only one visit. Although the children had to be fasting for the morning visit, the single 
visit minimised inconvenience and disruption in this largely school-attending cohort, 
whilst still producing data. The way the children were recruited also was shown, by the 
data produced, to have produced a cohort representative of the larger cohort and one 
mostly unaffected by the original recruitment (into growth or protein studies).   
The study used many different techniques to assess a wide range of metabolic 
outcomes. In practice this was challenging to arrange and program into one visit 
(requiring liaison with and training from with experts in various different fields). It 
required a lot of support in analysing the raw data from specialist techniques (e.g. 
MRS, nutritional recall and accelerometer) but this was achieved within a framework 
that would allow the study to be repeated in future studies. All of the methods used 
had been used in this age group before with the exception (locally) of the magnetic 
resonance protocol, which was unique in the centre’s experience to date, while being 
familiar to them in its components in other age groups.  
It is also a strength of the cohort that data from previous visits exists (in a longitudinal 
fashion). This allowed previous data, notably early growth patterns and changes in 
body composition (weight SDS score change) from the last visit to be used in analysis 
of the data from the study visits. The study design also meant that that other areas of 
both current (notably epigenetics) and potential future (metabolomic) research will 
have samples from this cohort visit to analyse in future and relate back to the cohort 
data. Although this research is not a feature in the analysis of this study, it adds to the 
strength of the overall data existing about this cohort.  
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It is hoped that this research will continue to be added to by analysis of samples stored 
from the cohort and ongoing analysis of existing data. Over time this will add to the 
knowledge of metabolic outcomes in ex-preterm infants. It is also improving 
knowledge of the normative reference data for this cohort of ex-preterm infants, 
which has not been collected before in a similar group of children. 
4.2 Weaknesses and confounding factors 
One of the most obvious weaknesses in the study design is that there are no control 
subjects. It would have been ideal to have had closely-matched, term-born adolescents 
undergoing the same procedures to provide comparative data. However, there were 
constraints of matching and budget to account for: to properly match to the cohort, 
we would have had to recruit 2:1 in favour of term-born adolescents, meaning that 
with the budget for 60 MRIs initially, we would have only gathered data on 20 of the 
unique individuals who make up the current cohort. To optimise resources, therefore, 
it was decided that it would be best to omit controls. It is also true that there is an 
inherent bias within the cohort regarding their original recruitment towards those 
recruited at more mature birth gestations being of relatively smaller birthweights. This 
was taken into account by using these data as part of the analysis. The cohort, 
however, are very representative of an important subset of preterm-born children: 
those who neonatologists would regard as ‘intact survivors’, in whom a normal 
childhood and subsequently fully participant adult life within society would be 
expected. Thus, any findings in their cohort which might be linked to early onset adult 
illness that could limit their quality of life, adversely influence the societal value of 
their ability to engage in work as an adult, and increase their need for long-term 
support from the nationalised health service are important. This is especially so, if 
these links could be modified in a positive way. While a lack of external controls 
prevents comparative statements about the cohort with respect to those born at term, 
knowing that the cohort are representative of a particularly important group of those 
born preterm means that the results are still generalizable to others who are born 
preterm and have similar neonatal outcomes.  
The children in the cohort spanned the full range of pubertal stages as categorised by 
Tanner Stage self-assessment. It has been shown in the literature that children who 
are obese are more likely to enter puberty early (Kleber et al., 2010) and once in 
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puberty, insulin sensitivity tends to decrease (Kurtoglu et al., 2010; Sinaiko and Caprio, 
2012). However, there is also some data to suggest that puberty may be delayed in 
girls born preterm but not in boys (Hui et al., 2012). Self-assessment of Tanner Stage 
was used for several pragmatic reasons. Firstly the cohort were familiar with this 
method from the study visit previous to this one, and it is thought to be a reliable 
method of assessing pubertal stage (Tanner et al., 1966a; Tanner et al., 1966b). It 
avoided the embarrassment (in a group of volunteers who were giving up their time to 
help us) that a physician-based assessment would involve. There was also no female 
staff member who could have performed these assessments in the research team. 
Secondly, this method imposed no restriction on when the subjects could visit. In order 
to assess the hormonal status of participants otherwise, it would involve serum testing 
which immediately restricts the number of people who could be assessed. It would 
also require specific constraints around timing within an individual female participant’s 
menstrual cycle (if they were of sufficient maturity) so that across the cohort, there 
was comparability of results in what are otherwise normally fluctuating hormonal 
levels. This study did not find any association or effect in multivariate modelling 
between Tanner-Stage and IS (measured by either of the study methods). It has to be 
considered as a possibility that this reflects type 2 error (if one considers the null 
hypothesis that ‘pubertal stage has no effect on IS’, based on the literature published). 
The source of such an error could be sample size: we had 45 individuals in whom we 
were able to calculate % sensitivity by the HOMA method and 44 for whom we could 
calculate the Matsuda Index. This may not have been enough to avoid error, as the 
sample size was calculated based on previous results. It could also be that the methods 
used to assess IS are not ones that are consistently accurate enough for use in the age 
group chosen. While the participants were also given instructions to fasted, and none 
reported deviating from this request, it is not possible to be absolutely sure of 
compliance.  However, there are multiple examples of HOMA being used in children in 
the literature, as summarised in my review (Tinnion et al., 2014), such that it can be 
reasonably expected that compared to similar groups it is an acceptable test to have 
used.  
With regard to overall sample size, a cohort of sixty is a relatively small number of 
subjects. In each of the different aspects of the study there were some who did not 
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take part (with the exception of auxological measurements, n=60). There was also 
some loss of data through the technical challenges of both acquiring the data and the 
quality control measures taken during processing. An example of this was the 31P-MRS 
processing whereby only 38 of the cohort had data that showed no problem with the 
collection in the post-collection analysis. These factors may also have led to type 2 
error being introduced into the dataset. Within the data, the cut-offs and inclusion 
criteria were kept strict (for example hours of activity recorded per day) and although 
this restricted eventual dataset sizes, it does mean that the data used was robust and 
reliable in quality. The presence of type 2 error may be represented in the results by 
the presence of numerous ‘trends’ in the data that do not reach significance. It would 
require a more extensive study with higher numbers of participants to assess this 
further. 
4.3 Technique-specific confounding  
4.3.1 Mitochondrial Oxidative Capacity 
As discussed previously, there was evidence in the cohort data of inorganic phosphate 
splitting secondary to placement of the sampling voxel across two or more functionally 
different muscle groups, with different rates of recovery after exercise. In the analysis 
this was accounted for at the expense of sample size. Likewise, analysis of the τ½PCr 
data showed that not all of the participants were able to fully deplete their PCr stores 
and their data was also not useable. While neither of these, from the study power 
calculation, should have adversely affected the results, they do raise the issue that in a 
similar age cohort in future, the technique might need modification to improve 
reliability especially if the MRS was used as a repeated measure over time.  
The τ½PCr results were also subject to post-collection correction by the Iotti method to 
validate within group analysis based on the mean minimum pH reached within the 
group during exercise. This method is based on the observation that adult τ½PCr can 
be influenced by pH (thought potentially to be a mechanism for stimulating 
mitochondrial ATP levels (Taylor et al., 1997)) whereas in children there is generally 
higher oxidative capacity(Ratel et al., 2002a; Ratel et al., 2002b). Adolescents lie 
between these two groups and given the data, to allow within cohort comparison, it 
was felt appropriate to apply the correction. This makes direct comparison with other 
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studies difficult in terms of absolute half-times generated, but trends within the data 
should be comparable. 
4.3.2 Vitamin D measurement 
Vitamin D has been discussed earlier in this thesis and the mechanisms by which it acts 
are, in the wider picture, not fully understood. Therefore, it is a notable weakness of 
this study that serum calcium and phosphate were not measured in those who had 
vitamin D measured. We have no good evidence to comment either way about the 
calcium or phosphate status of the cohort, but calcium and phosphate have potential 
to interact with muscles and cell receptors alongside vitamin D and are related to 
vitamin D by bone metabolism. With hindsight it would have been interesting 
information to have in identifying whether vitamin D alone was key, as we found it in 
the study, or whether calcium and phosphate were also having an effect. In terms of 
missing data potentially confounding the results, this omission may well be the most 
significant. It should be noted, however that vitamin D has been shown in isolation to 
have an effect on muscle oxidative function: Sinha and colleagues did not find any 
difference in Ca/PO4 levels between their vitamin D replete and deficient subgroups, 
yet found an effect on muscle (Sinha et al., 2013). 
4.3.3 Measurement of lipid compartmentalisation 
As noted in the results, measurement of IHL produced three distinct subgroups when 
compared to IS. The majority of the cohort had very low levels of intrahepatic lipid and 
there were only five in the subgroup with IHL>5%. It is likely that this reflects the 
population from which this cohort were drawn, but it increases the possibility that the 
when the IHL content is <5%, small differences between individuals might have 
relatively large effects which are not possible to detect with the MRS measures. It is 
also true (as with IS) that the assumption of a fasting state at scan was made. If the 
participants had not been fasting then there is the possibility of confounding within 
the data due to temporary lipid deposition in the liver as part of the normal metabolic 
processes following a meal. 
Similarly, the method of determining visceral/subcutaneous adipose tissue involved 
assessment of fat content of the tissues using 50% MRI signal intensity as the centre-
point on an MRI-generated image, around which a dichotomous result (fat tissue vs 
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non-fat) was generated using software programmes. While this was effective in 
generating data, it is not necessarily a true reflection of the nature of metabolically 
active tissue: in any given voxel where the fat content was <50% (and labelled ‘no fat’) 
there may well have been metabolically active fat that was essentially undetected. 
While this does not seem to have influenced the results, it is possible that in future 
studies a refinement of the technique using more grey-scale intervals, might give more 
accurate results in this assessment.  
4.3.4 Activity Measurement and Dietary Intake 
The study used accelerometers to directly measure activity and the SCRAN24 
computer software to assess dietary recall. The benefits of using these methods was 
outlined in the methods chapter of this thesis but both are subject to bias through 
participant use. Specifically, interpretation of the accelerometer data is helped by 
completion of a written activity diary which is subject to recall bias if not filled in 
contemporarily, and the accelerometers we used could not be worn in activity where 
they would get wet. Thus, where activities such as swimming were done, we had no 
way of assessing directly the nature or exact duration of the activity. Similarly the 
SCRAN24 software is a form of 24 hour recall diary and so is also subject to recall bias. 
The SCRAN24 diary data did not show any significant associations with any of the other 
variables which may reflect the possibility that the nature of influence that diet has on 
metabolism is a more long-term than a single 24-hour recall can elicit. In future 
studies, therefore, it may be necessary to use repeated measures of dietary intake 
over a longer time to accurately reflect dietary habits.  
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Chapter 5. Discussion 
At the start of this study, four null hypotheses were proposed regarding the metabolic 
status of this cohort of adolescents who were born preterm. The results for the 
investigation of each of the three main outcomes (IS, mitochondrial oxidative function 
and activity, and intrahepatic lipid levels) have been discussed at the end of each 
section in chapter 3.  
The study investigations showed that the null hypotheses were not entirely correct, 
but did identify some areas where unexpected results were found. The main 
associations found are outlined in table 45. In regard to mitochondrial oxidative 
function, no association was found with directly measured physical activity or adiposity 
but there was an association with vitamin D and fasting insulin sensitivity seen. A 
consistent and persistent association of τ½PCr in skeletal muscle after standardised 
exercise with gestational age at birth was also demonstrated such that the more 
preterm an individual at delivery, the lower their oxidative capacity was as measured 
using 31P-MRS in adolescence. The study demonstrated that the strongest predictors 
for raised IHL were raised serum triglyceride levels and visceral adipose tissue, but did 
not find any evidence to link IHL directly to insulin sensitivity in this cohort. When IS 
was investigated, it was shown that there were common factors which were strongly 
associated with both measures of IS (relating to adiposity and serum triglyceride 
levels) but unexpectedly there was also a strong association with serum vitamin D 
levels and both measures of IS. For IS measured by HOMA modelling, there was a 
linear association with change in weight SDS score between term equivalent age and 2 
years old which was not seen in analysis with IS measured by Matsuda Index. 
Reciprocally, there was an association with light activity levels and IS measured by 
Matsuda Index which was not seen when looking at IS by HOMA modelling. The 
correlation analysis between auxological and body composition measures showed 
good agreement between themselves and also with the directly measured 
visceral/subcutaneous lipid measurements. They did not, however, correlate well with 
the intrahepatic lipid levels measured by 1H-MRS. Bland Altman analysis showed that 
the two skinfold-measurement techniques used to generate body composition 
measures were not closely enough correlated with the BODPOD™ measurements to 
allow them to be used as an alternative method in clinical practice.  
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Outcome 
(dependant 
variable) 
Positive 
Associations 
Negative Associations Comments 
Intrahepatic Lipid 
Content (% 
measured by 1H-
MRS) 
Visceral Adipose 
Tissue 
Deposition 
Tanner stage 
influences 
multivariate 
modelling (increased 
TS is associated with 
reduced IHL) but in 
isolation it is not 
directly associated 
with IHL levels.  
Where increased 
IHL was present, 
there were 
increased markers 
of adiposity (BMI, 
FMI, Wt. SDS, 
Waist Circ.) but 
these were not 
predictive of IHL 
deposition 
Fasting IS 
(measured by 
HOMA % 
Sensitivity) 
Vitamin D levels 
 
Triglyceride levels 
Infant Growth (ΔWt 
SDS from term 
equivalent to 2 yrs) 
Subcutaneous lipid  
BMI SDS, FMI, waist 
Circumference, 
current weight SDS 
 
Glucose Disposal as 
measure of IS 
(measured by 
Matsuda Index) 
Vitamin D levels 
Light Activity 
Triglyceride levels 
Subcutaneous lipid 
BMI SDS, FMI, waist 
Circumference, 
current weight SDS 
Protein Intake 
trends towards a 
positive 
association. 
A trend towards 
association of 
increased visceral 
adipose tissue with  
worsening IS was 
also seen 
Mitochondrial 
Oxidative Function 
(measured by 
τ½PCr with 31P-
MRS) 
Fasting IS 
Serum Vitamin D 
Gestational Age at 
Birth 
 
Table 45: Summary of associations: main outcome variables with other measured 
variables. 
While these results are interesting as discrete, independent groups, the study has 
clearly shown that there are metabolic links between the main outcomes measured. 
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These are common factors which have an association with two, or more, of the 
outcomes studied, and may also be predictive when part of multivariate models.  
The overall purpose of studying the cohort since birth has been to try to find out what 
the metabolic life course of these children is: where neonatal and early life care rightly 
focuses on optimising brain development via growth and nutrition strategies, the focus 
shifts as they get older. In adolescence and early adulthood, especially in ‘intact’ NICU 
survivors, there is a population-based argument for identifying those at risk of 
developing adult health issues earlier than their term peers, as soon as possible. In 
parallel, trying to identify those factors which, if modifiable, might have a beneficial 
effect on these metabolic health outcomes would therefore potentially allow targeted 
intervention in this population.  
5.1 Common Metabolic Factors 
Figure 38 shows a model for the connections between the main metabolic variables 
measured in the cohort, as determined by analysis in this study. The only direct link 
found between two of the main outcome variables was that between fasting IS and 
mitochondrial oxidative function but, as discussed earlier, it is not possible to say 
whether this is a real effect (representing a mechanism by which substrate entry into 
the myocyte is restricted) or whether it is secondary to an association between 
oxidative function and vitamin D. Research on adults with type 2 diabetes, as well as 
no association with the Matsuda Index measurement, has shown that it is very unlikely 
that the effect is a primary mitochondrial defect across the cohort (Lim et al., 2011c; 
Lim et al., 2011b). On the other hand, the evidence across the literature for an 
influencing role of vitamin D on mitochondrial oxidative function is increasing. Our 
cohort demonstrated the same association between lower vitamin D levels and longer 
half times for PCR recovery, thus reduced mitochondrial oxidative capacity, as seen in 
other cohorts (Sinha et al., 2013).  
The other variable with a consistently significant association to measured outcomes 
was serum triglyceride levels (and to a lesser extent serum LDL-C and total cholesterol 
levels). Increasing triglyceride levels were strongly associated with reduced IS by both 
measures and also strongly associated with increased measured intrahepatic lipid 
content and subcutaneous adipose tissue deposition. As discussed earlier, the  
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Figure 38: Summary model showing the metabolic interactions found in this study. 
Purple: study outcomes; Blue: unmodifiable influences; Green: modifiable influences 
which might have a positive effect on metabolic status; Red: potentially modifiable 
metabolic influences associated with worse outcomes in the study. Arrows show 
general direction of effect as demonstrated in the study. Size of arrow is 
representative of approximate effect size seen in study. 
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decrease in insulin sensitivity with increased triglyceride levels is as would be 
expected, and it is intuitive that they might be associated with increased IHL. However, 
while triglyceride levels are an independent predictor for raised IHL, the data cannot 
definitively answer the question as to whether raised triglyceride levels are the cause 
or an effect of raised IHL. However, a fasting lipid profile favouring higher triglycerides 
is clearly a risk for metabolic problems, and even if it is a marker rather than cause, it 
provides an opportunity for monitoring and potentially intervention. It is interesting 
that the auxological and body composition data show a correlation with visceral and 
subcutaneous lipid deposition but not IHL. The data analysis defined a subgroup of 
adolescents who had both high IHL and low IS. These data suggest that the 
development of raised IHL may post-date reduction in IS and that there may be a 
metabolic threshold beyond which clinically significant IHL begins to accumulate. 
However, while the mechanism for this may not be clear, it has been shown in other 
populations that calorie restriction and resistance exercise can reduce IHL and 
pancreatic lipid (Kleber et al., 2010; Hallsworth et al., 2011; Lim et al., 2011a) and 
improve IS.  
From the data collected it is also clear that other measures of adiposity (FMI, BMI, 
Weight SDS) increasing are negatively associated with IS and vitamin D levels. The 
multivariate modelling would suggest that these changes in body composition and 
auxology are markers rather than independent predictors for IS. At the same time 
there was a clear positive association between Vitamin D levels and IS measured by 
both methods used in the study. If future research elucidates a direct cellular 
mechanism of action for vitamin D on insulin secretion in humans it may offer an 
explanation for the observed association in this study of reduced adiposity associated 
with improved IS.  
The evidence from the cohort does not necessarily support universal supplementation 
with vitamin D as this is only an observational study, not one looking at change after 
intervention. However, it would be reasonable to suggest that given its wide-ranging 
associations in this study, and the association with a negative trend through the winter 
months, optimisation of vitamin D levels where there was clinical deficiency would be 
advisable to help optimise metabolic status. 
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The final common factor of note is activity. In the study, we were able to measure this 
directly using accelerometry. The results showed that there was a trend towards 
association between sedentary activity and both auxological measures and vitamin D 
levels (with more sedentary time being associated with worse indices in both). 
Correspondingly, there was a positive association between light activity and both IS 
(Matsuda Index) and vitamin D levels. There was no association between any of the 
exercise variables and time of year to explain this association. It is possible that the 
association between light activity and vitamin D was mediated through increased 
activity time outside leading to increased endogenous vitamin D production (though 
we did not measure this) or it might have been related to subtle changes in body 
composition improved by activity which then influence circulating vitamin D levels. 
Similarly, the association between light activity and improved glucose disposal might 
be direct effects (for example aerobic conditioning improving overall metabolic 
flexibility) or via its association with vitamin D levels, improving IS by mechanisms 
discussed earlier. In either case it is only the light form of activity that has as positive 
effect. This has also been seen in animal models (Amaral et al., 2015), older humans 
(Loprinzi et al., 2014) and individuals at high risk of metabolic syndrome (Herzig et al., 
2014). In a group of adolescents it might be more possible to achieve changes in 
activity from sedentary to light activity more easily, and habitually, than it would 
introducing a programme of activity aimed at increasing MVPA. This then has potential 
for best gains in health at least perceived disruption of lifestyle.  
5.2 Non-modifiable factors 
The model shown in figure 38 suggests that there are two important non-modifiable 
factors with respect to the cohort. The first is gestational age at birth. This is 
unmodifiable by virtue of the fact that the causes for preterm delivery are legion and 
while obstetricians try to avoid it if possible, there will always be a clinical tension 
between safely delivering a baby early, to a live mother, and risking either maternal or 
infant death, or both by trying to prolong gestation. The second, and very applicable to 
this cohort, is puberty. During the transition to adulthood, humans will go through 
puberty and we have made attempts to adjust our data set to account for this. Our 
results showed that it appears to have an effect when considering IHL content such 
that as the cohort progressed through puberty, the IHL content decreased. As there 
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are other modifiable factors that also affect this IHL, there is still opportunity to 
intervene to modify outcome where it is thought an adolescent may be at risk, and the 
general trend is that progressing to a later pubertal status is beneficial. 
With respect to the current cohort, infant growth (as represented by Δ weight SDS 
from term equivalent to 2 years old) is effectively unmodifiable and, as discussed, the 
nutritional strategies relevant to infants before and in this period are those to protect 
and promote neurodevelopment. As we have shown, the magnitude of persistence of 
an effect into adolescence is reduced by other modifiable variables through childhood 
and adolescence. However, its detectable presence at all suggests that those tailoring 
neonatal nutrition, for similar cohorts in the future, should perhaps do so with one eye 
on later metabolic health. Where excessive growth can be limited in this period, 
without compromising neurodevelopment, this has potential for the best adult health 
outcomes. 
5.2.1 Consideration of the study results within the Developmental Origins 
Hypothesis.  
As discussed previously, the Developmental Origins of Health and Disease Theory 
(DOHaD) suggests that by interruption of normal development, or exposure of those 
normal processes to environment during critical windows, things can be changed 
(perhaps by mechanisms such as epigenetic modification of the genome) which have 
profound effects in later life. Those born preterm are at a higher risk of metabolic 
compromise in their life course (Parkinson et al., 2013) and this study raises two 
possible situations where this process may reflect the DOHaD theory. Firstly, the 
strong and persistent finding that gestational age is related to mitochondrial oxidative 
function (perhaps by a developmental arrest or restriction in skeletal muscle 
differentiation, as discussed earlier). Secondly, the association of early growth, though 
weakened by later influences, could be an example of metabolic programming. The 
other factors associated with outcome in the cohort would not, at face value, appear 
to be directly related to early life events. However, programming is such that it could 
be exerting effects via situation-specific intermediaries such as vitamin D. This is only 
speculation as there were no control subjects in the study.  
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5.3 Potential Interventions to improve metabolic health in the cohort.  
As outlined in this chapter, the results show associations which could be viewed as 
potential targets for intervention to improve metabolic health. 
These would be:  
1. Optimisation of vitamin D status. This would potentially help with both IS and 
mitochondrial oxidative function, though within the study results, it would not 
be possible to recommend universal supplementation beyond correction of 
clinical deficiency, if detected. It should be noted that where clinical vitamin D 
deficiency was found in individuals in the study, a letter was sent to them and 
their GP recommending supplementation be provided, if the participant 
wanted it. This was done based purely on serum level and with no knowledge 
of the participant’s corresponding IS or oxidative function results.  
2. Encouragement of light activity with associated calorie restriction. While the 
study data showed that there might be benefits from engaging in regular, 
prolonged, increased light activity periods (for both IS and vitamin D levels) we 
had no direct evidence of any association with calorie intake 9measured over a 
24 hour period), either benefit or harm, and any of the measured outcomes. It 
could be argued that calorie restriction cannot therefore be recommended, but 
there are limits on the dietary data collected (see chapter 4) and good evidence 
to suggest that reducing calorie intake can reduce IHL (Lim et al., 2011a). It is 
also the case that triglyceride levels will be related to longer term dietary 
habits, and with other substance such as fructose being linked to adverse 
metabolic outcomes (Bremer et al., 2012; Lustig, 2013), inclusion of dietary 
change alongside activity recommendations is unavoidable. Conversely, 
sedentary period should be discouraged. Section 3.5 outlines the type of 
interventions the cohort might engage with, and swimming (which could be 
tailored fit the light activity mould) was most favoured. 
5.4 Future Research 
Based on the findings of the current study cohort and the longitudinal data that exists 
in the cohort, there are two directions that should be considered for future research. 
Firstly, if possible, the cohort should be followed up in early-to-mid adulthood in order 
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to try to assess what actual adult health outcomes have occurred and then related 
these back to the longitudinal data that exists. Secondly, consideration should be given 
to repeating the research as done in the current cohort, with a bigger (possibly) 
multicentre cohort with the current generation of neonates. 
In the time since the original research started with recruitment and enrolment of the 
NPTBGS cohort, neonatology has progressed in keeping extremely preterm babies alive 
and is continually trying to improve their neurological outcomes (Wood et al., 2000; 
Costeloe et al., 2012; Moore et al., 2012). Alongside these increased survival rates, 
more information regarding the fact that moderate-to-late preterm infants are not the 
same as their term born peers is emerging (Ananth et al., 2013; Scheuchenegger et al., 
2014; Walsh et al., 2014; Kelly et al., 2015). In both groups, an understanding of how 
intervention and life-course affects metabolic outcome will be essential in ensuring 
todays preterm infants become tomorrow’s healthy adults. 
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Chapter 6. Appendix A: study documents 
6.1 Children’s Study Information Sheet 
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6.2 Participant’s consent form 
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6.3 Parent Information Sheet 
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6.4 Parent Consent Form 
 
6.5 Young Adult Consent Form 
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6.6 Lifestyle (Future interventions) Questionnaire: 
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